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ABSTRACT 
 
Myocardial infarction (MI) negatively impacts many aspects of a patient’s quality of life, one of 
which is sexual function. Though sexual function is a crucial component of quality of life for 
many individuals, it is critically understudied in the post-MI population. The lack of evidence 
has left health care providers and patients unsure on how sexual function components change 
when facing an acute or chronic illness, and what options are available to assist with maintaining 
optimal sexual function. Identification of modifiable predictors of both increased and decreased 
function is paramount before effective interventions can be developed. Therefore, the purpose of 
this dissertation was to illuminate the changes in sexual function over time and apply exploratory 
modeling to examine potential predictors of function in patients post-MI. The specific aims of 
this dissertation were three-fold including: 
1. Describe sexual function and satisfaction in a population of adults within two weeks and 
at three months post-MI, and examine changes from two weeks post-MI to three months 
post-MI. 
2. Determine the impact of depression, fear, anxiety, and use of coping strategies on 
predicting sexual function, satisfaction, and activity at three months post-MI. 
3. Describe the relationships between the biopsychosocial domains of sexual function and 
satisfaction at two weeks post-MI.  
  xvii 
A total of 99 patients in a Midwestern hospital were approached out of 395 screened. Of these, 
63 provided informed consent (consent/decline rate 63.6%). Participants were mailed surveys at 
two weeks and three months following discharge from the hospital for an MI. Sexual function 
data was captured with a multidimensional instrument, the Female/Male Sexual Function Index. 
Additionally, anxiety, depression, coping strategies, and sexual fear data were gathered using 
validated survey instruments. Cross-sectional and longitudinal description were performed, and 
linear and logistic regressions were utilized to examine associations with function and activity at 
three months. Eighteen participants returned all survey data (response rate 33%). There were 
three major findings from this dissertation. The first finding was that physical components of 
function (i.e. erection, orgasm), were poorly correlated with psychosocial components (i.e. 
sexual satisfaction) at both two weeks and three months post discharge for MI. The second 
finding was that sexual function scores improved among male participants within the first few 
months of discharge (18.8%), particularly among those who were sexually active at three 
months. The third finding was that sexual function was negatively associated with sexual fear, 
and positively associated with utilization of problem-solving and support-seeking coping 
strategies at three months. Furthermore, problem-solving and support-seeking strategies revealed 
a statistically significant association with function at three months, though clinically 
insignificant. Problem-solving and support-seeking strategies were also identified as positive 
predictors of sexual function in the models. Altogether, these results, while modest, help to 
contribute to our understanding of sexual function post-MI, particularly in a short-term capacity 
post discharge. The studies herein provide some intriguing avenues for predictive research to 
elucidate the relationship between utilization of coping strategies with sexual function. This 
study also provided information on functional components at a short time post-MI, which 
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providers and patients can utilize to understand what to expect after discharge. However, 
additional research is also needed with a more generalizable population to further explore the 
potential relationships observed in this dissertation. Additional descriptive work should also 
include more females and a broader distribution of racial minorities.
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CHAPTER I 
Introduction 
 
Background 
Coronary artery disease (CAD) remains the most common chronic condition in the 
United States, affecting approximately 18.2 million adults over the age of 20 (Virani et al., 
2020). Embedded within chronic CAD are acute events such as myocardial infarction (MI). 
Among adults age ≥35, 470,000 men and 335,000 women were hospitalized for either a new or 
recurrent MI between 2005 and 2014 (Virani et al., 2020). A review of recent incidence data 
reveals an average age for a first-time MI of 65.6 years for males and 72 years for females, with 
individuals >45 years of age comprising 97% of newly diagnosed events (Benjamin et al., 2019; 
Virani et al., 2020). While incidence rates of MI are substantial, evidence points to a decline in 
both short-term and long-term mortality rates over the past 30 years due to improved treatment 
and preventive strategies following hospital admission. Current in-hospital mortality rates of MI 
patients have decreased to 5% over the past decade, and 5-year survival rates post discharge 
range from 80% to 90% (Ko et al., 2020; Coles et al., 2012). The combination of both increased 
MI incidence rates with improved survival percentages have created a substantial post-MI 
population of 8.4 million adults over the past two decades (Virani et al., 2020).  
MI is associated with profound adverse health outcomes due to the resultant 
pathophysiology of the disease combined with its relative frequency. Although survival rates
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have improved, MI still precipitates destructive effects on the heart and vasculature. An MI is 
defined as an adverse outcome of obstructive atherosclerotic disease in the coronary arteries 
(Mehta et al., 2016). MI is primarily caused by either a disruption of a vulnerable plaque or by 
erosion of the coronary artery wall (Reed, Rossi, & Cannon, 2017). There are three events that 
can cause coronary occlusions: plaque rupture, plaque erosion, and development of calcific 
nodules (Mehta et al., 2016). Rupture is the most common cause, which manifests from lesions 
that damage the cardiovascular wall (Frangogiannis, 2015). These lesions can be slow 
progressing, involving microscopic lesions and small fatty areas, or complicated injuries 
involving rapid wall deterioration. Most ischemic MIs are caused by lesions that have an 
eccentric shape with irregular borders, a large, lipid-rich core, a thin fibrous cap, are high in 
macrophages (which increase inflammation), and are low in smooth muscle cells and collagen 
(Frangogiannis, 2015). Additional factors that affect plaque rupture include mechanical injury to 
the heart, or inflammation and infection of the cardiac tissue (Cheng, 2001). Stenosis of the 
coronary arteries can also precipitate turbulent blood flow, which is believed to initiate platelet 
aggregation and increase the risk of downstream occlusion. There are also two classifications of 
MI known as type 1 and type 2. While type 1 (ischemic) MIs are related to rupture and occlusion 
of the coronary wall, type 2 (demand) MIs are caused from an imbalance between blood supply 
and demand to the myocardial tissue. As a result, type 2 MIs can lead to myocardial ischemia 
without an associated coronary vessel occlusion (Guimarães et al., 2018). 
There are two severity levels of MI based on the subsequent electric activity in the heart 
following the event. These include ST segment elevated (STEMI) and non-ST elevated 
(NSTEMI). A STEMI is typically more serious and relates to a worse prognosis both inpatient 
and upon discharge (Cipriani et al., 2018). In contrast, an NSTEMI does not change the heart’s 
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electrocardiogram readout, and is associated with better outcomes (Cipriani et al., 2018). 
Severity of MI is also assessed using high sensitivity troponin T or troponin I levels. Troponin is 
an enzyme released when cardiac muscle is damaged, and so a higher value indicates a greater 
injury. Left ventricular ejection fraction (LVEF) is also utilized to assess the amount of blood 
leaving the heart with each ventricular contraction and indicates basic heart function (Thygesen 
et al., 2012).  
The typical trajectory of patients post-MI first involves stabilization in the inpatient 
setting, which can range from two to 14 days depending on the severity of the MI and the 
number of complications post-event. Patients are then either discharged to a subacute 
rehabilitation facility, nursing home, or with a referral to outpatient rehabilitation, which can last 
from two to four weeks for inpatient and two to 12 weeks for ambulatory rehabilitation 
(Piotrowicz & Wolszakiewicz, 2008). The level of care post-event and the outcomes post-
discharge largely depend on the severity of the MI along with the patient’s unique presentation, 
comorbidities, and social capacity. Adverse events related to MI include sudden cardiac death, 
which can occur rapidly and lead to cardiogenic shock in the short-term and heart failure in the 
long-term. Complications also include bleeding from the antithrombotic and antiplatelet agents 
used to address the occlusion, mechanical complications including mitral valve regurgitation and 
septal rupture, and heart rhythm complications (Mehta et al., 2016). In addition to physical 
complications, MI profoundly effects a patient’s health-related quality of life (HRQOL). MI can 
decrease overall quality of life through its impact on vasculature and cardiac work effort. There 
is a growing body of evidence that HRQOL domains such as physical function and activity 
tolerance are reduced after MI and that psychosocial complications post-MI can include marked 
depression and anxiety (Daniel et al., 2018; Roest, Martens, Denollet, & de Jonge, 2010).  
  4
While the pathophysiology of MI is well known, its effects on some components of 
HRQOL are less understood. One understudied HRQOL domain in this population is sexual 
health. Sexual health is defined as “a multifaceted concept that encompasses social constructs 
and individual behaviors, promoting the best possible sexual functioning in physical, 
psychological and social environments” (Corona, Jannini, & Maggi, p. 236). Sexuality is an 
integral part of sexual health and is made up of biological (sexual activity, sexual function) and 
psychosocial components (desire, sexual/relationship satisfaction) (Tierney, 2008). Sexual 
activity is defined as “a voluntary activity with or without a partner that includes sexual contact, 
which may or may not include intercourse or orgasm” (Lindau et al., 2012, p. 1440). Sexual 
function is defined as “sexual activity with transition through the phases from arousal to 
relaxation with no problems, and with a feeling of pleasure, fulfilment and satisfaction” (Corona, 
Jannini, & Maggi, 2006). Classical conceptualization of sexual function includes four main 
phases: excitement, plateau, orgasm, and resolution (Masters & Johnson, 1966). These phases 
were traditionally presented in a successive or linear progression from excitement to resolution. 
However, recent revisions were made to address criticisms with the model’s lack of applicability 
to female sexual function. Following these updates, function was conceptualized as a more 
circular model in females (Basson, 2001). In addition to sexual function, sexual satisfaction 
pertains to an individual’s appraisal of the contentedness of their physical and emotional 
satisfaction within their relationship or overall sex life (Ashdown, Hackathorn, & Clark, 2011).  
Many conditions outside of MI can negatively impact sexual health, and as a result 
research has expanded into chronic illness-associated sexual dysfunction (Basson, Rees, Wang, 
Montejo, & Incrocci, 2010). Sexual dysfunction is defined as a “heterogeneous group of 
disorders that are typically characterized by a clinically significant disturbance in a person’s 
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ability to respond sexually or to experience sexual pleasure” (American Psychiatric Association, 
2013). In men, coronary artery disease can impair the endothelium of the penile artery through 
inflammation, which increases the threshold for vasodilation and subsequent erection 
(Vlachopoulos, Jackson, Stefanadis, & Montorsi, 2013). In females, vasocongestion and vaginal 
lubrication are both products of vascular dilation and thus are also hindered by decreased blood 
supply (Nappi, Albani, Chiovato, & Polatti, 2009).  
Sexual health requires a positive and respectful approach to sexuality and sexual 
relationships, as well as the possibility of having pleasurable and safe sexual experiences (World 
Health Organization, 2006). However, MI threatens the quality of an optimal sexual experience. 
In particular, sexual dysfunction in patients post-MI is thought to be caused by an impairment of 
blood flow to sex organs. Decreased blood flow to the heart and periphery increases cardiac 
effort, fatigue, and chest pain during sexual activity and can be a subsequent source of anxiety 
and fear, decreasing overall desire for sexual activity (Kriston, Gunzler, Agyemang, Bengel, 
Berner, & SPARK Study Group, 2010). Symptoms in males include erectile dysfunction, 
orgasmic dysfunction, decreased sexual desire, and decreased satisfaction with intercourse 
(Puchalski, Szymanski, Kowalik, & Filipiak, 2013). Sexual dysfunction in females post-MI is 
characterized by decreased vaginal lubrication, decreased libido, orgasmic problems, relationship 
deterioration, and doubt and fear related to sexual activity (Søderberg, Johansen, Herning, & 
Berg, 2013; Zeydi, Sharafkhani, Armat, Gould, Soleimani, & Hosseini, 2016; Oskay, Can, & 
Camci, 2015). Additionally, depression, fatigue, anxiety, and sleep disturbances have been well 
documented in patients post-MI which can further contribute to male and female sexual 
dysfunction (Johansson, Karlson, Grankvist, & Brink, 2010; Søderberg, Johansen, Herning, & 
Berg, 2013; Kriston, Gunzler, Agyemang, Bengel, Berner, & SPARK Study Group, 2010). These 
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changes indicate that sexual health is a commonly affected, yet seldom addressed component of 
HRQOL (Roest, Martens, Denollet, & de Jonge, 2010; Kriston, Gunzler, Agyemang, Bengel, 
Berner, & SPARK Study Group, 2010).  
Significance 
For patients discharged post-MI, the consequences of decreased sexual health are often of 
serious concern. Throughout the trajectory of stabilization to rehabilitation and discharge, 
sexual health needs are often neglected, and this leaves post-MI patients uncertain on how to 
resume sexual activity or adapt to sexual health changes (D’Eath, Byrne, Doherty, McGee, & 
Murphy, 2013). Current studies affirm that sexual health is rarely discussed because healthcare 
providers often lack the confidence and knowledge about sexual health issues (Byrne, Doherty, 
McGee, & Murphy, 2010; Jaarsma et al., 2010). This creates an unmet need in this population, 
as data suggest that patients are sexually active throughout the lifespan (Clayton, Harsh, & 
Clayton, 2016), and that adults of all ages desire information about sexual health following 
hospitalization (Mosack & Steinke, 2009). There is also some preliminary research that has 
reported a protective effect of sexual activity on prevention of a repeat cardiac event (Liu, 
Waite, Shen, & Wang, 2016). Assessing sexual health has been defined as an essential 
component of holistic nursing practice by the American Nurses’ Association (ANA) (Dattilo & 
Brewer, 2005), and is a key recommendation of the American Heart Association (Levine et al., 
2012). Therefore, nurses are uniquely positioned to counsel patients about their sexual 
dysfunction concerns (Vassiliadou et al., 2008). However, while sexual counseling and 
intervention have been promoted as a standard of care (Steinke, Mosack, & Hill, 2013), 
providers remain reluctant to discuss sexual health issues with patients (Ivarsson, Fridlund, & 
Sjöberg, 2010; Jaarsma et al., 2010; D’Eath, Byrne, Doherty, McGee, & Murphy, 2013).  
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A potential explanation for provider reluctance is the general paucity of research on 
sexuality issues. To date, few studies have been published on the topic of sexual health in 
patients following an MI. Given that sexual health is a multidimensional construct, improving 
and maintaining positive sexual health requires a multifaceted approach. However, there are few 
well validated multidimensional measurements of sexual health post-MI, with the current 
literature focusing primarily on sexual activity, or on one isolated component of sexual function. 
This lack of robust multidimensional data is evident when evaluating the contemporary 
intervention for sexual dysfunction - sexual counseling. A meta-analysis on sexual counseling 
interventions in patients post-MI found that conducted studies were of generally poor quality and 
produced mixed effects on return to sexual activity and reduction of sexual problems (Byrne et 
al., 2016). Therefore, this area of study is in its infancy and further research is warranted before 
interventions can be developed and care can improve. The current state of the science points to 
the need for more descriptive information on the effects of MI on sexual health.  
Purpose 
 Given the incidence and survival rates of MI, the physical and psychosocial 
complications post event, and the importance of sexual health to patients, the assessment and 
management of sexual health is vital to improving recovery care in this population. However, to 
date no multidimensional measurement of sexual health exists. Given this disparity, sexual 
function was selected as the outcome of interest in this dissertation. This outcome was selected 
given the connection between the pathophysiologic ramifications of MI on sexual function, 
combined with the need for additional descriptive research and preliminary predictive modeling 
of sexual function. Therefore, this dissertation examined longitudinal changes in sexual function, 
operationalized through a validated multidimensional instrument: the Female and Male Sexual 
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Function Index (FSFI/MSFI) (Rosen et al., 2000; Kalmbach, Ciesla, Janata, & Kingsberg, 2012). 
Ultimately, identification of predictors of sexual function and satisfaction is a necessary step in 
the development of effective interventions in post-MI patients. 
 
Specific Aims 
Aim 1). Describe sexual function and satisfaction in a population of adults within two weeks and 
at three months post-MI, and examine changes from two weeks post-MI to three months post-
MI. 
• Hypothesis: Within two weeks of MI, the total score and subscale scores will remain in 
the dysfunctional range of the FSFI/MSFI but will improve at three months. 
Aim 2). Determine the impact of depression, fear, anxiety, and use of coping strategies on 
predicting sexual function, satisfaction, and activity at three months post-MI. 
• Hypothesis: Higher levels of sexual fear, depression, anxiety, and lower utilization of 
positive coping strategies will be associated with reduced sexual activity, function, and 
satisfaction at three months. 
Aim 3). Describe the relationships between the biopsychosocial domains of sexual function and 
satisfaction at two weeks post-MI. 
• Hypothesis: Sexual satisfaction will be less closely correlated with the other components 
of sexual function at two weeks post-MI. 
 
 
  9
References 
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental 
disorders (5th ed.). Arlington, VA: American Psychiatric Publishing. 
Ashdown, B. K., Hackathorn, J., & Clark, E. M. (2011). In and out of the bedroom: Sexual 
satisfaction in the marital relationship. Journal of Integrated Social Sciences, 2(1), 40-57. 
Basson, R. (2001). Using a different model for female sexual response to address women’s 
problematic low sexual desire. Journal of Sex & Marital Therapy, 27, 395-403. 
Basson, R., Rees, P., Wang, R., Montejo, A. L., & Incrocci, L. (2010). Sexual function in chronic 
illness. The Journal of Sexual Medicine, 7(1), 374-388.  
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., … 
Kwan, T. W. (2019). Heart disease and stroke statistics-2019 update: A report from the 
American Heart Association. Circulation, 139(10), e56–e66.  
Byrne, M., Doherty, S., Fridlund, B. G., Martensson, J., Steinke, E. E., Jaarsma, T., & Devane, 
D. (2016). Sexual counselling for sexual problems in patients with coronary artery 
disease. The Cochrane Database of Systematic Reviews, 2, CD010988.  
Cheng, J. (2001). Recognition, pathophysiology, and management of acute myocardial 
infarction. American Journal of Health-System Pharmacy, 58(18), 1709-1721. 
Cipriani, A., D'Amico, G., Brunello, G., Perazzolo Marra, M., Migliore, F., Cacciavillani, L., & 
D'Amico, G. (2018). The electrocardiographic “triangular QRS-ST-T waveform” pattern 
in patients with ST-segment elevation myocardial infarction: Incidence, pathophysiology 
and clinical implications. Journal of Electrocardiology, 51(1), 8-14.  
  10 
Clayton, A., Harsh, V., & Clayton, A. H. (2016). Sexual function across aging. Current 
Psychiatry Reports, 18(3), 1-9. 
Coles, A., Fisher, K., Darling, C., McManus, D., Maitas, O., Yarzebski, J., & Goldberg, R. J. 
(2012). Recent trends in post-discharge mortality among patients with an initial acute 
myocardial infarction. American Journal of Cardiology, 110(8), 1073-1077.  
Corona, G., Jannini, E. A., & Maggi, M. (2006). Inventories for male and female sexual 
dysfunctions. International Journal of Impotence Research, 18(3), 236-250.  
Dattilo, J., & Brewer, M. K. (2005). Assessing clients’ sexual health as a component of holistic 
nursing practice. Journal of Holistic Nursing, 23(2), 208-219.  
Daniel, M., Agewall, S., Berglund, F., Caidahl, K., Collste, O., Ekenbäck, C., ... Tornvall, P. 
(2018). Prevalence of anxiety and depression symptoms in patients with myocardial 
infarction with non-obstructive coronary arteries. American Journal of Medicine, 131(9), 
1118–1124. 
D’Eath, M., Byrne, M., Doherty, S., McGee, H., Murphy, A.W. (2013) The Cardiac Health and 
Assessment of Relationship Management and Sexuality study: a qualitative inquiry of 
patient, general practitioner, and cardiac rehabilitation staff views on sexual assessment 
and counseling for cardiac patients. Journal of Cardiovascular Nursing, 28(2), E1-13. 
Defining sexual health: Report of a technical consultation on sexual health, 28-31 January 2002, 
Geneva. (2006). Geneva: World Health Organization. 
Frangogiannis, N. G. (2015). Pathophysiology of myocardial infarction. Comprehensive 
Physiology, 5(4), 1841-1875.  
  11 
Guimarães, P. O., Leonardi, S., Huang, Z., Wallentin, L., de Werf, F. V., Aylward, P. E., & 
Tricoci, P. (2018). Clinical features and outcomes of patients with type 2 myocardial 
infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction 
in Acute Coronary Syndrome (TRACER) trial. American Heart Journal, 196, 28-35.  
Heidenreich, P., Trogdon, J., Khavjou, O., Butler, J., Dracup, K., Ezekowitz, M., & Woo, Y. 
(2011). Forecasting the future of coronary artery disease in the United States: A policy 
statement from the American Heart Association. Circulation, 123(8), 933-944.  
Ivarsson, B., Fridlund, B., & Sjöberg, T. (2010). Health professionals' views on sexual 
information following MI. British Journal of Nursing, 19(16), 1052-1054. 
Jaarsma, T., Strömberg, A., Fridlund, B., De Geest, S., Mårtensson, J., Moons, P., & Thompson, 
D. (2010). Sexual counselling of cardiac patients: nurses' perception of practice, 
responsibility and confidence. European Journal of Cardiovascular Nursing, 9(1), 24-29.  
Johansson, I., Karlson, B., Grankvist, G., & Brink, E. (2010). Disturbed sleep, fatigue, anxiety 
and depression in myocardial infarction patients. European Journal of Cardiovascular 
Nursing, 9(3), 175-180.  
Kalmbach, D. A., Ciesla, J. A., Janata, J. W., & Kingsberg, S. A. (2012). Specificity of 
anhedonic depression and anxious arousal with sexual problems among sexually healthy 
young adults. The Journal of Sexual Medicine, 9(2), 505-513.  
Kriston, L., Gunzler, C., Agyemang, A., Bengel, J., Berner, M. M., & SPARK Study Group. 
(2010). Effect of sexual function on health-related quality of life mediated by depressive 
symptoms in cardiac rehabilitation. Findings of the SPARK project in 493 patients. The 
Journal of Sexual Medicine, 7(6), 2044-2055.  
  12 
Ko, D. T., Khera, R., Lau, G., Qiu, F., Wang, Y., Austin, P. C., ... Krumholz, H. M. (2020). 
Readmission and mortality after hospitalization for myocardial infarction and heart 
failure. Journal of the American College of Cardiology, 75(7), 736-746.  
Lindau, S. T., Abramsohn, E., Gosch, K., Wroblewski, K., Spatz, E. S., Chan, P. S., ... 
Krumholz, H. M. (2012). Patterns and loss of sexual activity in the year following 
hospitalization for acute myocardial infarction (a United States national multisite 
observational study). The American Journal of Cardiology, 109(10), 1439-1444.  
Liu, H., Waite, L. J., Shen, S., & Wang, D. H. (2016). Is sex good for your health? A national 
study on partnered sexuality and cardiovascular risk among older men and women. 
Journal of Health & Social Behavior, 57(3), 276–296.  
Levine, G. N., Steinke, E. E., Bakaeen, F. G., Bozkurt, B., Cheitlin, M. D., Conti, J. B., ... 
Council on Quality of Care and Outcomes Research. (2012). Sexual activity and coronary 
artery disease: A scientific statement from the American Heart Association. Circulation, 
125(8), 1058-1072.  
Masters, W., & Johnson, V. (1966). Human sexual response. Boston, MA: Little, Brown. 
Mehta, L. S., Beckie, T. M., DeVon, H. A., Grines, C. L., Krumholz, H. M., Johnson, M. N., & 
Wenger, N. K. (2016). Acute myocardial infarction in women: A scientific statement 
from the American Heart Association. Lancet, 387 North American Edition (10018), 506.  
Mosack, V., & Steinke, E. E. (2009). Trends in sexual concerns after myocardial infarction. 
Journal of Cardiovascular Nursing, 24(2), 162-170.  
  13 
Nappi, R. E., Albani, F., Chiovato, L., & Polatti, F. (2009). Local estrogens for quality of life and 
sexuality in postmenopausal women with coronary artery disease. Climacteric: The 
Journal of the International Menopause Society, 12 Suppl 1, 112-116.  
Oskay, U., Can, G., & Camci, G. (2015). Effect of myocardial infarction on female sexual 
function in women. Archives of Gynecology & Obstetrics, 291(5), 1127-1133.  
Piotrowicz, R., & Wolszakiewicz, J. (2008). Cardiac rehabilitation following myocardial 
infarction. Cardiology Journal, 15(5), 481-487. 
Puchalski, B., Szymanski, F., Kowalik, R., & Filipiak, K. J. (2013). Sexual dysfunction in men in 
the first 9 months after myocardial infarction. Psychiatria Polska, 47(5), 811-826. 
Reed, G. W., Rossi, J. E., & Cannon, C. P. (2017). Acute myocardial infarction. Lancet, 389 
North American Edition (10065), 197-210.  
Roest, A., Martens, E., Denollet, J., & de Jonge, P. (2010). Prognostic association of anxiety post 
myocardial infarction with mortality and new cardiac events: A meta-analysis. 
Psychosomatic Medicine, 72(6), 563-569.  
Rosen, C., Brown, J., Heiman, S., Leiblum, C., Meston, R., Shabsigh, R., & D’Agostino, R. 
(2000). The Female Sexual Function Index (FSFI): A multidimensional self-report 
instrument for the assessment of female sexual function. Journal of Sex and Marital 
Therapy, 26, 191–208.  
Søderberg, L. H., Johansen, P. P., Herning, M., & Berg, S. K. (2013). Women's experiences of 
sexual health after first-time myocardial infarction. Journal of Clinical Nursing, 22(23-
24), 3532-3540. 
  14 
Steinke, E. E., Mosack, V., & Hill, T. J. (2013). Sexual self-perception and adjustment of cardiac 
patients: a psychometric analysis. Journal of Research in Nursing, 18(3), 191-201.  
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D.,  ... 
Mendis, S. (2012). Third universal definition of myocardial infarction. Circulation, 
126(16), 2020-2035.  
Tierney, D. (2008). Sexuality: a quality-of-life issue for cancer survivors. Seminars in Oncology 
Nursing, 24(2), 71-79. 
Vassiliadou, A., Stamatopoulou, E., Triantafyllou, G., Gerodimou, E., Toulia, G., & Pistolas, D. 
(2008). The role of nurses in the sexual counseling of patients after myocardial infarction. 
Health Science Journal, 2(2), 111-118. 
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., ... 
American Heart Association Council on Epidemiology and Prevention Statistics 
Committee and Stroke Statistics Subcommittee. (2020). Heart disease and stroke 
statistics-2020 update: A report from the American Heart Association. Circulation, 
141(9), e139-e596. 
Vlachopoulos, C., Jackson, G., Stefanadis, C., & Montorsi, P. (2013). Erectile dysfunction in the 
cardiovascular patient. European Heart Journal, 34(27), 2034-2046.  
Zeydi, A. E., Sharafkhani, M., Armat, M. R., Gould, K. A., Soleimani, A., & Hosseini, S. J. 
(2016). Women's sexual issues after myocardial infarction: A literature review. 
Dimensions of Critical Care Nursing, 35(4), 195-203. 
  15 
CHAPTER II 
Literature Review and Conceptual Framework 
 
Introduction 
 While a growing body of literature has developed regarding post-MI sexual health, the 
state of the science remains poorly articulated overall. In addition, the differentiation of sexual 
health in MI compared to chronic CAD is unexplored. As such, two separate reviews of the 
literature were conducted to gain a broad understanding of sexual health in patients in general 
CAD and post-MI. This literature search aimed to evaluate theoretical and operational definitions 
of sexual health and its components, and the capacity in which sexual health was empirically 
measured in these two populations. Pertinent strengths, weaknesses and gaps in the literature are 
also presented. 
Methods 
The databases included the Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), PubMed, Scopus, PsycINFO, and the Cochrane Database for Systematic Reviews 
(CDSR). All searches were done by title, and relevant search terms with the appropriate Boolean 
operators were entered in separated searches for MI and CAD. The search included terms and 
synonyms for components of sexual health, such as function (libido, orgasm, sexuality, 
dyspareunia, and erectile dysfunction), activity, intimacy, and pleasure. Synonyms for MI
  16 
included heart attack and cardiac event. A 15-year cutoff was selected to only capture recent 
representative literature. These terms are presented in Table 2.1, 2.2 and 2.3. 
Table 2. 1 - Coronary artery disease search terms by database 
Pubmed 
“cardiovascular disease*” [MeSH Terms] OR (“cardiovascular” [Tiab] AND “disease*” 
[Tiab]) OR “cardiovascular diseases” [Tiab] OR (“cardiovascular” [Tiab] AND “disease” 
[Tiab]) OR “cardiovascular disease” [Tiab] OR “CVD” [Tiab] OR “cardiac illness” OR 
(“heart” [Tiab] AND “disease” [Tiab]) OR “heart disease” [Tiab] OR “coronary artery 
disease” [Tiab]. 
CINAHL, PsycINFO, CDSR 
“cardiovascular disease” OR (“cardiovascular” AND “disease”) OR “cardiovascular diseases” 
OR (“cardiovascular” AND “diseases”). 
CINAHL: Cumulative Index to Nursing and Allied Health Literature; CDSR: Cochrane Database for Systematic 
Reviews 
 
Table 2. 2 - Myocardial infarction search terms by database 
Pubmed 
“myocardial infarction” [MeSH Terms] OR (“myocardial” [Title] AND “infarction” [Title]) 
OR “myocardial infarction” [Title] OR “MI” [Title] OR “cardiac event” [Title]. 
CINAHL, PsycINFO, CDSR 
“myocardial infarction” OR “myocardial infarction” OR “cardiac event” OR “MI”. 
CINAHL: Cumulative Index to Nursing and Allied Health Literature; CDSR: Cochrane Database for Systematic 
Reviews 
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Table 2. 3 - Sexual health search terms by database 
Pubmed 
 “sexual dysfunction” [Title] OR (“sexual” [Title] AND “satisfaction” [Title]) OR “sexual 
satisfaction” [Title] OR “sexual pleasure” [Title] OR (“sexual” [Title] AND “pleasure” 
[Title]) OR “sexuality” [Title] OR “sexual identity” [Title] OR “ sexual function” [Title] OR 
(“sexual” [Title] AND “function” [Title]) OR “sexual behavior” [MeSH Terms] OR “libido” 
[MeSH Terms] OR “orgasm” [MeSH Terms] OR “sexuality” [MeSH Terms] OR “intimacy” 
[Title] OR “intimate” [Title] OR “sexual health” [Title] OR “Partner” [Title] OR “arousal” 
[Title] OR “desire” [Title] OR “erectile dysfunction” [Title]. 
CINAHL, PsycINFO, CDSR 
“sexual dysfunction” OR (“sexual” AND “satisfaction”) OR “sexual satisfaction” OR “sexual 
pleasure” OR (“sexual” AND “pleasure”) OR “sexuality” OR “sexual identity” OR “sexual 
function” OR (“sexual” AND “function”) OR “sexual behavior” OR “libido” OR “orgasm” 
OR “sexuality” OR “intimacy” OR “intimate” OR “sexual health” OR “Partner” OR “arousal” 
OR “desire” OR “erectile dysfunction”. 
CINAHL: Cumulative Index to Nursing and Allied Health Literature; CDSR: Cochrane Database for Systematic 
Reviews 
The inclusion criteria were descriptive cross-sectional or longitudinal studies using 
quantitative methods written in English and conducted in either men or women aged 20 years or 
older. Subgroup analyses of each gender were required if both men and women were included in 
the same study. Studies of participants who had a marked history of depression, anxiety disorder, 
schizophrenia, or other mental illness were excluded as these conditions could confound the 
relationship between CAD/MI and sexual health. Outcomes that were reported by surrogates 
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(family members, spouses or significant others, providers), and studies of patients with a 
diagnosis of stroke, congestive heart failure, or congenital heart defects were excluded. Lastly, 
intervention studies (such as a pharmaceutical, sexual counseling, or marital therapy) were 
excluded.  
Articles were evaluated by their sampling and data collection procedures, their diagnostic 
criteria for CAD or MI, the theoretical and operational definitions of sexual health presented, and 
the selection and measurement of individual outcomes. The individual study designs, methods, 
and results were charted in a synthesis table. The strengths and weaknesses of each study were 
analysed, and pertinent findings and gaps were synthesized. Statistical factors such as sample 
size, power analysis, and statistical/clinical significance were also considered.  
Results 
An initial total of 879 articles were retrieved from the CAD literature. After the removal 
of duplicates, 485 articles were screened by title and abstract. After title and abstract screening, 
446 articles were removed, and the remaining 39 articles were reviewed by full text. From this 
screening, seven articles were included in the final CAD review. The literature search for sexual 
health in patients post-MI yielded 471 studies and was reduced to 339 after removal of 
duplicates. Following initial title and abstract screening, the remaining 22 articles were reviewed 
by full text. From these, four articles were included in the final MI review. A Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram showing the 
search strategy and the number of articles retrieved, included, and excluded for each search is 
presented in Figure 2.1 and 2.2. 
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Figure 2. 1 - PRISMA diagram for sexual health in patients with coronary artery disease. 
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 Figure 2. 2 - PRISMA diagram for sexual health in patients post myocardial infarction 
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Study Characteristics 
Seven articles from the CAD literature were included in this review. One study was 
conducted in Denmark (Rundblad et al., 2017), three in Iran (Assari, Lankarani, Ahmadi, & 
Kazemi Saleh, 2014; Ghanbari Afra, Taghadosi, & Gilasi, 2015; Kazemi Saleh, Pishgou, 
Farrohki, Assari, Fotros, & Naseri, 2008), one in Israel (Justo et al., 2010), one in Turkey (Kaya, 
Yilmaz, Nurkalem, Ilktac, & Karaman, 2007), and one in Norway (Træen & Olsen, 2007). Five 
different questionnaires were used among five of the seven studies. These included the Larson's 
Sexual Satisfaction Questionnaire (LSSQ) (Larson, Anderson, Holman, & Niemann, 1998), the 
Sexual Health Inventory for Males (SHIM) (Rosen, Cappelleri, Smith, Lipsky & Pena, 1999), the 
Female Sexual Function Index (FSFI) (Rosen et al., 2000), the Relation and Sexuality Scale 
(RSS) (Berglund et al., 2001), and the Revised Dyadic Adjustment Scale (RDAS) (Busby et al., 
1995). The remaining two articles used investigator developed questionnaires (Træen & Olsen, 
2007; Rundblad et al., 2017).  
Of the four articles included from the MI literature, one was conducted in Bosnia and 
Herzegovina (Hodžić, Durek, Begić, Šabanović Bajramović, & Durak-Nalbantić, 2019), one in 
Turkey (Oskay, Can, & Camci, 2015), one in the United States (Lindau et al., 2012), and one in 
the United States and Spain concurrently (Lindau et al., 2016). Two of the studies utilized 
previously developed and validated questionnaires including the Female Sexual Function Index 
(FSFI) (Rosen et al., 2000) and the International Index Of Erectile Function 5-item (IIEF-5) 
(Rosen, Cappelleri, Smith, Lipsky & Pena, 1999), while the remaining two used investigator 
developed questionnaires (Lindau et al., 2012; Lindau et al., 2016). Table 2.4 compares the 
characteristics of the included CAD and MI studies including study designs, sample sizes, 
genders included, and measurements utilized. 
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Table 2. 4 - Characteristics among CAD and MI studies 
 CAD (n=7) MI (n=4) 
Gender, No. (%) 
Men only 
Women only 
Both genders 
 
1 (14.3) 
1 (14.3) 
5 (71.4) 
 
1 (25) 
1 (25) 
2 (50) 
Sample sizes, Mean 
Average 
Range 
 
597 
20 - 1,664 
 
1,193 
45 - 2,802 
Study design, No. (%) 
Cross-sectional 
Longitudinal 
 
7 (100) 
0 (0) 
 
3 (75) 
1 (25) 
Outcomes, No. (%)* 
Sexual activity 
Sexual function 
Sexual satisfaction 
 
0 (0) 
6 (85.7) 
3 (42.9) 
 
2 (50) 
3 (75) 
1 (25) 
Measurements, No. (%) 
FSFI: 
LSSQ: 
RSS: 
RDAS: 
SHIM: 
IIEF-5: 
Investigator-developed: 
 
1 (14.3) 
1 (14.3) 
1 (14.3) 
1 (14.3) 
1 (14.3) 
- 
2 (28.6) 
 
1 (25) 
- 
- 
- 
- 
1 (25) 
2 (50) 
FSFI: Female Sexual Function Index; IIEF-5: International Index of Erectile Function; LSSQ: Larson’s Sexual 
Satisfaction Questionnaire; RDAS: Revised Dyadic Adjustment Scale; RSS: Relation and Sexuality Survey; SHIM: 
Sexual Health Inventory for Men. 
*Some studies measured more than one outcome 
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Sampling, Inclusion, and Exclusion 
The sampling techniques, diagnostic techniques, and inclusion criteria varied in the CAD 
literature. Three studies sampled from a retrospective cohort (Ghanbari Afra, Taghadosi, & 
Gilasi, 2015; Træen & Olsen, 2007; Rundblad et al., 2017). Four studies compared patients with 
CAD to a control population (Ghanbari Afra, Taghadosi, & Gilasi, 2015; Kaya, Yilmaz, 
Nurkalem, Ilktac, & Karaman, 2007; Træen & Olsen, 2007 Justo et al., 2010). Studies applied 
various diagnostic techniques for inclusion. Four studies utilized selective coronary angiography 
with a threshold of either 40% occlusion or 50%-70% stenosis (Assari, Lankarani, Ahmadi, & 
Kazemi Saleh, 2014; Justo et al., 2010; Ghanbari Afra, Taghadosi, & Gilasi, 2015; Kaya, 
Yilmaz, Nurkalem, Ilktac, & Karaman, 2007), while two studies screened using a diagnosis from 
the medical record (Kazemi Saleh, Pishgou, Farrohki, Assari, Fotros, & Naseri, 2008; Rundblad 
et al., 2017). The remaining study did not provide diagnostic criteria (Træen & Olsen, 2007). 
 The selected studies also varied in exclusion criteria. Three studies did not provide any 
criteria (Rundblad et al., 2017; Træen & Olsen, 2007; Justo et al., 2010), while one excluded 
based on withdrawal from the study or hospitalization (Kazemi Saleh, Pishgou, Farrohki, Assari, 
Fotros, & Naseri, 2008). Conversely, the remaining three studies applied extensive exclusion 
criteria including systemic and psychologic disease, comorbidity scores, and medications that 
could interfere with sexual health (Kaya, Yilmaz, Nurkalem, Ilktac, & Karaman, 2007; Ghanbari 
Afra, Taghadosi, & Gilasi, 2015; Assari, Lankarani, Ahmadi & Kazemi Saleh, 2014). The 
inclusion of a comorbidity score in these studies reduced potential confounders significantly. 
However, two studies required that patients be married to participate, which decreased 
generalizability to unpartnered individuals (Ghanbari Afra, Taghadosi, & Gilasi, 2015; Kazemi 
Saleh, Pishgou, Farrohki, Assari, Fotros, & Naseri, 2008). 
  24 
Study designs, sampling techniques, inclusion criteria, and exclusion criteria for the MI 
literature also varied across studies. Two studies applied active data collection, while the 
remaining two were secondary data analyses. The length of time that patients were surveyed 
post-MI were 1 month, three months, and longitudinally from 1 month to 1 year (Lindau et al., 
2016). One study included a range of timepoints post-event from 1 month to more than one year 
(Hodžić, Durek, Begić, Šabanović Bajramović, & Durak-Nalbantić, 2019). Three studies 
recruited patients who were hospitalized for an MI, while one study recruited patients admitted 
to an outpatient heart health clinic (Hodžić, Durek, Begić, Šabanović Bajramović, & Durak-
Nalbantić, 2019). Only one study provided their diagnostic criteria for MI, which consisted of an 
increased troponin above the 99th percentile (>18 ng/mL) with at least one symptom of ischemia 
or electrocardiogram changes (Lindau et al., 2016). One study did not provide exclusion criteria, 
while another only excluded based on presence of endocrine diseases and endocrine cancers 
(Hodžić, Durek, Begić, Šabanović Bajramović, & Durak-Nalbantić, 2019). One study excluded 
patients who were incarcerated or had an MI from outside factors (Lindau et al., 2016). The most 
comprehensive exclusion criteria were for previous history of MI, presence of advanced disease, 
reproductive surgery, depression, or taking an antidepressant or hormone replacement (Oskay, 
Can, & Camci, 2015). 
Coronary Artery Disease Literature 
The broad outcomes of function and satisfaction were theoretically defined and 
operationalized in different capacities across the selected CAD studies. Theoretical definitions of 
sexual function ranged from “a complex process coordinated by the neurological, vascular and 
endocrine systems” (Kaya, Yilmaz, Nurkalem, Ilktac, & Karaman, 2007, p. 236), to “distressing 
disturbances in the sexual response cycle” (Rundblad et al., 2017, p. 786), to specifically erectile 
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dysfunction defined as “the inability to attain and/or maintain penile erection sufficient for 
satisfactory sexual performance” (Justo et al., 2010, p. 41). Two studies did not provide a 
theoretical definition (Assari, Lankarani, Ahmadi, & Kazemi Saleh, 2014; Kazemi Saleh, 
Pishgou, Farrohki, Assari, Fotros, & Naseri, 2008). Sexual function was operationalized as either 
severity of functional problems, or the percentage of individuals who experienced a 
subcomponent of sexual dysfunction (e.g. erectile dysfunction, dyspareunia). Satisfaction was 
operationalized as either overall degree of satisfaction, or the frequency of individuals satisfied 
with their sex lives. Two studies operationalized both sexual function and satisfaction 
concurrently (frequency and severity) (Træen & Olsen, 2007, Justo et al., 2010). Two studies 
measured a broad theoretical outcome of sexuality and sexual well-being, although one was 
operationalized through a narrow focus on satisfaction with sex life (Træen & Olsen, 2007), 
while the second was focused sex life, frequency of penetrative and non-penetrative intercourse, 
change in ability to orgasm, and sexual fear (Kazemi Saleh, Pishgou, Farrohki, Assari, Fotros, & 
Naseri, 2008). 
Sexual function was studied more frequently compared to satisfaction and aligned into 
two categories - frequency of sexual problems, and severity of sexual dysfunction. While both 
men and women experienced a broad range of functional issues across the continuum of the 
sexual response cycle, a higher percentage of men reported having at least one sexual issue 
compared to women (M: 53-57.7%; F: 31.3-43%) (Træen & Olsen, 2007; Rundblad et al., 2017). 
However, women experienced dysfunction more profoundly than men. The most common sexual 
problems were ejaculation difficulties (M: 91.4%), erectile difficulties (M: 74-85.8%), premature 
or delayed orgasm (M: 11-49%; F: 13-37.3%), arousal difficulties (M: 21.4-44%; F: 24-74%), 
lubrication difficulties (F: 15.5-37%), and pain with intercourse (F: 4-6%) (Træen & Olsen, 
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2007; Rundblad et al., 2017; Assari, Lankarani, Ahmadi, & Kazemi Saleh, 2014; Justo et al., 
2010). When examining severity of sexual problems, women experienced more severe 
dysfunction compared to both men and healthy controls. Function scores in women with CAD 
were lower compared to healthy controls for desire, arousal, lubrication, orgasm, and pain with 
intercourse (Kaya, Yilmaz, Nurkalem, Ilktac, & Karaman, 2007), and were lower compared to 
men in overall function scores (Kazemi Saleh, Pishgou, Farrohki, Assari, Fotros, & Naseri, 
2008). 
 The confidence in these data is strengthened by the broad range of well validated 
measurements for sexual function with robust sampling techniques and inclusion criteria. The 
inclusion of comorbidity scoring prior to inclusion improved the internal validity of the study 
findings (Kazemi Saleh, Pishgou, Farrohki, Assari, Fotros, & Naseri, 2008; Assari, Lankarani, 
Ahmadi, & Kazemi Saleh, 2014). However, the studies conducted by Træen and colleagues and 
Rundblad and colleagues implemented inadequately validated measurements without prior 
evidence of psychometric testing. In addition, Træen and Olsen did not provide any diagnostic 
criteria for inclusion from their sampled registry, which produces questions on whether the target 
population was adequately chosen. Furthermore, the authors also do not state whether the control 
registry was free of people without CAD, only stating that it was a representative sample (Træen 
& Olsen, p. 195).  
Comparably to sexual function, sexual satisfaction was also aligned into severity and 
frequency. Studies measured the overall level of sexual satisfaction, and the percentage of 
participants satisfied with their overall sex life. Across the three articles included in this review, 
sexual satisfaction was consistently higher in patients despite reduced sexual function. 
Furthermore, sexual satisfaction scales were not statistically higher in women with CAD when 
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compared to healthy controls, which was observed across different measurements (FSFI and 
LSSQ) (Ghanbari Afra, Taghadosi, & Gilasi, 2015; Kaya, Yilmaz, Nurkalem, Ilktac, & 
Karaman, 2007). In terms of frequencies, 47% of men and 64% of women older than 49 years of 
age were satisfied with their sex life, which was also comparable to a general population (Træen 
& Olsen, 2007).  
The confidence in these results is strengthened as each study utilized different 
measurements yet all appreciated the same outcome. In addition, both studies utilized well 
validated measurements for sexual satisfaction, albeit with different topics and phrasing. Two 
studies applied rigorous sampling and exclusion criteria to control for potential confounding 
factors. However, one study reported significant differences between the CAD and control group 
in terms of gender, education, employment, medical history and use of cardiac medications, 
which affects the internal validity of the study findings (Ghanbari Afra, Taghadosi, & Gilasi, 
2015). Furthermore, as with the sexual function measurements, Træen & Olsen did not use a 
validated tool for sexual satisfaction. Table 2.5 details the individual study characteristics 
including sample sizes, study designs, dependent variables, and measurements. Table 2.6 
provides the key findings, strengths, and weaknesses of the included articles. 
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Table 2. 5 - Individual CAD study characteristics 
Study Sample Study design Dependent Variables Measurement and validation 
Assari, 
Lankarani, 
Ahmadi, & 
Kazemi Saleh, 
2014 
Sample size: 551 with CAD 
(155F, 396M). Average age: 
F:56.3, M: 57.2. Racial makeup 
was not reported. 
Cross-sectional 
(active data 
collection) 
 
Sexual function  RDAS, 14 items, entire scale used. 
Validation not provided.  
RSS, 10 items, entire scale used. 
Validated in target population 
(Tavallaii et al., 2007). 
Ghanbari Afra, 
Taghadosi, & 
Gilasi, 2015 
Sample size: 150 with CAD (44F, 
106M), 150 controls (83F, 67M). 
Average age and racial makeup 
were not reported. 
Cross-sectional 
(retrospective 
cohort) 
Sexual satisfaction 
 
 
LSSQ, 25 questions, entire scale 
used. Validated in study 
population (a=0.98) (Bahrami, 
Yaghoob zadeh, Sharif Nia, 
Soliemani, & Haghdoost, 2016). 
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Justo et al., 2010 Sample size: 112M with CAD, 12 
controls. Average age: 74.6 in 
entire sample, 78.2 in controls. 
Racial makeup was not reported. 
Cross-sectional 
(active data 
collection) 
 
Sexual function 
 
SHIM, 5 questions, entire scale 
used. Validation not provided. 
Kaya, Yilmaz, 
Nurkalem, 
Ilktac, & 
Karaman, 2007 
Sample size: 20F with CAD, 15 
controls. Average age: 38.2 in 
CAD, 37.9 in control. Racial 
makeup was not reported. 
Cross-sectional 
(active data 
collection) 
 
Sexual function, 
sexual satisfaction 
 
 
FSFI, 19 questions, entire scale 
used. Validated in target 
population (a=0.95) (Oksuz & 
Malhan, 2006). 
Kazemi Saleh, 
Pishgou, 
Farrohki, Assari, 
Fotros, & Naseri, 
2008 
Sample size: 635 with CAD 
(171F, 464M). Average age: F: 
56.3, M: 57.1. Racial makeup was 
not reported. 
Cross-sectional 
(active data 
collection) 
 
 
Sexual function RDAS, 14 items, entire scale used. 
Validation not provided.  
RSS, 10 items, entire scale used. 
Validated in target population 
(Tavallaii et al., 2007). 
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Rundblad et al., 
2017 
Sample size: 1,036 with CAD 
(344F, 692M). Average age and 
racial makeup were not reported. 
Cross-sectional 
(retrospective 
cohort) 
Sexual function 
 
Investigator developed 
questionnaires. Validation not 
provided. 
Træen & Olsen, 
2007 
Sample size: 1,093 with CAD 
(612F, 481M). Average age and 
racial makeup were not reported. 
Cross-sectional 
(retrospective 
cohort) 
Sexual function, 
sexual satisfaction 
Investigator developed 
questionnaires. Validation not 
provided. 
CAD: Coronary artery disease; LSSQ: Larson’s Sexual Satisfaction Questionnaire; FSFI: Female Sexual Function Index; RDAS: Revised Dyadic 
Adjustment Scale; RSS: Relation and Sexuality Survey; SHIM: Sexual Health Inventory for Men
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Table 2. 6 - Sexual function and satisfaction in patients with CAD with study strengths and limitations 
Authors Effects on function and satisfaction Strengths Limitations 
Assari, 
Lankarani, 
Ahmadi, & 
Kazemi 
Saleh, 2014 
Sexual function: Women had more 
frequent issues with libido and orgasm 
compared to men. Arousal disorders 
scores were similar among men and 
women. In men, 91.4% had an 
ejaculation disorder, and 15.5% of 
women had lubrication difficulties. 
The study found a mild to moderate 
association between function and 
marital quality. 
A broad multidimensional 
measurement of sexual function 
was applied in this study and fit 
the theoretical definitions. The 
study controlled for several key 
covariates including a comorbidity 
scale used during screening. 
The study results may not be 
applicable to CAD participants outside 
of Israel. The study’s predictor 
analysis is limited given the cross-
sectional nature of the data. Time 
since diagnosis of CAD was not 
reported. Other components of sexual 
health were not examined. 
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Ghanbari 
Afra, 
Taghadosi, & 
Gilasi, 2015 
Sexual satisfaction: Sexual 
satisfaction scores were similar (101.5 
compared to 101) even after 
controlling for confounding factors. 
70.7% of patients with CAD and 64% 
of healthy subjects respectively were 
“highly satisfied” with their sexual 
relationships. There was a significant 
correlation with satisfaction and 
gender and use of cardiac medications. 
The study recruited a large sample 
size and used a validated tool for 
sexual satisfaction. The use of 
diagnostics via an artery occlusion 
threshold strengthened the internal 
validity of the study. The study 
controlled for cardiac medications 
in their analysis which was an 
important confounder. 
The study only measured sexual 
satisfaction and is missing additional 
components of sexual health. There 
were significant differences between 
the two groups in gender, education, 
employment, medical history, and use 
of medications. The study only 
recruited partnered individuals which 
limits the study’s external validity.  
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Justo et al., 
2010 
Sexual function: Erectile dysfunction 
was more common among men with 
CAD compared to men without CAD, 
although there was not a significant 
difference between the two groups 
(85.7 vs.72.7%). Age was the only 
variable associated with increased 
scores on the SHIM outside of 
cardiovascular risk factors, and 
severity of CAD. 
The theoretical and operational 
definitions fit with the 
measurements chosen. The SHIM 
is a well validated instrument for 
sexual function. The study used 
angiography and a stenosis 
threshold to control for severity of 
CAD. The high compliance rate 
with the surveys mitigates bias in 
the sample. The study controlled 
for cardiac comorbidities and 
medications as well, which 
reduced issues of internal validity. 
The SHIM only assesses erectile 
quality and as such other components 
of sexual function are absent, 
including orgasm, arousal, and desire. 
Exclusion criteria were not provided. 
Patients were interviewed after 
completing the survey, but the content 
of this survey was not disclosed, and it 
is unclear if it might have biased 
survey responses. 
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Kaya, 
Yilmaz, 
Nurkalem, 
Ilktac, & 
Karaman, 
2007 
Sexual function: Women with CAD 
were diagnosed with female sexual 
dysfunction 60% of the time 
compared to healthy women (33%). 
The domain scores for arousal, 
lubrication, orgasm, and pain were all 
statistically decreased in women with 
CAD. 
Sexual satisfaction: Satisfaction was 
not statistically significant between 
women with CAD and healthy 
controls (3.9 vs.4.8). 
The FSFI is an appropriate, well 
validated multidimensional tool 
for sexual dysfunction. The 
theoretical and operational 
definitions fit with the 
measurement chosen. The study 
utilized a control group for 
comparison of function and 
satisfaction scores. The study 
measured both function and 
satisfaction within the same 
cohort. 
The sample size was small, and the 
study was only conducted with female 
participants, limiting the translatability 
of the results across other genders. 
The only exclusion criteria were those 
who wanted to withdraw from the 
study or were re-hospitalized, which 
does not account for additional 
comorbid conditions or cardiac 
medications.  
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Kazemi 
Saleh, 
Pishgou, 
Farrohki, 
Assari, 
Fotros, & 
Naseri, 2008 
Sexual function: Men had 
significantly lower scores on sexual 
function (10.4 vs.11), sexual 
frequency (5.5 vs.6.5), and total RSS 
scores, indicating that men had better 
overall sexual function. Men had 
significantly higher sexual fear scores 
(0.8 vs.0.3). Total RSS scores were 
also correlated with marital quality. 
The study used validated 
measurements with a robust 
sample size. The RSS measures 
function, activity, and fear, which 
is multidimensional. The addition 
of a comorbidity measurement 
upon recruitment to ensure that 
patients did not present with other 
comorbid conditions that could 
influence the sexual health data 
was valuable. 
It is unclear how they diagnosed 
people with CAD or how the inclusion 
criteria were determined. The study 
was only limited to married 
individuals and the study 
acknowledges that cultural differences 
may impact the study's applicability to 
other populations. The RSS does not 
measure sexual satisfaction, which is a 
key component of sexual health. time 
since diagnosis of CAD and use of 
cardiac medications was not reported. 
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Rundblad et 
al., 2017 
Sexual function: The total percentage 
of participants with sexual difficulties 
was 46.4%. The most common 
problem in men was arousal or 
orgasmic difficulties (45.9%), while in 
women desire was the most reported 
(23.4%). Furthermore, 21.2% of men 
and 12.3% of women had hesitancy 
towards having sex. 
The study leveraged a large 
nationally representative dataset. 
The study captured frequencies of 
sexual function and fear which 
approached a comprehensive 
sexual health measurement. The 
collection of multiple chronic 
conditions outside of CAD 
allowed for interesting 
comparisons across diagnoses. 
The study questionnaires were 
developed by the investigators with 
limited disclosure on how these 
measurements were validated. Sexual 
arousal and orgasm were assessed 
with one question but are separate 
components of the sexual response 
cycle. The study reported a response 
rate of 51% for men and 41.2% for 
women which could indicate response 
bias or selection bias. 
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Træen & 
Olsen, 2007 
Sexual function: More patients with 
CAD had sexual issues (26%) 
compared to healthy controls (11%). 
However, the healthy controls had 
greater difficulty achieving orgasm 
than the cardiac group.  
Sexual satisfaction: A total of 66% of 
healthy controls reported being 
satisfied with their sex life while this 
was 53% in the CAD group. 
The study was conducted in a 
large nationally representative 
sample using a multidimensional 
measurement of sexual health. The 
study measured both function and 
satisfaction within the same cohort 
which allowed for comparison 
across the two components of 
sexual health. 
While somewhat multidimensional, 
the measurements used were not 
previously validated. Patients had to 
be enrolled in a heart or lung registry 
before their data could be included in 
the study, but this process was not 
discussed. There were statistically 
significant differences between the 
population and control groups at the 
beginning of the survey. This means 
that changes in prevalence of sexual 
problems in the Norwegian population 
may have occurred between 1997 and 
2005.  
CAD: Coronary artery disease; LSSQ: Larson’s Sexual Satisfaction Questionnaire; FSFI: Female Sexual Function Index; RDAS: Revised Dyadic Adjustment 
Scale; RSS: Relation and Sexuality Survey; SHIM: Sexual Health Inventory for Men
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Myocardial Infarction Literature 
While sexual function was the most common outcome, none of the included studies 
provided a theoretical definition. Sexual activity was the second most common outcome and was 
theoretically defined as “any mutually voluntary activity with another person that involves sexual 
contact, whether or not intercourse or orgasm occurs” in two studies (Lindau et al., 2012, p. 
1440; Lindau et al, 2016, p. 756). Sexual satisfaction was also not theoretically defined in the 
one study it was measured in. Similarly to the CAD literature, sexual function was 
operationalized as either the percentage of patients reporting a specific problem (Lindau et alk, 
2016), or severity scores of a particular function problem (Oskay, Can, & Camci, 2015; Hodžić, 
Durek, Begić, Šabanović Bajramović, & Durak-Nalbantić, 2019). In the study of only men, 
sexual function was only operationalized as erectile function (Hodžić, Durek, Begić, Šabanović 
Bajramović, & Durak-Nalbantić, 2019). Sexual activity was operationalized as the presence of 
any sexual activity in the time since their MI (either one month or one year post event).  
Sexual activity was studied in half of the selected articles. After an MI, 34.6-73% of 
women and 46.8-85% of men were sexually active (Lindau et al., 2012; Lindau et al., 2016). 
Most sexually active participants were engaging at a frequency of 2-3 times per month or less 
(Lindau et al., 2016). Among patients who were sexually active before their event, 48% of men 
and 59% of women reduced sexual activity post-MI, and men were more likely than women to 
have resumed sexual activity by one month (Lindau et al., 2012; Lindau et al., 2016). 
Approximately 13% of patients never returned to sexual activity post-event (Lindau et al., 2016). 
Only 9.1% of men and 4.0% women who were previously inactive attempted sexual activity in 
the year after their MI (Lindau et al., 2012). Based on retrospective data collection on pre-MI 
sexual activity rates, predictors of return to sexual activity in men included no discharge 
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instructions, no discussion with a physician, and lower physical function (Lindau et al., 2012). 
There were conflicting findings surrounding age as a predictor for sexual activity; age was 
reported as a significant predictor of sexual activity resumption in the Lindau 2016 article but 
was not significant in the Lindau 2012 article. This may have been due to the different 
population ages in each study.  
Three articles measured sexual function, with one reporting severity of sexual function 
problems and two reporting frequency of problems. The sexual problems reported were lack of 
interest (F: 40%, M: 19%); inability to climax (F: 19%, M: 13%); experienced orgasm too 
quickly (M: 14%); trouble with erection (M: 22%), or lubrication (F: 22%), or experienced 
physical pain (F: 10%, M: 4%). Regarding erection difficulties, one study found that 77.1% of 
patients with MI reported at least some erectile dysfunction, compared to 51% in the control 
group (Hodžić, Durek, Begić, Šabanović Bajramović, & Durak-Nalbantić, 2019). The overall 
prevalence of sexual dysfunction according to the criteria of the FSFI was 75.6% (Oskay, Can, & 
Camci, 2015), compared to a separate study which found that 59% of women and 46% of men 
reporting at least one sexual problem (Lindau et al., 2016). The total FSFI scores were 16.41 ± 
8.04, compared to 23.13 ± 3.95 in healthy controls, out of a total score of 36 points. The domains 
of desire, lubrication, arousal, orgasm, and pain were all decreased in the MI group compared to 
healthy controls, indicating worse sexual function. Interestingly, 88.4 % of patients were worried 
about another MI upon resuming sexual activity, which was also present in 58% of the patients’ 
husbands (Oskay, Can, & Camci, 2015). 
Only one article measured sexual satisfaction using a validated measure. Satisfaction was 
the one domain that remained high in the MI population as scores were 4.03 ±1.13 compared to 
4.11±1.07 in the control group (Oskay, Can, & Camci, 2015). There were no statistical 
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significances between the two groups. Both satisfaction scores approached the maximum score 
of 6 for the scale. In addition, Lindau et al., (2016) found that 85.8% of women and 88.6% of 
men still felt sexual satisfaction with their significant other despite the decreased frequency; 
however, the operationalization of this outcome was not provided. 
The strengths of the MI literature were the strong number of large-sample, multi-site 
studies. Some studies used well validated measurements, including the FSFI and the IIEF-5. 
However, as seen in the CAD literature, many studies did not define or operationalize their 
outcomes using validated measures, and most studies did not apply a multidimensional 
perspective to sexual health. The operationalization of sexual activity within the articles was 
often based over an entire year, which reduced sensitivity on when individuals returned to 
intercourse. Definitions of “early resumer” and “late resumer” for activity used in the Lindau 
articles do not possess enough capacity to determine what a normal or expected timeframe would 
be for resumption of sexual activity. As such, the attempts to estimate predictors of sexual 
activity is hampered by this vague outcome variable. Furthermore, these studies only predicted 
resumption of sexual activity, without considering sexual function or satisfaction with sex, which 
are important variables to consider. One study excluded patients older than 55 years of age which 
only constitutes 20% of all patients post-MI, and as such limited applicability to the majority of 
post-MI patients. Lastly, the data are also hindered on reliance on retrospective data collection 
over a year, which introduces a significant risk of recall bias. Table 2.7 presents the individual 
study characteristics of the MI articles including sample sizes, study designs, dependent 
variables, and measurements utilized. Table 2.8 provides the pertinent sexual health findings 
from each article, along with the strengths and limitations.
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Table 2. 7 - Individual MI study characteristics 
Study Sample Study design Dependent Variable Measurement and validation 
Hodžić, Durek, 
Begić, Šabanović 
Bajramović, & 
Durak-Nalbantić, 
2019 
Sample size: 48M post-MI, 51 
controls. Average age: 57.1 in MI 
sample, 55.2 in controls. Racial 
makeup was not reported. 
Cross-sectional 
(active data 
collection) 
 
Sexual function  IIEF, 5 scale version used 
entire scale used. Validation 
not provided. 
Lindau et al., 2012 Sample size: 1,879 post-MI (605F, 
1,274M). Average age: F: 61.1, M: 
58.6. Racial makeup: 71% white, 
21.6% black, 7.4% other. 
Cross-sectional 
(secondary 
analysis) 
Sexual activity 
 
 
Investigator developed 
questionnaires. Validation 
not provided. 
Lindau et al., 2016 Sample size: 2,802 post-MI (1889F, 
913M). Median age: F: 49, M: 48. 
Racial makeup: 79.6% white, 
14.7% black, 6.7% other. 
Longitudinal 
(secondary 
analysis) 
 
Sexual activity, 
Sexual function 
 
Investigator developed 
questionnaires. Validation 
not provided. 
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Oskay, Can, & 
Camci, 2015 
Sample size: 45F post-MI, 50 
controls. Average age: 62.7 in MI 
sample, 63.68 in controls. Racial 
makeup was not reported. 
Cross-sectional 
(active data 
collection) 
 
Sexual function, 
sexual satisfaction 
 
 
FSFI, 19 questions, entire 
scale used. Validated in 
target population (a=0.95) 
(Oksuz & Malhan, 2006). 
FSFI: Female Sexual Function Index; MI: Myocardial Infarction; IIEF-5: International Index of Erectile Function; ED: Erectile dysfunction 
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Table 2. 8 - Sexual function and satisfaction in patients with MI with study strengths and limitations 
Authors Effects on function and satisfaction Strengths Limitations 
Hodžić, 
Durek, 
Begić, 
Šabanović 
Bajramović, 
& Durak-
Nalbantić, 
2019 
Function: Approximately 77% of patients 
with MI reported at least some ED, compared 
to 51% in the control group. In the post-MI 
group, 33.33% had mild ED, 20.83% had 
mild to moderate ED, 12.5% had moderate, 
and 10.42% had severe ED. 
The study applied a strong 
measurement of sexual 
function, though it is only 
focused on erectile function. 
The use of a control group 
allowed comparisons to a 
health population. 
Validation for the IIEF in a post-
MI population was not provided. 
Collapsing the scores on the IIEF 
into categories (i.e. without ED, 
mild ED, moderate ED) masks the 
broad range of scores post-event, 
which are discussed minimally in 
the manuscript. The study did not 
appear to control for any 
confounding variables. The 
theoretical definition of sexual 
function was not provided. 
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Lindau et al., 
2012 
Activity: Patients who were sexually active 
before their MI, 48% of men and 59% of 
women engaged in sexual activity at a lower 
frequency, and 11% of men and 13 of women 
did not engage in sexual activity at all. 
Predictors of better sexual activity included 
having a discussion with a physician, having a 
partner, and being male. 
The study recruited and 
measured a large sample of 
men and women. 
Oversampling women helped 
to answer some understudied 
questions surrounding activity 
in women post-MI. The study 
was also able to measure 
individuals of different races, 
which are also understudied. 
Capturing of depression 
allowed for controlling by 
some psychological conditions. 
Asking patients to rate sexual 
activity over a period of 12 months 
severely hampers sensitivity of the 
data as it raises questions on how 
early or late patients actually 
resumed activity. All questions 
were investigator developed and 
are not validated or 
psychometrically tested. The 
inclusion criteria for the sample 
used in this secondary analysis 
was not discussed. Pre-MI sexual 
activity data was collected 
retrospectively which introduces 
recall bias. 
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Lindau et al., 
2016 
Activity: A total of 13% of patients never 
returned to sexual activity post-event. 
However, while patients decreased their 
overall frequency, 85% of men and 72.6% of 
women were still sexually active after 1 year. 
In addition, 85.8% of women and 88.6% of 
men still felt sexual satisfaction with their 
significant other despite the decreased 
frequency. 
Function: The sexual problems reported were 
lack of interest (Female: 40%, Male: 19%); 
inability to climax (Female: 19%, Male: 
13%); experienced orgasm too quickly (Male: 
14%); trouble with erection (Male: 22%), or 
lubrication (Female: 22%), or experienced 
physical pain (Female: 10%, Male: 4%). 
The study recruited and 
measured a large sample of 
men and women. The study 
oversampled women compared 
to men which aims to answer 
understudied questions 
regarding sexual function and 
activity. The study was able to 
measure individuals of 
different races. The study 
captured a wide range of 
sexual function problems in 
their survey, though they only 
measured prevalence rather 
than severity. 
The capturing of frequency of 
sexual problems produces 
questions about the actual severity 
of those problems. The questions 
were investigator developed and 
their psychometric properties were 
not provided. The exclusion of 
patients older than 55 years of age 
limits applicability to older 
populations. The study classifies 
expected resumption of sexual 
activity for its analysis but does 
not provide any justification or 
evidence for their presented 
operationalization. 
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Oskay, Can, 
& Camci, 
2015 
Function: Patients post-MI had statistically 
significantly lower scores on all subscales of 
the FSFI except for pain (16.41 ± 8.04 vs. 
23.13 ± 3.95). Approximately 88% of patients 
were worried about another MI. 
Satisfaction: Satisfaction scores were not 
statistically significant between patients post-
MI and healthy controls (4.03 ± 1.13 vs. 4.11 
± 1.07). 
The study utilized the FSFI, 
which is a strong 
multidimensional measurement 
of sexual function and 
satisfaction. The study 
compared the findings to 
healthy controls, which 
reduced concerns regarding 
internal validity. The study 
controlled for several 
covariates including 
depression and comorbidities. 
The study required participants to 
be married and have a regular sex 
life before taking the surveys, but 
a “regular” sex life is not defined 
by the study authors. Patients were 
asked about worries regarding 
their sex life, but these questions 
were not validated. The researcher 
provided guidance during survey 
collection which may have 
introduced bias or influenced 
respondents. Theoretical definition 
of sexual function and satisfaction 
was not provided. 
FSFI: Female Sexual Function Index; MI: Myocardial Infarction; IIEF-5: International Index of Erectile Function; ED: Erectile dysfunction 
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Discussion 
In this limited set of studies, a diverse range of sexual function issues were reported by 
patients with CAD and MI including orgasmic, erectile, arousal, and lubrication difficulties, in 
rates as high as 80-90%. The selected MI and CAD studies examined a constellation of outcomes 
that were operationally defined with numerous measures, most consistent with the theoretical 
definitions but not all adequately validated. Only three studies across the CAD and MI literature 
measured function and satisfaction concurrently. The overall dearth of literature in this 
population carries important implications for treatment and intervention, particularly given the 
large number of CAD and post-MI patients who experience sexual health issues. Given that 
sexual dysfunction and dissatisfaction is frequently seen in other chronic illness populations but 
receive considerably more study (Basson, Rees, Wang, Montejo, & Incrocci, 2010), more 
research is needed in CAD and post-MI populations to create a complete representation of sexual 
health that can be addressed with subsequent intervention. 
While men reported sexual problems more frequently, limited evidence suggests that 
women with CAD experience dysfunction more profoundly than men. However, despite marked 
sexual dysfunction, a consistent finding was that sexual satisfaction remained high in both CAD 
and MI populations and was comparable to healthy controls. This may indicate that in coping 
with CAD or MI, patients redefine new expectations and perceptions of sexual health while their 
physical sexual function worsens. Previous literature has found that coping strategies were 
pivotal for maintenance of general well-being with adjusting to cardiovascular disease, and so 
this could also apply to maintenance of sexual health issues (Mahrer-Imhof, Hoffmann, & 
Froelicher, 2007).  
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Among all the outcomes in the MI literature, sexual activity was studied the most often. 
Lindau et al. (2016) reported that despite a significant decrease in sexual activity at one month 
after MI, sexual activity rates rebounded in the timeframe between one month and one year for 
both men and women. In an earlier study, Lindau et al. (2012) also reported that among patients 
who had been sexually active, both men and women reported less frequent sexual activity in the 
year post-event. Based on the evidence presented above, it can be reasonably concluded that 
sexual activity is decreased or not resumed at all in 50-60% of previously sexually active patients 
following an MI, and that the most common sexual health problems include erectile dysfunction 
in men, and a general loss of interest and desire in both genders.  
While some predictors can be hypothesized from the evidence presented, the lack of 
appropriate statistical methods in the current literature precludes definitively identifying these 
important variables. While there was stronger evidence of predictors in the MI literature, the two 
articles that were methodologically rigorous enough to identify predictors only targeted sexual 
activity, and relied on retrospective data collection. While there is one previously conducted 
study that has modeled predictors of function and activity, the study was conducted with a 
mixture of MI, heart failure, angina, acute coronary syndrome, peripheral bypass, pacemaker 
implantation, implantable cardiac defibrillator, and coronary bypass patients, and also included 
patients with emphysema and stroke, while declining to separate by cardiac condition and so 
results were not transferrable to post-MI patients (Mosack, Hill, & Steinke, 2015). This study 
was not included in this review given its lack of cardiac condition-specific results. 
Despite the identified evidence, there were several methodologic inadequacies in the 
available MI and CAD literature. Seven of 11 studies provided unclear or unreported diagnostic 
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and sampling procedures, and four studies utilized poorly validated measurements. Overall, 
studies overwhelmingly targeted specific outcomes of sexual health, with few focusing on a 
broad biopsychosocial representation. An explanation for this could be that sexual function is a 
complex multidimensional construct, and as such it remains an empirical challenge to study. As a 
result, synthesizing the impact of MI or CAD on sexual function is made difficult when multiple 
different measurements are used to operationalize the same theoretical outcome. This review 
highlights the complex operationalization of sexual function into multiple components that are 
not consistent across studies. This was made evident by the six different measurements that were 
used for individual components of sexual function and satisfaction, with only two studies 
capturing a complete multidimensional representation using the FSFI (Kaya, Yilmaz, Nurkalem, 
Ilktac, & Karaman, 2007; Oskay, Can, & Camci, 2015). Furthermore, studies utilizing 
investigator developed questionnaires were unclear on how they were developed and did not 
provide evidence for their validity or reliability (Træen & Olson, 2007; Rundblad et al., 2017; 
Lindau et al., 2012; Lindau et al., 2016).  
This review also revealed numerous gaps in the current literature alongside the general 
observation of how little robust research has been published in both areas. Overall, the studies 
identified were primarily descriptive and cross-sectional. In addition, no study examined patients 
past one year, so it is uncertain how these trends could change over a longer timeframe. The lack 
of data on racial and sexual minorities in the CAD literature indicate that additional studies with 
diverse populations would be needed to stratify by sexual orientation, sexual identity, and race. 
Second, five studies excluded non-married individuals, citing their sample’s culturally based 
reluctance to disclose sexual health information. Cultural differences in expression of sexuality 
may provide important direction when counseling, assessing, and aiding patients with sexual 
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issues, so further research is indicated to provide culturally sensitive sexual care to these 
populations (Goossens et al., 2011). Lastly, few studies compared patients post-MI to a general 
healthy population, which reduces the internal validity of those findings. 
Overall, the literature provided a limited definition of sexual health, particularly in 
patients post-MI. This indicates that the landscape of sexual health in this population remains 
fragmented and under-supported. In summary, the key gaps identified from this review of the 
literature are the lack of a consistent definition of “sexual health” in this population, little 
consensus on the definition of sexual health components, the absence of robust MI-specific 
predictor research, and a lack of longitudinal data on sexual health changes over time, 
particularly at a short term-post discharge. The absence of robust longitudinal models is a key 
gap to address in order to advance the state of the science. Thus, the next step is to apply a 
prospective longitudinal study to both identify sexual health over time and to evaluate modifiable 
predictors of positive and negative sexual health. 
Conceptual Framework 
The results of the literature review identified a need for multidimensional longitudinal 
sexual health data in the post-MI population. Expanding the current understanding of the 
relationship between MI and sexual health is vital to improving patient-centered care and 
HRQOL. As such, a conceptual framework was developed to visualize the components of sexual 
health that are affected by an MI in the context of relevant moderators and mediators, while also 
applying a longitudinal lens. 
The conceptual framework that served as the basis for this dissertation research was the 
International Classification of Functioning, Disability, and Health (ICF). The ICF was introduced 
by the World Health Organization (WHO) in 2001 after extensive testing across multiple 
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disciplines to provide a standard tool for measuring health and disability across a variety of 
conditions. The model serves as a conceptual basis for the definition and measurement of any 
pathologic or physical disability and is operationalized to apply across the entire lifespan (WHO, 
2001, p. 7). The ICF model creates a dynamic interaction between a person’s health condition by 
providing a research tool for measuring outcomes and quality of life, with both environmental 
factors and personal factors moderating outcomes. The ICF was created to provide a scientific 
basis for understanding and studying both health and disease, and so is appropriate for this 
application to patients post-MI (WHO, 2001, p. 5). To date, the ICF has not been used in the 
context of sexual health with cardiac patients, but is applicable given the original model was 
designed to capture many disease-specific effects on function and disability (WHO, 2001, p. 5; 
McDougall, Wright, and Rosenbaum, 2010). Thus, a theory synthesis was conducted to explicate 
the key concepts, external and internal drivers, and visualize the overall effects of MI on sexual 
health.  
The aim of a synthesis is to construct a theory of interrelated ideas from available 
evidence, integrating concepts and statements into an organized network (Walker & Avant, p. 
140). The steps of theory synthesis are as follows: 1) to specify the focal concepts as the 
foundation for the synthesized theory; 2) review the literature to identify factors related to the 
focal concepts; and 3) organize concepts and statements into a representation of the phenomena 
of interest that is both efficient and detailed (Walker & Avant, p. 140). For this synthesis, the 
ICF is applied as the foundation for extrapolating the relationships between sexual health and 
MI. An MI represents a critical event that produces changes to sexual health, and as such will 
represent the health condition at the top of the model. From this, revised versions of the ICF 
model from other literature - and an additional sexual health conceptual model - are integrated to 
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fully represent the concepts relevant in post-MI sexual health. Table 2.9 details the steps of a 
theory synthesis as outlined by Walker and Avant. 
Table 2. 9 - Steps of a theory synthesis (Walker & Avant, 2011) 
Step Description Page 
1 Designation of a topic of interest 52 
2 Identify the factors related to focal concepts 55 
3 Create and visualize the relationships among variables and focal 
concepts (moderators and mediators) 
59 
4 Construct an integrated representation 62 
 
Specification of Focal Concepts 
According to Walker and Avant, a theory synthesis begins with designating a topic of 
interest (Walker & Avant, p. 140). In this exercise, the topic of interest is conceptualizing the 
effects of MI on sexual health. The first step is to define the focal concepts germane to the parent 
model or theory. The focal concepts from the original ICF are “body functions and structures” 
“activities” and “participation” (WHO, 2001, see figure 2.3), which are explained in greater 
detail below. First, the general model is briefly discussed, then the model’s applicability to MI-
induced sexual dysfunction is elaborated. 
International Classification of Functioning, Disability and Health Model 
The ICF model is appropriate for a focus on sexual health given that individuals are 
sexual beings throughout the lifespan, even into older age (WHO, 2001, p. 7). First, the basic 
premise of the original ICF model was intentionally kept neutral to capture a comprehensive 
spectrum of the effects of MI on sexual functioning (WHO, 2001, p. 8). This is applicable 
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because treatment for sexual dysfunction post-MI means identifying both positive and negative 
influencers of sexual health to be reinforced or addressed, respectively. The ICF also details an 
interaction between function and disability, conceptualized as collective terms stemming from a 
biological, individual, and social perspective.  
Figure 2. 3 - Original ICF model and components (WHO, 2001) p. 18 
 
 
 
 
 
Body Functions and Structures 
The components of “body functions and structures” are classified according to their 
response to a disease. Function is defined in a broad capacity, as the “…positive or neutral 
aspects of the interaction between a person’s health condition and that individual’s contextual 
factors and environmental factors” (WHO, 2001, p. 8). Body functions and structures encompass 
  54 
anatomical systems including mental, sensory, speech, cardiovascular, immunological, 
respiratory, neurological, musculoskeletal, and integumentary. Importantly, they also include 
reproductive systems, which are especially relevant given the subject matter of sexual health. In 
this synthesis exercise, function was given more attention than structure. This is because the 
original ICF operationalizes structure loss in terms of total or partial absence of body parts, such 
as loss of limbs, which are less relevant in this population (WHO, 2001, p. 24). 
Activities and Participation 
The original conceptual model groups “activities and participation” into one domain. This 
encompasses how patients learn and apply knowledge, communication, general mobility, and 
self-care for participation in major and minor life endeavors (WHO, 2001). This domain also 
includes interpersonal interactions and relationships in community, social, and civic life (WHO, 
2001). 
Personal and Environmental Factors 
The “personal and environmental factors” play an important role in the ICF model and 
may vary from patient to patient (WHO, 2001). They are external to the individual and can exude 
either a positive or negative influence on the components of function, activities, and 
participation. Personal factors can include age, sex, marital status, number of children, 
occupation, upbringing, culture, and religious beliefs (WHO, 2001). This also includes 
behavioral factors such as coping styles, behavioral patterns, gender roles, and the individual’s 
psychological makeup (WHO, 2001, p. 17). These factors represent the complete background of 
the individual at the personal level, separate from the health condition or health state (WHO, 
2001).  
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The environmental factors can include products, technologies, relationships, attitudes, 
services, systems, and policies (WHO, 2001). In addition, they are further divided into the 
immediate environment factors, which includes the home, workplace, or school, while the 
societal factors include higher-level systems such as community and government networks. 
(WHO, 2001).  
Factors Related to Focal Concepts 
The second step in a theory synthesis is to identify the related factors, which involves 
reviewing the literature to identify the key focal points or concepts in the original framework 
(Walker & Avant, p. 145). First, the construct of sexual health is elaborated upon in greater 
detail. The World Health Organization defines sexual health as “a state of physical, emotional, 
mental and social well-being in relation to sexuality; it is not merely the absence of disease, 
dysfunction or infirmity. Sexual health requires a positive and respectful approach to sexuality 
and sexual relationships, as well as the possibility of having pleasurable and safe sexual 
experiences, free of coercion, discrimination, and violence. For sexual health to be attained and 
maintained, the sexual rights of all persons must be respected, protected and fulfilled.” (World 
Health Organization (WHO), 2017 p. 3).  
A review of outside conceptual models published in the literature was conducted to 
identify previously created representations of sexual health. In breast cancer, Barton and 
colleagues (2004) detail a schematic depicting the three major components of sexual health and 
sexuality (p. 600). The concepts of function, interest and satisfaction influence each other and 
consist of their own sub-components. Interest is made up of libido, motivation, physiology, self-
image, cognition, emotion, and relationship. Function consists of arousal, orgasm, physiology, 
anatomy, cognition, and emotion. Lastly, satisfaction is made up of resolution, physiology, 
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cognition, emotion, and relationship. This conceptualization represents a multidimensional 
construct of sexual health, which was incorporated into the resulting conceptual framework in 
the subsequent paragraphs. Figure 2.4 details this schematic of sexuality and sexual functioning 
(Barton, Wilwerding, Carpenter, & Loprinzi, 2004). 
Figure 2. 4 - Schematic of Concepts Involved in Sexuality and Sexual Functioning (Barton, 
Wilwerding, Carpenter, & Loprinzi, 2004) 
 
 
The first focal concept of the ICF is body functions, defined as the “physiological and 
psychological functions of body systems” (WHO, 2001, p. 12). There are also impairments to 
body functions, defined as the “problems that stem from a significant loss or deviation from the 
norm” (WHO, 2001 p. 12). The presented body function definitions are applicable to sexual 
health in how physiological damage from MI affects the completion or initiation of the sexual 
response cycle. The functional changes experienced by patients post-MI are conceptually similar 
to how “reproductive systems” are impacted from a disease or condition as described in the 
original ICF (WHO, 2001, p. 29). There is a growing body of evidence on the effect of MI on 
sexual function that directly impairs the completion of this cycle, matching the conceptual 
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definition in the ICF. Latent class analysis of sexual dysfunction has found groupings of 
symptoms in sexual arousal, desire, and pain, which are all relevant phenomena observed in 
post-MI patients (Laumann, Paik, & Rosen, 1999). Erectile dysfunction and vaginal dryness are 
common symptoms in patients post-MI that affects sexual organs and limits their function (Kaya, 
Yilmaz, Nurkalem, Ilktac, & Karaman, 2007). Furthermore, cross-sectional studies have reported 
that sexual function scores, including orgasm and lubrication, are lower in women with MI 
compared with control groups (Oskay, Can, & Camci, 2015).  
One key psychological component of sexual health is sexual fear. There is a growing 
body of evidence on sexual fear as a common complication of MI development and has been 
documented in as high as 88% of women and in 58% of their husbands (Oskay, Can, & Camci, 
2015). In another study, fear of resuming sexual activity was expressed by 51% of patients and 
44% of partners, and negatively impacted sexual activity (Eyada & Atwa, 2007). Patients post-
MI are fearful about returning to sexual activity, and desire discussion with providers about the 
topic (Kaya et al, 2007). However, only 3% of men and 18% of women are adequately educated 
prior to discharge (Bedell, Duperval, & Goldberg, 2002). Furthermore, a cross-sectional study of 
302 patients across 3 separate hospital samples found that communication issues stemmed from a 
lack of information from providers, and a reduced shared intimacy between the individual and 
their partner (Mosack & Steinke, 2009).  
The second focal concept, activity, is defined in the original ICF model as “the execution 
of a task or action by an individual… and the activity limitations they experience” (WHO, 2001 
p. 29). This is appropriate to sexual health given that sexual activity constitutes a primary act of 
sexual expression taken either individually or with one or more partners. Sexual activity can also 
encompass a variety of activities including penetrative and non-penetrative intercourse such as 
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masturbation, fondling, kissing, and hugging (Steinke et al., 2013). Sexual activity has been the 
dependent variable in several previous sexual health studies with patients post-MI. A secondary 
data analysis conducted in the United States and Spain found that 48% of men and 59% of 
women had reduced sexual activity post-MI, while 11% of men and 13% of women never 
resumed sexual activity in the following year (Lindau et al., 2014).  
The third focal concept of participation is defined as “involvement in a life situation” 
ingrained in individual, community, social, and civic life (WHO, 2001). This can include 
interpersonal interactions, relationships, learning, or applying knowledge (WHO, 2001, p. 14). 
Participation in the context of sexual health was conceptualized as sexual satisfaction, which ties 
into emotional involvement of the individual as a sexual being. The literature has indicated that 
partnered individuals retain high satisfaction, but that MI can cause poorer dyadic satisfaction 
and overall marital relations (Kazemi Saleh, Pishgou, Farrokhi, Fotros, & Assari, 2008). A 
second cross-sectional study of 462 men and women found that both groups reported less 
satisfaction with sexual activity post-MI, directly related to perceived health pre-event compared 
to post-event (Drory, Kravetz, & Weingarten, 2000). 
Personal and Environmental Factors 
The contextual factors of person and environment in the ICF act as both moderators and 
mediators of the relationship between MI development and sexual health. In the chronic disease 
literature, the ICF model has been modified to further detail the outside influences on quality of 
life at both the internal and external level (Rivers et al., 2017). Sexual health components are 
also influenced by moderators, which include personal and environmental factors. The 
moderators and mediators in this conceptual model are explained in further detail. 
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Personal factors include age, race, gender, education, employment status, MI severity, 
partner status, and comorbidities. Pertinent cardiac comorbidities include cancer, diabetes, 
chronic obstructive pulmonary disease (COPD), and neurologic disorders. There is a growing 
body of evidence to suggest that these comorbidities can also negatively impact sexual function 
through either impaired genital response from cancer treatment and hormonal changes (Basson, 
Rees, Wang, Montejo, & Incrocci, 2010; Westermann, Wolford, & Krychman, 2016), the 
physiological and psychologic challenges of breathlessness that comes with COPD (Vincent & 
Singh, 2007), the damage to the vasculature caused by diabetes (Steinke, Mosack, & Hill, 2014), 
and the psychological and functional deficits from neurological impairment such as multiple 
sclerosis, spinal cord injury, or stroke (Basson, Rees, Wang, Montejo, & Incrocci, 2010). MI 
severity can have varying effects on patient outcomes depending on if their MI was STEMI or 
NSTEMI, or was classified as type 1 or type 2. Environmental factors exist outside the individual 
but could nonetheless moderate the relationship between an MI and sexual health. One such 
factor includes rehabilitation status. Cardiac rehabilitation is an intervention that approximately 
half of post-MI patients undergo upon discharge from the hospital (Fang, Ayala, Luncheon, 
Ritchey, & Loustalot, 2017). Rehabilitation may improve functional status and tolerance, in turn 
influencing tolerance for sexual activity.  
Moderators 
Based on the currently available literature, several factors were considered as moderators 
of the relationship between MI and sexual function. These included depression, anxiety, familial 
support, relationship dynamics, religion, spirituality, and cultural backgrounds. These act as 
moderators of the strength and/or direction of the association between MI and sexual health 
(Bennett, 2000). They are split between personal and environmental factors in the final model, 
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though some listed above were not included in the final model as elaborated below (see figure   
2.5). 
First, depression is common in patients post-MI and can play a major role in recovery and 
subsequently impact participation in sexual activity (Eyada & Atwa, 2007). Depression rates are 
higher in post-MI patients (35%) compared to general populations (9%) (Daniel et al., 2018). 
Given that depression was identified in 20% of 10,785 MI patients over eight studies, depression 
could also play a key role in sexual satisfaction, as depression reduces desire for many activities, 
including sexual activity. A cohort study of 493 patients found that depressive symptoms played 
a significant factor in the relationships between sexual function and quality of life (Kriston, 
Gunzler, Agyemang, Bengel, Berner, & SPARK Study Group, 2010). An additional systematic 
review and meta-analysis also found a bidirectional relationship between sexual dysfunction and 
depression (Atlantis & Sullivan, 2012).  
Another important psychosomatic symptom that often presents alongside depression is 
anxiety. Like depression, anxiety rates in post-MI patients are larger than a general population. A 
recent cohort study of 99 reported that of 37% of patients post-MI had anxiety, which was 
considerably larger compared to the 7% rates among healthy participants (Daniel et al., 2018). 
Additional studies have reported that anxiety can persist upwards of five months post recovery 
for MI (Steinke & Swan, 2004). Previous studies have found associations between anxiety and 
sexual function. In a cohort study of 64 patients, sexual satisfaction was inversely related to 
anxiety with an odds ratio of -2, and sexual satisfaction also accounted for 42% of the variance in 
anxiety scores (Steinke & Wright, 2006).  
Third is familial support, which may play a role in how individuals rely on family 
members outside of their spouse for management of stressful situations. Social and familial 
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support is directly related to self-efficacy and hopelessness following MI (Garcia, Denardin 
Budó, Schwartz, Simon, & da Silva, 2015; Smallheer & Dietrich, 2019). A cohort study found 
that social support played a key role in coping strategies with post-MI anxiety and this could 
extend to sexual function (Son, Friedmann, Thomas, & Son, 2016). 
Some moderators were not included in this conceptual model due to a lack of concrete 
evidence or a well validated measurement. Cultural backgrounds have been studied in both 
cardiac and post-MI patients and are known to influence how patients discuss sexual concerns 
with providers (Goossens et al., 2011; Altıok & Yılmaz, 2011). In addition, patient spirituality 
has been found to play a role in improving quality of life in patients post-MI, and so may also 
exhibit an effect on management of sexual dysfunction (Wachelder, Moulaert, van Heugten, 
Gorgels, Wade, & Verbunt, 2016). In cardiac illness, religiosity or spirituality was linked with 
improved HRQOL and illness adjustment and so may be an important interaction to study in 
patients post-MI (Trevino & McConnell, 2014). However, measuring and quantifying cultural, 
religious, or spiritual preferences may be too complicated and nuanced, and the evidence as a 
whole remains underdeveloped. Community and employment support (outside of employment 
status) were also not measured as their effects are difficult to capture due to the broad range of 
possible responses and the lack of robust measurements. Furthermore, relationship dynamics 
assumes the presence of a partner, and may not be the case for single patients, and so was not 
directly measured as a predictor, although marital status was collected as a covariate. Lastly, the 
influence of the medical professional or hospital network was not explored due to the lack of 
robust surveys. 
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Mediators 
One variable was conceptualized as a mediator of the relationship between MI and sexual 
function: utilization of coping styles. The methods through which an individual adjusts and copes 
with life events is also an internal pathway for which sexual health adjusts after an event. There 
is some preliminary evidence to support the effect of coping strategies by regulating distress and 
mediating the changes in well-being post event (Kroemeke, 2016). For example, a longitudinal 
study of 460 patients post-MI found that education, anxiety, and social support also played key 
roles in coping strategies which may in turn affect how sexual dysfunction is managed by the 
patient (Son, Friedmann, Thomas, & Son, 2016).  
Construction of an Integrated Representation 
The third step in a theory synthesis is to create and visualize the relationships among 
variables and focal concepts (Walker & Avant, p. 145). First, the overall relationship is 
described. The event of MI causes changes to a multidimensional construct of sexual health and 
is as such placed at the top of the model in similar fashion to the ICF. Personal factors that are 
unique to the individual and outside factors related to the environment both moderated the 
relationship between the disease progression and the outcome of sexual health. Coping was 
depicted as a mediator along the trajectory from MI to sexual health. Sexual health was split into 
the concepts of physical, psychological, and social as organized by the ICF model and Barton, 
Wilwerding, Carpenter, & Loprinzi (2004).  
Second, the nature of each relationship in the proposed model is described in further 
detail. The illness condition (MI) was placed at the top of the model to designate a unidirectional 
relationship with the outcome of sexual health. The ICF model places the external factors outside 
of the system, playing a unidirectional influence on the transition process. In this synthesis, these 
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are moved alongside the condition at the top of the sexual health system to symbolize the 
upstream role they play on influencing sexual health over time. The bottom of the model is 
where the construct of sexual health was placed and contained three components including 
physical, psychological, and social. The bidirectional relationships between the components 
illustrates the multifaceted and complex nature of sexual health as visualized in Barton, 
Wilwerding, Carpenter, & Loprinzi (2004) as well as other sexual health literature (Basson, 
2001). The domains of physical, psychological, and social were distinguished as separate 
entities, but were still interconnected to illustrate the interaction between the different domains. 
This representation is appropriate as the ICF model allows for either partial overlap or utilization 
of all domains under all the subheadings (WHO, 2001, p. 16).  
The personal and environmental factors that were measured in this proposal are included 
in the final conceptual framework. However, for the purposes of this dissertation, only some 
variables were included and measured. First, only sexual activity, sexual function, sexual 
satisfaction, and sexual fear was included in this framework and measured in the study. To date, 
there is no validated measure that captures a complete representation of sexual health. While 
sexual health is a multidimensional construct that contains many biopsychosocial components 
unmentioned in this conceptual framework including intimacy, body image, partner sexual 
function and role engagement, there is no validated measurement that captures every component 
of sexual health. As a result, sexual health was operationalized by measuring desire, arousal, 
lubrication/erection, satisfaction, and pain with intercourse through two well validated measures: 
the Male/Female Sexual Function Index (MSFI/FSFI). Sexual fear was added to capture an 
additional psychological domain. 
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The moderators included in the final framework were anxiety, and depression. As 
previously mentioned, these variables were supported by the current evidence, and as such were 
recognized as potential predictors that were assessed in the second aim of this dissertation. 
Furthermore, coping is an important potential mediator of the relationship between the event of 
MI and the outcome of sexual health, and so was also included and measured in the final model.  
In summary, the final synthesized theory details the external and internal relationships 
and integrates a multidimensional representation of sexual health based on current evidence. 
Overall, the presentation of sexual health post-MI is understudied, as the effect of many external 
and internal factors are poorly articulated. While there has been a recent call for outside 
interventions including sexual counseling as a component of standard care (Steinke et al., 2013), 
sexual counselling has not been well implemented and the effects of rehabilitation on sexual 
health in patients post cardiac event are largely unknown (Byrne et al., 2016). Exploring the 
impact of predictors through this conceptual model will help to illuminate targets to evaluate for 
potentially effective interventions. Ultimately, it is crucial to apply this model empirically in a 
patient sample, as overall a theory cannot provide explanations, predictions, or control for 
phenomena on their own without being tested (Walker & Avant, p. 80).  
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Figure 2. 5 - Conceptual model 
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CHAPTER III 
Methods 
 
Study Design 
This study employed a prospective cohort design. The study aims were to 1). describe 
sexual function and satisfaction within two weeks and at three months post-MI; 2). determine if 
depression, anxiety, and utilization of coping strategies are associated with changes in sexual 
function and satisfaction from two weeks to three months post-MI; 3). describe the relationships 
between the multiple domains of sexual function within two weeks post-MI. The study was 
approved by the Institutional Review Board (IRBMED) regulatory body (HUM00147371). 
Study Participants 
Sample Size and Power Analyses 
Power analyses were conducted for all three aims using SAS software version 9.4 (SAS 
Institute, Cary, NC). Power analysis for a paired samples t-test was conducted for the first aim. 
The standard deviations and means for this power analysis were adopted from a previous study 
that applied the FSFI in a cohort of patients post-MI (Oskay, Can, & Camci, 2015). The previous 
mean of FSFI scores in women post-MI at three months was 16.41, while a hypothesized mean 
of FSFI scores at two weeks was conjectured at 12.35. Applying an alpha level of 0.05 and a 
power of 0.8, 14 participants (with two time points) were needed to determine a statistically 
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significant correlation with a magnitude of at least 0.5 from two weeks to three months. The final 
sample size of 21 pairs with these conjectured scores equated to 0.957 power.  
Power analysis for the second aim was conducted using a treatment by time approach 
with two groups of covariate scores (low and high) in SAS. An exemplary data set with means 
for each group of a selected predictor variable (depression) across the two timepoints was created 
(Castelloe, 2014). The conjectured standard deviation in depression scores used was 2.5. The 
correlation between timepoints and decay between timepoints within a LEAR correlation was 0.6 
and 0.8 respectively. Applying an alpha of 0.05 and power of 0.8 equated to 10 required 
participants with two data points. The primary aim of increased sexual function with a sample 
size of 13 male participants equated to a power of 0.936. The secondary aim of sexual activity 
with a sample size of 18 males equated to 0.993 with these hypothesized score changes.  
Power analysis for the third aim was conducted in SAS. The number of variables adjusted 
for in the correlation between MSFI domains of sexual function and sexual fear was set at 0 
given the smaller sample size. The correlation coefficient (alpha) was set at 0.5 and power of 0.8. 
Applying these settings produced a total required sample size of 29. The final sample of 28 
achieved a power of 0.799.  
Study Procedure 
Recruitment and Consent 
Recruitment of adult participants was conducted on inpatient units 7B (Cardiology and 
General Medicine Telemetry) and 7C (Cardiac Step-Down) at the University of Michigan Health 
System (Michigan Medicine) in Ann Arbor, Michigan. Eligible participants were first 
approached on these inpatient units to promote face-to-face interaction when discussing the 
details of the study. The study’s purpose, risks, benefits, and the right to decline participation 
  76 
were explained to the patient. Given the sensitive nature of the study questionnaires, patients 
were offered a follow up phone call post-discharge to discuss the study in a more private setting. 
If a patient declined participation, they were asked to complete a brief 4-item survey which 
measured age, gender, race, and ethnicity, in order to compare demographics of those who 
agreed vs. declined to participate. If an individual agreed to participate, he or she signed 
informed consent at the bedside. The patient’s address and phone number were also reviewed 
with the patient at the bedside from the medical record to ensure accuracy. A schematic of the 
entire recruitment process is detailed in figure 3.1. 
Figure 3. 1 - Recruitment schematic 
 
Eligibility Criteria 
The primary investigator screened for eligible subjects by identifying the patient’s 
admitting diagnosis on the inpatient floor census. Inclusion and exclusion criteria were verified 
using the patient’s medical record. The inclusion and exclusion criteria were as follows:  
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Inclusion Criteria 
• Adult male and female patients (over 21 years of age). 
• Diagnosed with a myocardial infarction within the past 7 days. 
• Troponin T or I value exceeding the 99th percentile of a normal reference population 
(Thygesen et al., 2012). 
• Able to read and write English. 
Exclusion Criteria 
• Patients with a pertinent medical or mental condition that would interfere with survey 
data (breast/gynecologic cancer, prostate cancer, COPD, or HIV infection). 
• Patients who were intubated or otherwise medically or psychologically unstable (alcohol 
withdrawal, suicide precautions). 
• Patients with co-morbidities or terminal disease which limited life expectancy to less than 
1 year. 
Data Collection 
Following consent, data from validated self-report questionnaires were collected at two 
timepoints (baseline-post-MI [two weeks post discharge from the hospital], and [three months 
post discharge from the hospital]). Consented participants were mailed survey questionnaires 
within one week of discharge, generally within the first day. These questionnaires were then 
completed at the participant’s residence and returned to the investigator in a pre-addressed, 
stamped envelope. A mailed photocopy of the signed consent form including the investigator’s 
phone number was provided with the first round of questionnaires. The return envelope did not 
include a return address to protect confidentiality. Follow up phone calls were made at both 
timepoints following the mailing of the questionnaires to assess for potential questions and 
inform the patient of upcoming questionnaire completion. As an incentive, only individuals who 
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completed both timepoints received a 30-dollar gift card provided by the Human Subject 
Incentives Program (HSIP). The full data collection schematic is detailed in figure 3.2.  
Figure 3. 2 - Data collection schematic 
Days represent time after discharge date 
Data Management 
 Names and addresses were collected on printed labels used to mail the surveys. 
Participants were identified with a unique research identification number. All forms were labeled 
with this unique research number and were stored in a locked cabinet. The mailing labels and 
consent forms were kept in separate locked cabinets from the data. Access to all electronic data 
were password encrypted and accessible to only the primary investigator and the primary mentor 
behind the University of Michigan’s firewall.  
All study data were entered using REDCap (Research Electronic Data Capture) electronic 
data capture tools hosted at the University of Michigan (Harris, Taylor, Thilke, Payn, Gonzalez, 
& Conde, 2009; Harris et al., 2019). This was done to utilize an intuitive data capture interface, 
and to provide a direct export platform into common statistical software packages. Data were 
first entered in REDCap data management software before export to Microsoft Excel for 
cleaning. All data was double entered and cross-referenced to check for errors. The subsequent 
processed data was then downloaded into SAS software version 9.4 (SAS Institute, Cary, NC) 
for analysis. 
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Measures 
The theoretical definitions and operationalization of the dependent variables are 
summarized in table 3.1, while the predictors and covariates are summarized in table 3.2. In this 
study, the dependent variable was sexual function and satisfaction, while potential predictors 
were selected from the developed conceptual framework detailed in chapter two (Fig. 2.5, p. 65). 
These predictors included depression, anxiety, and use of coping strategies, and were based on 
relevant literature surrounding sexual health in the MI population. The measurements are 
described in further detail in accordance with each study aim. 
Dependent Variables 
Sexual health is a multidimensional construct made up of physical, psychological, and 
social components. However, to date there is no validated measure that captures a complete 
representation of sexual health. As a result, function and satisfaction were measured instead of 
sexual health due to wider availability of validated measures. Sexual function was 
operationalized using the Female Sexual Function Index (FSFI) (Rosen et al., 2000), and the 
Male Sexual Function Index (MSFI) (Kalmbach, Ciesla, Janata, & Kingsberg, 2012). The FSFI 
is the best available measurement to capture sexual function as a multidimensional construct and 
is considered the gold standard by the International Society for the Study of Women's Sexual 
Health (ISSWSH). The FSFI is a well-validated measure with 19 items in six subscales covering 
the entire sexual response cycle. These include desire, arousal, lubrication, orgasm, satisfaction, 
and pain during intercourse. Questions on the FSFI are answered on Likert-type scales which are 
then transformed into a continuous outcome for each scale. Raw scores are multiplied by a factor 
before totaling, with desire being multiplied by a factor of 0.6, orgasm, satisfaction, and pain by 
a factor of 0.4, and arousal and lubrication by a factor of 0.3 (see appendix A). Scores can range 
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from 2-36, with a higher score indicating better sexual function. The measurement also has a cut 
off score of 26.55 which clinically indicates sexual dysfunction (Wiegel, Meston, & Rosen, 
2005). The internal consistency of the measures is 0.93–0.97 for the total score, and 0.89–0.92, 
0.90–0.95, 0.93–0.96, 0.91–0.94, 0.82–0.91, and 0.92–0.94 for each subscale (Rosen et al., 
2000). The test-retest reliability of the measures is 0.88 for the total score and 0.83, 0.85, 0.86, 
0.80, 0.83, and 0.79 for each subscale, validated in a population of adult women (Rosen et al., 
2000). The measurement has been used in patients post-MI (Oskay, Can, & Camci, 2015). 
Appendix A contains the FSFI questionnaires and the domain scoring algorithm. 
 In male post-MI participants, sexual function was measured using the Male Sexual 
Function Index (MSFI). This measurement consists of 16 items and was adapted from the FSFI 
using the same domains of desire, arousal, and orgasm. The MSFI was selected to provide a 
consistent operationalization of sexual function and satisfaction with the FSFI. Thus, in areas 
that are conceptually and operationally similar in both males and females, such as satisfaction, 
orgasm, and arousal, item structure and the number of questions are the same to maintain 
consistency. In subscales that are different, such as lubrication/erection and pain, the measures 
were revised to capture the physiological differences in male and female sexual function. In the 
MSFI, lubrication was exchanged with erectile function, and pain was removed (Kalmbach, 
Ciesla, Janata, & Kingsberg, 2012). The other questions remained unaltered from the original 
phrasing in the FSFI. Like the FSFI, desire is multiplied by a factor of 0.6, orgasm and 
satisfaction a factor of 0.4, and erection and arousal a factor of 0.3 when calculating the final 
scores (see appendix B). The measurement can range from 2-30, with a higher score indicating 
better sexual function. A clinical cut off score for dysfunction has not been established for this 
measurement. The internal consistencies for the MSFI were 0.85, 0.82, 0.76, 0.66 and 0.82 for 
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each of the subscales. (Kalmbach et al., 2015). Appendix B contains the MSFI questionnaire and 
scoring algorithm.  
In addition to the above functional measures, a psychological component of sexual 
health, sexual fear, was measured using the sexual fear subscale of the Multidimensional 
Sexuality Questionnaire (MSQ). The original measurement consists of 100 questions with 20 
subscales with Cronbach’s alphas ranging from 0.72 to 0.91 (Snell, Fisher, & Walters, 1993). 
The sexual fear subscale is five questions and is graded from 1-4, with a Cronbach’s alpha of 
0.82 (Snell, Fisher, & Walters, 1993). The score can range from 0-20, with higher scores 
indicating more sexual fear. The reliability score of the sexual fear subscale is 0.67 (Snell, 
Fisher, & Walters, 1993). The measurement was developed in an adult English-speaking 
population but has not been used in cardiac patients, meaning that the questions are not gauged 
specifically towards MI (Snell, Fisher, & Walters, 1993). To address this, a header was added to 
the questionnaire that asked the patient to think about sexual fear in the context of since they had 
their MI. This clause was adopted from the Impact of Events Scale-Revised (IES-R) (Weiss, 
2007). The sexual fear subscale with this additional header is presented in appendix C. 
Table 3. 1 - Theoretical definitions and operationalization of outcomes 
Outcome Theoretical Definition Operationalization 
Overall 
function 
“Normal sexual functioning comprises sexual 
activity with transition through the phases from 
arousal to relaxation with no problems, and 
with a feeling of pleasure, fulfilment and 
satisfaction” (Corona, Jannini, & Maggi, 2006). 
Total Female Sexual 
Function Index or Male 
Sexual Function Index 
scores 
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Desire 
Sexual interest, sexual thoughts or fantasies, 
and motivations for attempting to become 
sexually aroused (Lewis et al., 2010). 
Desire subscale of the 
Female Sexual 
Function Index or Male 
Sexual Function Index 
Questions 1-2 
Arousal 
“The feeling of being ‘turned on’ or ‘excited’” 
(Corona, Jannini, & Maggi, 2006, p. 245). 
Arousal subscale of the 
Female Sexual 
Function Index or Male 
Sexual Function Index 
Questions 3-6 
Erection 
The process in which penile tissues become 
engorged due to increased blood flow (Hill, 
2008, p. 252). 
Erection subscale of 
the Male Sexual 
Function Index 
Questions 7-10 
Lubrication 
The process in which the labia majora and 
minora become engorged with moisture 
seeping through vaginal walls due to increased 
blood pressure (Hill, 2008, p. 252). 
Lubrication subscale of 
the Female Sexual 
Function Index  
Questions 7-10 
Orgasm 
“Subjective feelings of intense sensation and 
pleasure, including a sudden discharge of 
accumulated erotic tension at sexual climax and 
a temporarily altered state of consciousness” 
(Garcia, Lloyd, Wallen, & Fisher, 2014, p. 2). 
Orgasm subscale of the 
Female Sexual 
Function Index or Male 
Sexual Function Index 
Questions 11,12,13 
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Pain 
Pain during sexual intercourse that is not 
otherwise attributable to other sexual 
dysfunction problems (McCabe et al., 2016, p. 
137). 
Pain subscale of the 
Female Sexual 
Function Index 
Questions 17, 18, 19 
Sexual 
satisfaction 
“The response and feeling that one’s sexual 
needs are being met as well as the needs of 
their partner” (Ashdown, Hackathorn, & Clark, 
2011). 
Satisfaction subscale of 
the Female Sexual 
Function Index or Male 
Sexual Function Index 
Questions 14, 15, 16 
Sexual fear 
“A fear of engaging sexually with an 
individual” (Snell, Fisher, & Walters, 1993, p. 
31) 
Sexual fear subscale of 
the Multidimensional 
Sexuality 
Questionnaire 
 
Predictors 
The hypothesized predictors included depression, anxiety, and utilization of coping 
strategies. First, depression and anxiety were assessed with the Patient-Reported Outcomes 
Measurement Information System (PROMIS) for depression and anxiety-short forms (Cella et 
al., 2007). These measurements consist of four questions each for anxiety and depression and 
possess strong evidence for clinical validity in multiple chronic conditions; however, from a 
cardiac perspective, only heart failure has been currently analyzed. Construct validity was 
assessed through qualitative item review via focus groups and cognitive interviewing (DeWalt, 
Rothrock, Yount, & Stone, 2007). The Cronbach’s alphas for these measurements were 0.89 for 
anxiety and 0.93 for depression (Kroenke, Yu, Wu, Kean, & Monahan, 2014). Both scales are 
scored from 0-20, with higher scores indicating worse anxiety or depression. The items of the 
short form anxiety 4a and depression 4a are presented in appendix D and E, respectively. 
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Coping styles were measured using the Coping Strategy Indicator (CSI) a 33-item 
questionnaire with three subscales with a response scale of 1-3 (total score range 33-99). Higher 
scores indicate an increased use of coping strategies. The subscales are Problem Solving, or an 
individual’s active attempts to manipulate or manage an outside stressor (i.e. a fight response); 
Seeking Social Support, or an individual’s attempt utilized outside social resources for 
addressing a stressor, and Avoidance, which are attempts to separate from the stressor typically 
entailing a withdrawal or “flight” response (Amirkhan, 1990). The measurement was developed 
with a population of 1000 English-speaking adults (Amirkhan, 1990). The internal consistency of 
the subscales ranged from 0.84 to 0.93, and the test-retest reliability of the subscales varied from 
0.77 to 0.86 (Amirkhan, 1990). The items in this scale are presented in appendix F. 
Covariates 
In addition to the identified predictors, several potential confounding factors were 
considered for this study. These included gender, age, race, severity of MI (left ventricular 
ejection fraction, and troponin levels), education attainment (some high school, high school 
degree, some college, college, graduate degree), rehabilitation status, (currently enrolled, 
previously enrolled, not enrolled, planning to enroll), employment status (employed [full time, 
part time], unemployed, retired, and medical leave), partner status (single, in a relationship 
[living/not living together], married, divorced, widowed), and familial support. These variables 
were collected from either the demographic questionnaire or medical record. A complete list of 
these covariates and their source (operationalization) is described in table 3.2.  
One covariate, familial support, was measured with a unique instrument, the family 
subscale of the Multidimensional Scale of Perceived Social Support (MSPSS) (Zimet, Dalhem, 
Zimet, & Farley, 1998). The MSPSS was originally developed in students but has also been 
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validated in older adults. A total of four questions were used from this measure. The total score 
can range from 4-28, with higher scores indicating better familial support. The measurement has 
strong evidence for internal consistency (Cronbach’s alpha ranged from 0.87 to 0.94), and test-
retest reliability (total score: 0.73, family subscale: 0.74) in older adults (Stanley, Beck, & Zebb, 
1988). The Cronbach’s alpha for the family subscale was 0.85. The items of the MSPSS are 
presented in appendix G. 
Table 3. 2 - Predictors and covariates 
Predictor Operationalization Data Source 
Anxiety 
Patient-Reported Outcomes Measurement 
Information System - Anxiety 4a 
TP1, TP2 survey 
Depression 
Patient-Reported Outcomes Measurement 
Information System - Depression 4a 
TP1, TP2 survey 
Coping strategies Coping Strategy Indicator TP1, TP2 survey 
Covariate Operationalization Data Source 
Age 
 
Demographic survey 
Sex Male, Female Demographic survey  
Race 
Caucasian, Black/African Descent, Asian, 
Other 
Demographic survey  
Education 
Some high school, high school degree, 
some college, college, graduate degree  
Demographic survey 
Employment status 
Employed (full or part time), unemployed, 
retired, on medical leave 
Demographic survey 
Partner status 
Single, in a relationship (living/not living 
together), married, divorced, widowed 
Demographic survey 
  86 
Rehabilitation status 
Currently enrolled, previously enrolled, not 
enrolled, planning to enroll 
Demographic survey 
Family support 
Family Subscale - Multidimensional Scale 
of Perceived Social Support  
Demographic survey 
MI severity 
STEMI or NSTEMI, left ventricular 
ejection fraction, HS troponin T levels, 
troponin I levels 
Medical record 
STEMI/NSTEMI: ST(Non)-Elevated Myocardial Infarction, TP1(2): Timepoint 1(2) 
 
Analyses 
The measures were summarized as frequencies, means (SD), and ranges for the 
dependent variable, predictors, and covariates at each data point. Approximately 98% of 
demographic survey questions were completed, 99% of dependent variable questions were 
completed for timepoint 1, and 98% were completed for timepoint 2. Approximately 99% of 
covariate questions were completed for both timepoints. Thus, imputation was deemed not 
appropriate, given that most missing data were from biomarkers in the demographic survey (i.e. 
LVEF and troponin values), and not the dependent variable nor covariates. There was some 
missing data among the satisfaction subscale of the FSFI and MSFI, and so those missing data 
were excluded when tabulating total and satisfaction subscale scores, as these data were likely 
missing not at random. 
Demographic data between consented and declined participants were compared with 
independent samples t-tests for continuous variables and chi-square tests for the categorical 
variables. Given the attrition rates across the first timepoint, demographic data were compared 
between those who had sent in at least one packet of surveys and those who were lost to follow 
up (defined as returning no data). In addition to demographic analysis, univariate statistics were 
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applied to examine the outcomes and changes in covariates across the two timepoints and assess 
whether the underlying distributional assumptions of statistical tests were met. The normality of 
the MSFI/FSFI and covariates were checked using a Shapiro-Wilk test. For distributions that did 
not meet an assumption of normality, nonparametric methods were used where appropriate. A 
more detailed description of the analyses utilized for the dissertation aims are described in 
subsequent chapters. 
Results 
Recruitment took place over 14 months, in which 395 participants were initially screened 
from the inpatient record. Of these, 44.5% were only partially eligible (n=176). These reasons 
included an unclear differential diagnosis in the medical record, the patient was in a follow-up 
admission from a MI diagnosis made more than 7 days ago, or inconclusive lab results combined 
with a lack of conclusive clinical symptoms noted in the history and physical. The remaining 219 
(55.6%) patients were excluded based on several criteria. Half of those excluded (52%) were for 
pertinent medical conditions (i.e. dementia, problems with writing or seeing) or comorbidities 
which are known to directly influence sexual health and as such could interfere with the findings. 
These conditions included breast and gynecologic cancer (Basson, Rees, Wang, Montejo, & 
Incrocci, 2010; Westermann, Wolford, & Krychman, 2016), prostate cancer (Wittmann et al., 
2015), COPD (Vincent & Singh, 2007), and HIV infection (Toorabelly et al., 2020). An 
additional 29% were excluded for skilled nursing facility disposition, or a projected life 
expectancy of less than one year. Another 16% were excluded for stability concerns (suicide, 
alcohol withdrawal). The remaining 3% were excluded for other reasons, primarily for distance 
in mailing the surveys. Figure 3.3 details a pie chart of ineligible patients. 
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Figure 3. 3 - Distribution of excluded participants 
 
Of the remaining eligible patients, 113 were approached. Of these, 14 participants were 
unable to be contacted during their hospital stay because they were in a procedure or were 
discharged before in-person contact could be made. An amendment was approved which allowed 
letters to be sent to patients missed during the initial contact attempt. Seven letters were sent out, 
with one participant returning a call to decline participation. Of the remaining 99 participants 
approached, 63 consented to join the study, while 36 declined. Of those declined, 27 filled out a 
decliner survey. The final consent/decline ratio was 63.6%. Of the 63 participants who were 
mailed a survey, 28 returned the first round of questionnaires, for a 44% response rate. Of these 
28 participants, 21 returned the second round of questionnaires, for a response rate of 75%. The 
final study completion rate was 33%. Figure 3.4 details a flowsheet of all recruitment and data 
collection processes including attrition rates.
16%
29%52%
3% Unstable
Life expectancy of less
than one year
Comorbidity interfering
with survey collection
Other reasons
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Figure 3. 4 - Recruitment and attrition flowchart 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Screened: 395 
Partial eligibility: 176 
Ineligible: 219 
Declined: 36 
Consented: 63 
Received both surveys: 21 
Aim 1: 21 (18M, 3F) Aim 3: 28 (24M, 4F) 
Received one survey: 28 
Withdrew: 3 
Lost to follow up: 31 
Ineligible: 1 
Deferred: 14 
Approached: 113 
Decliner survey: 27 
Contacted: 7 No answer: 6 
Declined: 1 
Withdrew: 1 
Lost to follow up: 5 
Deceased: 1 
Aim 2: 18 (18M) 
Consent to 
TP1 attrition: 
66.6% 
TP1 to TP2 
attrition: 25% 
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There were no statistically significant differences for any sociodemographic or clinical 
variables among those who consented vs. declined, nor between those who sent data vs. those 
who did not send data. However, given the small sample size, greater attention was paid to the 
actual tallies of each demographic group rather than the statistical significance. Patients who 
declined were slightly older than those consented, while patients who sent in data were slightly 
older than those lost to follow up. There was a slightly higher percentage of women who 
declined to participate in the survey (14.5% vs. 18.5%). Furthermore, among the three African 
Americans who were consented to the study, none returned any survey data. The data that were 
collected were among those who were older (70.8 years among sent data, 57.6 years among those 
who did not send data). Among sex, one trans female was recruited who did not return survey 
data. Table 3.3 displays the demographic data of the entire consented vs. declined sample, and 
table 3.4 compares between those who were consented and returned data with those who did not 
return any data. Table 3.5 compares consent, decline and data status within sex and race. 
Table 3. 3 - Demographics: consented vs. declined (n=89)  
 Consented (n=62)* Declined (n=27) p-value 
Mean age (SD) in years 
Range 
62.4 (13.2) 
29-89 
64.9 (10) 
48-87 0.38 
Sex, No. (%) 
Male 
Female 
Trans female 
 
52 (83.9) 
9 (14.5 
1 (1.6) 
 
22 (81.5) 
5 (18.5) 
0 (0) 
0.73 
Race, No. (%) 
White/Caucasian 
African American 
Other 
 
58 (93.6) 
3 (4.8) 
1 (1.6) 
 
24 (88.9) 
3 (3.7) 
2 (7.4) 
0.43 
*Ineligible participant removed from consented total 
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Table 3. 4 - Demographics: any data vs. no data (n=62)  
Sample size, No. Any Data (n=28) No Data (n=34) p-value 
Sociodemographic characteristics    
Mean age (SD) in years 63.7 (13.4) 61.4 (13.1) 0.49 
Sex, No. (%) 
Male 
Female 
Trans female 
 
24 (85.7) 
4 (14.3) 
0 (0) 
 
28 (82.4) 
5 (14.7) 
1 (2.9) 
0.66 
Race, No. (%) 
White/Caucasian 
African American 
Other 
 
27 (96.4) 
0 (0) 
1 (3.6) 
 
31 (91.2) 
3 (8.8) 
0 (0) 
0.15 
Marital status, No. (%)* 
Partnered 
Unpartnered 
 
23 (82.1) 
5 (17.9) 
 
23 (82.1) 
5 (17.9) 
>0.99 
Clinical characteristics    
MI Severity, No. (%) 
STEMI 
NSTEMI 
 
8 (28.6) 
20 (71.4) 
 
10 (29.4) 
24 (70.6) 
0.29 
MI Type, No. (%) 
Type 1 
Type 2 
22 (78.6) 
6 (21.4) 
27 (79.4) 
6 (20.6) 
0.94 
Mean troponin (SD) in ng/mL 999 (1842.3) 823.4 (1722.8) 0.72 
Mean LVEF (SD) in % 49 (16.7) 47.1 (16.4) 0.68 
Ineligible participant removed from consented total  
* Partnered consisted of individuals who were married or in a relationship. Unpartnered consisted of individuals 
who were single, divorced, or widowed. 
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Table 3. 5 - Consented, declined, and data status among age, sex, race, and marital status 
 # 
Approached 
Consented/ 
Declined 
%  
#  
Consented 
Sent Data/ 
No Data 
%  
Within age (years) 
 
  
60/66 
63.4/58.7 
 
  
62.5/62.2 
70.8/57.6 
 
Within sex 
Male 
Female 
Trans female 
 
64 
14 
1 
 
52/22 
9/5 
1/0 
 
70.2 
64.5 
100 
 
52 
9 
1 
 
24/28 
4/5 
0/1 
 
46.2 
44.4 
0 
Within race 
White/Caucasian 
African American 
Other 
 
82 
4 
3 
 
58/24 
3/1 
1/2 
 
70.7 
75 
33 
 
57 
4 
1 
 
27/30 
0/4 
1/0 
 
47.3 
0 
100 
Within marriage* 
Partnered 
Unpartnered 
 
 
Unknown 
Not 
collected 
for decline 
n/a 
 
46 
10 
 
23/23 
5/5 
 
50 
50 
Ineligible participant removed from consented total  
* Partnered consisted of individuals who were married or in a relationship. Unpartnered consisted of individuals 
who were single, divorced, or widowed 
 
In answering the first aim of this dissertation, the longitudinal data were analyzed. The 
complete results and discussion surrounding this aim are elaborated in Chapter IV: “Sexual 
Function and Satisfaction Post-Myocardial Infarction: An Explorative Longitudinal Study”, and 
will be submitted to the Archives of Sexual Behaviour. Three months after MI, most participants 
were sexually active. Sexual activity and sexual function scores did increase over the three 
months in males, but not as much in the few females who participated. Unsurprisingly, males 
who were sexually active had better improvements in function compared to those who were 
inactive. Despite these improvements, 28% of male and 66% of female participants were not 
sexually active three months after their MI.  
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For the second aim of identifying predictors, modeling was conducted with the 
longitudinal data. A full discussion of the results for this aim are detailed in Chapter V: 
“Exploratory Modeling of Predictors of Sexual Function and Satisfaction Post-Myocardial 
Infarction”, which will be submitted to the Canadian Journal of Cardiac Nursing. The strongest 
relationships between the independent and dependent variables were sexual fear, support-
seeking, and problem-solving strategies with MSFI scores. There was also a strong relationship 
among the psychological covariates (anxiety and depression). Positive coping strategies also 
predicted changes in sexual function.  
The third aim utilized the cross-sectional data at the first timepoint. These results and a 
complete discussion are described in Chapter VI: “The Relationship Between Sexual Function, 
Satisfaction, and Fear Post-Myocardial Infarction: A Preliminary Analysis”. This manuscript will 
be submitted to the Journal of Cardiovascular Nursing. Average scores on both the MSFI and 
FSFI were low. Strong correlations among the physical components of function were found in 
both sexes. However, desire and satisfaction were only weakly to moderately correlated with 
arousal, erection, and orgasm in male participants, while satisfaction was not correlated with any 
of the subscales in female participants. An expected negative correlation was found between 
sexual fear and the other components of function, though these correlations were weak and male 
participants, and strong in female participants.  
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Abstract  
Myocardial infarction (MI) decreases sexual function and desire, but there are few studies that 
have examined changes in sexual function over a longer period. This study aimed to 
longitudinally describe negative and positive changes in sexual function and satisfaction over 
time in a sample of male and female post-MI patients. Twenty-one patients were recruited from a 
Midwestern hospital and mailed surveys at two weeks and three months post discharge. Sexual 
function was measured with the Female/Male Sexual Function Index. Important covariates 
collected included sexual fear (Multidimensional Sexuality Questionnaire), anxiety and 
depression (Patient-Reported Outcomes Measurement Information System Anxiety and 
Depression 4a) and use of coping strategies (Coping Strategy Indicator). Sexual function scores 
among males increased from 8.9 (SD 7.3) at two weeks to 14.6 (SD 8.9) at three months (18.8% 
improvement, p=0.04). Males who were sexually active improved their scores by 27.3% 
(p=0.01), while males who were not decreased their scores by 2.3% (p=0.5). Scores in females 
increased from 13.7 (10.5) at two weeks to 16.3 (12.2) at three months (7.1% improvement, 
p=0.5). Depression and anxiety scores were low and relatively stable across timepoints, though 
there were some slight improvements among males who were sexually active compared to those 
who were not. Decreased utilization of avoidance coping strategies was reported in sexually 
active versus inactive men. Further research is needed with larger sample sizes to understand 
these changes in sexual function across a longer period, and to examine any potential influence 
of these psychosocial predictors. 
 
 
Keywords: Sexual function, sexual satisfaction, longitudinal, myocardial infarction 
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Background 
Myocardial infarction (MI) remains a notable acute exacerbation of chronic 
cardiovascular disease in the United States due to its high prevalence rates and negative effects 
on patient health. Approximately 470,000 men and 335,000 women were hospitalized for either a 
new or recurrent MI between 2005 and 2014 (Virani et al., 2020). These incidence rates have 
created a substantial population of 8.4 million adult survivors (Virani et al., 2020). Whether a 
first-time or recurrent MI, both experiences introduce new challenges for patients. The 
pathophysiological ramifications of MI increase activity intolerance, anxiety and depression, and 
probability of a repeat event (Daniel et al., 2018; Kriston, Gunzler, Agyemang, Bengel, Berner, 
& SPARK Study Group, 2010). While mortality and readmission rates have declined due to 
improvements in medical management of MI, other issues remain unaddressed during the 
trajectory of care (Hammill, Curtis, Schulman, Whellan, & Whellan, 2010; Dunlay, Pack, 
Thomas, Killian, & Roger, 2014). One component that often goes unrecognized during post-MI 
care is diminished sexual function (Byrne, Doherty, McGee, & Murphy, 2010; Puchalski, 
Szymanski, Kowalik, & Filipiak, 2013). Sexual function consists of four main phases including 
excitement, plateau, orgasm, and resolution (Masters & Johnson, 1966). In males, these phases 
are traditionally presented in a successive or linear progression, while in females it is 
conceptualized as a more circular model, particularly among desire and arousal with other 
components (Basson, 2001). In addition to sexual function, sexual satisfaction pertains to an 
individual’s appraisal of the contentedness of their sexual relationship and can include both 
physical and emotional satisfaction (Ashdown, Hackathorn, & Clark, 2011).  
While there is some cross-sectional literature evaluating sexual health, there are very few 
studies that model a complete representation of sexual function and satisfaction in post-MI 
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patients over a longer timeframe. Previous longitudinal studies have focused primarily on sexual 
activity while neglecting sexual function and satisfaction (Lindau et al., 2016). Furthermore, 
sexual function can be influenced by several psychological factors. Fear of sexual activity, as 
well as anxiety and depression - commonly seen by clinicians in patients after MI - can all 
reduce desire for sexual activity and thus negatively influence sexual function and satisfaction 
(Oskay, Can, & Camci, 2015; Thombs et al., 2006; Steinke & Wright, 2006). However, previous 
longitudinal studies have only measured frequency of sexual problems, which leaves gaps in our 
understanding on how dysfunctional severity changes over time (Lindau et al., 2016). Indeed, 
focusing only on sexual activity without also comprehensively exploring the longitudinal 
changes in the functional domains produces an incomplete picture of sexual health and limits 
effective prescription of the support patients need to improve sexual function (sexual aids) and 
overall sexual confidence (counseling). Therefore, the current state of the science points to the 
need for more descriptive longitudinal research to understand the trends in sexual function and 
satisfaction over time and the factors that influence it. Development and testing of effective 
treatments requires a more comprehensive understanding of sexual function issues. 
The purpose of this study was to examine changes in sexual function and satisfaction as 
well as anxiety, depression, sexual fear, and utilization of coping strategies over time in a cohort 
of patients post-MI. The specific aim of this study was to describe sexual function and 
satisfaction, sexual fear, anxiety, depression, and utilization of coping strategies in a population 
of adults within two weeks and at three months post-MI. 
Methods 
The study applied a prospective longitudinal design to capture changes in sexual function 
and satisfaction at two timepoints; two weeks and three months after discharge from the hospital 
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setting. Patients were mailed questionnaires the day following discharge from the hospital. A 
follow up phone call was made with participants before two weeks and three months to remind 
them of study requirements and answer potential questions. The study received Institutional 
Review Board (IRB) approval before data were collected. 
Study Population 
A total of 99 patients of 395 screened were approached during their inpatient 
hospitalization for an MI at one Midwestern hospital. The inclusion criteria were adult men and 
women admitted to the hospital with an MI who could read and write English. Diagnosis of MI 
was confirmed using chart review in addition to a troponin T value exceeding the 99th percentile 
of a normal reference population (>18 ng/mL) (Thygesen et al., 2012). The exclusion criteria 
included patients who had a pertinent comorbidity that would interfere with any sexual health 
data collected (prostate cancer, breast/gynecologic cancer, COPD, or HIV infection), patients 
who were medically unstable (suicide, alcohol withdrawal), or patients who had a life 
expectancy of less than one year. A total of 63 signed informed consent, with 21 individuals 
returning all survey materials (final study completion rate was 33%). 
Measures 
The dependent variables were sexual function and satisfaction, which were 
operationalized using the subscales of the Female Sexual Function Index (FSFI) and the Male 
Sexual Function Index (MSFI). The FSFI is made up of six subscales including desire (score 
range 1.2-6), arousal (score range 0-6), lubrication (score range 0-6), orgasm (score range 0-6), 
satisfaction (score range 0-6) and pain with intercourse (score range 0.8-6), for a total score 
range of 2-36 (Rosen et al., 2000). The FSFI also has a designated cut-off score for sexual 
dysfunction, of 26.55 (Wiegel, Meston, & Rosen, 2005). The Cronbach's alphas are 0.92, 0.95, 
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0.96, 0.94, 0.89, and 0.94 for each subscale and 0.97 for the totals scale (Rosen et al., 2000). The 
MSFI was based on the wording of the FSFI and was selected to provide consistency in 
measurement across fields of desire (score range 1.2-6) orgasm (score range 0-6), and 
satisfaction (score range 0-6). The modified subscales from the FSFI were lubrication, which 
was replaced with erection (score range 0-6) and pain with intercourse was also removed 
(Kalmbach, Ciesla, Janata, & Kingsberg, 2012). The Cronbach's alphas for the MSFI subscales 
are 0.85, 0.82, 0.76, 0.66 and 0.82 for each subscale (Kalmbach et al., 2015). The total score 
range for the MSFI is 2-30. Higher scores on these measurements indicate better sexual function. 
Patients were not required to be sexually active to complete these surveys, but sexual activity 
status does influence scoring on the arousal, erection/lubrication, orgasm, and pain scores of the 
MSFI and FSFI.  
Several key variables related to sexual function shown to be important in the literature 
were measured in this study. Sexual fear was measured using the sexual fear subscale of the 
Multidimensional Sexuality Questionnaire (MSQ). The sexual fear subscale ranges from 0-20, 
with higher scores indicating more sexual fear. The Cronbach's alpha of the sexual fear subscale 
is 0.82 (Snell, Fisher, & Walters, 1993). Anxiety and depression were measured with the Patient-
Reported Outcomes Measurement Information System (PROMIS) - Anxiety and Depression 
Short Form 4a. Both measurements range from 0-20 with higher scores indicating worse anxiety 
or worse depression. The Cronbach's alpha is 0.89 for the Anxiety Short Form and 0.93 for the 
Depression Short Form (Kroenke, Yu, Wu, Kean, & Monahan, 2014). Lastly, utilization of 
coping strategies was measured with the Coping Strategy Indicator (CSI). The CSI is made up of 
three subscales: Seeking Support, Problem Solving, 
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subscale is scored from 11-33, with a higher score indicating a higher use of that coping strategy. 
The Cronbach’s alphas for these subscales range from 0.84 to 0.93 (Amirkhan, 1990). 
The demographic variables that were collected included employment status, marital 
status, cardiac rehabilitation status, and education status. These were collected using a 
demographic survey. Left ventricular ejection fraction (LVEF) percentages were collected from 
the medical record to assess for basic cardiac function. Whether the MI was an ST or non-ST 
segment elevated (STEMI/NSTEMI), and the troponin T values were also collected from the 
medical record to assess for MI severity.  
Statistical Analyses 
All analysis was conducted using SAS statistical software version 9.4 (SAS Institute, 
Cary, NC). FSFI and MSFI scores were summarized as frequencies, means (SD), and ranges for 
at each timepoint. The continuous subscales of desire, arousal, lubrication/erection, orgasm, 
satisfaction, and pain scores on the FSFI/MSFI were compared from two weeks to three months. 
Univariate statistics were applied to check the normality of the data. The MSFI and FSFI scores 
were not normally distributed at the first timepoint, so Wilcoxon signed rank tests were used. 
Furthermore, some data were missing among the satisfaction subscales (four males and one 
female), so these and the total score changes were calculated with these participants removed. 
Given that these data were likely missing not at random, multiple imputation was deemed not 
appropriate. Subgroup analyses among males were conducted to assess for differences among 
those who were sexually inactive at three months compared to those who either became or were 
always active. A paired t-test was utilized to calculate mean changes in the covariates of 
depression, anxiety, use of coping strategies, and sexual fear as they fell along an approximately 
normal distribution. T-score transformation of the PROMIS measurements were calculated to 
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assess for clinical significance based on established cut points among adults (mean age 59.3 
years) (Rothrock, Amtmann, & Cook, 2020). Percent changes were calculated as a change of the 
total possible score of a measurement or subscale rather than change over the first timepoint. A 
statistical significance level of 0.05 was applied.  
Results 
The study sample (N=21) included 17 Caucasian men, 1 Native American man, and 3 
Caucasian females. The mean age of the sample was 60.5 ± 13.6 years for male participants and 
70 ± 9.9 years for female participants. Participants were primarily married (M: 61.1%, F: 100%), 
college educated (M: 50%, F: 66.7%), and most of the female participants were retired (M: 
33.3%, F: 66.7%). Cardiac function was below a normal LVEF in males and approached a below 
normal level for females (M: 48.5%, F: 57%; normal range: 55%-70%). There were no 
statistically significant differences among the demographic variables. Additional clinical and 
sociodemographic characteristics are presented in table 4.1. 
Average sexual function scores among male participants were 8.9 at two weeks (SD 7.3, 
median 5.35, range 3.6-26.2) which increased to 14.6 (SD 8.9, median 12.45, range 3.8-30) at 
three months. Sexual function scores improved in 61.1% of the sample, with an overall score 
improvement of 18.8% (p=0.04). While 61.1% of the sample improved, 22.2% decreased. The 
remaining 16.7% did not noticeably change over time. The largest percent change among the 
subscales were erection (27.8%, p=0.01), and orgasm (25.9%, p=0.04). Desire improved the 
least among men, at 8.9% (p=0.06). Table 4.2 presents the total and subscale scores of the MSFI 
and covariates among the entire sample, and these are also visualized in figure 4.1. Individual 
items were also examined among the male participants to assess for clinical significance. At 
three months, 50% had at least moderate desire (improved from 38.9%), 38.9% had at least 
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moderate arousal (improved from 22%), 50% had either slight or no difficulties with erection or 
orgasm (improved from 16.7%), and 38.9% were at least equally satisfied and dissatisfied with 
their overall sex live (improved from 33.3%). 
The proportion of males who were active at two weeks and three months were also 
calculated. Among the 13 who were sexually inactive at two weeks (72% of the total sample), 
61.5% resumed sexual activity by three months (n=8). At three months, 72.2% of the sample 
was sexually active. Approximately 28% were sexually active at both timepoints (n=5), while an 
additional 28% of the sample were not active at either timepoint (n=5). Male participants who 
were sexually active were not statistically different compared to those who were inactive in 
terms of age, (active: 60.2 years, inactive: 61.2 years, p=0.91), LVEF (active: 46.3%, inactive: 
54.8%, p=0.35), or marital status (p=0.59). Those who were sexually active had higher troponin 
levels, though the difference was not statistically significant (active: 1285.5 ng/mL, inactive: 
471.3 ng/mL, p=0.91). Interestingly, a statistically larger proportion of males who were sexually 
active were diagnosed with an ST-segment elevated MI (STEMI) (p=0.03). Scores were mostly 
unchanged among sexually inactive males, with two subscales decreasing slightly (arousal and 
erection). Total MSFI score changes were mixed among those who were active at both 
timepoints; two had stable scores, while two decreased slightly, and one increased. Figure 4.5 
shows individual score changes among the male participants. 
Score changes on the MSFI were also examined by sexual status. Males post-MI who 
were sexually active at three months improved their total scores by 27.3% (p=0.01), while those 
who were not sexually active decreased their total scores by 2.3% (p=0.5). Interestingly, the 
largest decrease in total scores (-12.3%) was in a man who had been sexually active at both 
timepoints, but was not an outlier for age or any disease characteristic compared to the average 
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of the group. This man’s largest subscale decreases were in orgasm scores (-53.3%), followed by 
arousal (-15%) and satisfaction (-13.3%). Conversely, all males who became sexually active at 
three months had higher total scores on the MSFI over time, with the largest improvement being 
68%. Two subscales (desire and satisfaction) of the MSFI were not statistically increased among 
sexually active males. The largest changes among those who were sexually active were erection 
(38.8%, p=0.003) and orgasm (35.9%, p=0.04), followed by arousal (27.9%, p=0.04), 
satisfaction (15.3%, p=0.18) then desire (12.3%, p=0.06). Subscale scores in male participants 
who were not sexually active averaged a 2% change overall. Arousal subscale scores were the 
same across both timepoints (1.9, possible score 0-6). Unsurprisingly, orgasm scores were 0 
across both data points in those who were not sexually active. Table 4.3 shows sexual function 
scores by sexual status.  
Score changes on the FSFI were evaluated among the female sample. All females 
improved their sexual function scores, though by a smaller percentage (7.1%), which was not 
statistically significant (p=0.5). Two females were never sexually active from two weeks to three 
months while one woman was sexually active at both timepoints. The one female who was 
sexually active at three months improved by 11.9%, compared to a 2.2% increase among those 
who were not sexually active. The largest percentage increases in the FSFI subscale scores were 
satisfaction (16.7%), followed by desire and arousal (6.7%). Two subscales in females did not 
change across timepoints (lubrication and pain). Changes of female sexual function scores are 
presented in figure 4.3 and 4.4, while figure 4.6 shows individual scores. 
 The covariates were examined among the entire sample. PROMIS anxiety and 
depression scores were generally low in both sexes, indicating a lack of anxiety and depression. 
Depression scores in female participants changed the most, worsening by 10%. Interestingly, 
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overall anxiety scores in males decreased slightly (-2.2%), and overall sexual fear scores were 
slightly increased in females (5%), but these were not statistically significant changes. Despite 
the low overall scores, some interesting changes were observed among the t-score 
transformations. At two weeks, 57.1% of depression t-scores were within normal limits, while 
33.3% were in the mild depression range, and 9.5% were in the moderate depression range. This 
changed to 57.1% within normal limits, 19% in the mild depression range, and 23.8% in the 
moderate depression range at three months. When examining anxiety t-scores, 47.6% were 
within normal limits, while 28.6% were in the mild anxiety range, and 23.8% were in the 
moderate anxiety range at two weeks. This changed to 42.9% within normal limits, 47.6% in the 
mild anxiety range, and 9.5% in the moderate anxiety range at three months. The percentage of 
participants with moderate anxiety decreased from 23.8% to 9.5%, while the percentage of 
participants with moderate depression increased from 9.5% to 23.8%.  
Male participants had slightly improved fear scores, but still scored low at both 
timepoints, while fear scores among female participants only changed by 5% (M: 8.3-7.2, F: 4-5, 
possible score 0-20). Use of problem-solving and support-seeking coping strategies decreased 
among all male and female participants, though not by a statistically significant percentage. 
Interestingly, problem-solving and seeking support strategies decreased more among female 
participants than male participants (M: -0.3, -1.2%, F: -15.2, -18.2%). Use of avoidance coping 
strategies decreased in both samples (M: -1.3%, F: -4.3%). Table 4.2 and 4.3 contain the data for 
male covariate scores as an entire cohort, while table 4.4 details the changes in covariates among 
the females sampled. Figure 4.2 and 4.4 display bivariate associations of covariates with the 
MSFI or FSFI scores. 
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Covariates were also examined in males stratified by sexual status. Depression scores 
worsened slightly among all males (1.1%), while anxiety improved (-2.2%). However, among 
those who were sexually active, anxiety and depression scores improved slightly. As with the 
entire cohort, overall subgroup changes were small (within 3%). Changes in covariates were 
slightly more pronounced among males who were sexually inactive. While anxiety scores in 
sexually inactive males only worsened by 1%, depression worsened by approximately 7%, while 
sexual fear scores improved by 13%. The one sexually active man who decreased his total scores 
by 12.3% also had 20% worse anxiety scores, but only a 5% change in fear and depression 
scores. Those who were sexually active increased use of problem-solving and support-seeking 
coping strategies and reduced the amount of avoidance coping strategies. These changes in 
scores were small, however. The opposite effect was observed in males who were not sexually 
active; use of problem-solving and support-seeking coping strategies decreased, while use of 
avoidance coping strategies increased. Table 4.3 shows changes in covariate scores by sexual 
status.  
Discussion 
This study described changes in sexual function, anxiety, depression, use of coping 
strategies, and sexual fear in male and female post-MI patients from two weeks to three months. 
Male score changes fell across a broad range, with some drastically improving over three months 
while others remained stable or improved only minimally. To our understanding, this is the first 
time that sexual function and satisfaction have been longitudinally reported over a short-term 
trajectory in a post-MI population. Previous longitudinal studies have found a potential 
protective effect of sexual activity on cardiac risk in older patients, and so it would be important 
to better understand how these changes in function shape over time in order to promote 
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enjoyable sexual activity (Liu, Waite, Shen, & Wang, 2016). One large longitudinal cohort study 
did examine whether patients developed functional problems one-year post-MI but only reported 
frequencies rather than severity, and was conducted in a sample aged 18-55 (Lindau et al., 2016). 
Sexual function studies in men post-MI have primarily focused on erectile quality, (Hodžić, 
Durek, Begić, Šabanović Bajramović, & Durak-Nalbantić 2019), and so this study also provides 
a unique contribution by characterizing a more comprehensive representation of sexual function.  
For the most part, the males who were sexually active had higher sexual function scores 
over time than those who were not sexually active. In addition, physical components of function 
(arousal, erection, orgasm) improved more than psychosocial components (desire, satisfaction) 
over three months. To our understanding, no prior studies have stratified sexual function by 
different sexual activity statuses in post-MI males and females. The improvement in sexual 
activity rates from 33.3% to 72% among the male participants might explain the observed 
improvements in the physical components, though this could also be due to a better relationship 
with their partner or generally increased motivation or interest. Regardless, these changes 
indicate that sexual function and satisfaction can decrease or increase dramatically within a short 
time post-discharge, as much as 38% observed in this sample. As a result, pre-discharge 
interaction that provides information on managing sexual problems and returning to safe sexual 
activity may improve function in this population, especially within the physical components 
(Steinke et al., 2013). However, the overall improvement of 18.8% in the entire male sample is 
still relatively modest, and it is also unclear if these trends will continue to improve beyond three 
months.  
In comparison to males post-MI, there were little to no score changes over time among 
the females sampled. However, scores at three months were comparable to a previously 
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conducted cross-sectional study of 45 women post-MI (16.3 vs. 16.41) (Oskay, Can, & Camci, 
2015). Interestingly, this previous study required women to have a “normal sex life” as part of 
the inclusion criteria, so it is unclear whether a larger sample of active and inactive females 
would have changed the mean scores seen in this study. Regardless, the observed lack of changes 
in physical function scores in females is most likely due to 67% of the sample being sexually 
inactive. Furthermore, the sample was likely all postmenopausal, which may have played a role 
in low sexual function, though this is not always the case. The effects of menopause on sexual 
function should be explored in the context of other influencing biopsychosocial variables 
including hormonal changes, partner function, reproductive history, and medical conditions 
(Heidari, Ghodusi, Rezaei, Kabirian Abyaneh, Sureshjani, & Sheikhi, 2019). Despite this, sexual 
satisfaction scores still improved by 16.7% over time despite a lack of sexual activity. It may be 
that the female participants were maintaining satisfaction by applying adaptive coping strategies 
over time. This hypothesis is supported by a study of 460 post-MI patients which found that 
women typically utilized more coping strategies than men (Son, Friedman, Thomas & Son, 
2016). However, as in men, it is also possible that these women did not return to sexual activity 
due to inadequate guidance post-discharge. As such, additional research with a larger female 
sample is needed to further examine these potential score changes. 
Scores on anxiety and depression were relatively stable over time. It is important to 
consider that approximately 57% of depression and 43-48% of anxiety t-scores were within 
normal limits in this population at either timepoint, with very few moderate and no severe cases. 
However, males who were sexually active reported lower anxiety and depression scores 
compared to those who were not sexually active post-MI. It is also interesting that the percentage 
of those with moderate anxiety decreased over three months, and that the percentage of those 
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with moderate depression increased. Previous research has reported that depression and anxiety 
are often associated with decreased sexual activity. A previous cross-sectional cohort study of 
493 patients found that depression significantly influenced the relationship between sexual 
function and quality of life (Kriston, Gunzler, Agyemang, Bengel, Berner, & SPARK Study 
Group, 2010). In another cohort study of 64 patients, sexual satisfaction was negatively related to 
anxiety, and sexual satisfaction also accounted for 42% of the variance in anxiety scores (Steinke 
& Wright, 2006). This could either be because depression and anxiety precipitate decreased 
desire or interest for sexual activity, or because low sexual function are depressing and anxiety 
producing for men. However, the observed changes in depression and anxiety across timepoints 
were considerably small, and so further research is needed to undertake these potential 
hypotheses.  
Another interesting finding revolved around the use of coping strategies, particularly 
among males by sexual status. A recent review found that common positive coping strategies 
among those with chronic conditions involved both religious coping and utilization of social 
support (Cheng, Inder, & Chan, 2020). In the MI literature specifically, reduced social support 
was associated with lower overall coping scores and decreased use of positive coping strategies, 
leading to a more passive overall coping style utilization (Son, Friedman, Thomas & Son, 2016). 
As such, it may be that males who are sexually active were able to cope better with MI compared 
to those who were not active. However, this relationship constitutes a preliminary finding and 
should be explored further given the small effect size. 
Males who were sexually inactive had more sexual fear, which is expected, given that 
those who are not engaging might be afraid of causing additional cardiac complications. 
However, inactive males also decreased fear scores over time, which was unexpected, though 
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fears were naturally decreasing over time in both samples. Previous studies have found 
prevalence rates for sexual fear in post-MI samples ranging from 58.82% (Eyada & Atwa, 2007) 
to 88.4% (Oskay, Can, & Camci, 2015). Among those who were not sexually active, low 
functional scores may have been interacting with depression and anxiety. However, while these 
studies have identified potential associations, no study has determined whether these psychologic 
variables directly predict changes in sexual function. In addition, the observed changes in sexual 
fear were not statistically significant. 
The results of this study should be considered in the context of some limitations. Without 
pre-MI sexuality data, it is difficult to determine what kind of loss of function these participants 
experienced due to the MI. However, collecting pre-MI sexual function data after discharge 
could be subject to recall bias and may not be entirely reliable. The small sample was primarily 
Caucasian, well-educated, and married. Additionally, the sample included a small proportion of 
males to females, at 16% and 84 %. This is a considerably skewed proportion compared to recent 
national estimates of MI, which are approximately 60% male and 40% female (Virani et al., 
2020). A possible explanation could be an observed greater interest in discussing sexual health 
topics by men (Lindau et al., 2007). It may also be that the sample of females were older and as 
such less likely to be sexually active. Regardless, the very small number of females reduces the 
capacity of the study to make conclusions of overall changes in female post-MI patients. Third, 
the study did not capture whether the included participants had any activity restrictions from 
their physician, which could have influenced scores. Lastly, while this study captured several 
covariates, the limited sample size prevented any statistical adjustment for these variables.  
  
114 
 
Conclusion 
Participants in this study demonstrated statistically significant improvements in total 
MSFI scores from two weeks to three months in males post-MI, but these changes were either 
minimal or absent in females. Both sexes reported sexual function scores in the dysfunctional 
range. Descriptive analysis between males who were sexually active compared to those who 
inactive helped to contextually explain positive changes over time. The results from this study 
suggest the need for providers to be aware of and offer guidance and information to men and 
women post-MI who are struggling with sexual function issues. Sexual function and interest in 
sex should be assessed regularly in patients with heart disease so that if an MI occurs, baseline 
sexual health information would already have been provided. Future longitudinal studies with 
larger sample sizes should be conducted to confirm whether these observed changes in sexual 
function can be replicated. Further research should also examine these concurrent psychosocial 
variables including anxiety, depression, coping strategies, or sexual fear, to better understand 
their association and mutual influence.
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Tables and Figures 
Table 4. 1 - Characteristics of study participants 
 Male (n=18) Female (n=3) 
Sociodemographic characteristics   
Mean age (SD) in years 60.5 (13.6) 70 (9.9) 
Race, No. (%) 
White/Caucasian 
Other 
 
17 (94.4) 
1 (5.6) 
 
3 (100) 
0 (0) 
Marital status, No. (%) 
Single 
In a relationship 
Married 
Divorced 
Widowed 
 
2 (11.1) 
2 (11.1) 
11 (61.1) 
2 (11.1) 
1 (5.56) 
 
0 (0) 
0 (0) 
3 (100) 
0 (0) 
0 (0) 
Education status, No. (%) 
Some high school 
High school degree 
Some college 
College degree 
Graduate degree 
 
2 (11.1) 
2 (11.1) 
5 (27.8) 
3 (16.7) 
6 (33.3) 
 
0 (0) 
0 (0) 
1 (33.3) 
1 (33.3) 
1 (33.3) 
Rehabilitation status, No. (%) 
Currently enrolled 
Planning to enroll 
Not enrolled 
 
3 (16.7) 
7 (38.9) 
8 (44.4) 
 
0 (0) 
2 (66.7) 
1 (33.3) 
Employment status, No. (%) 
Employed 
Unemployed 
Retired 
Medical Leave 
 
9 (50) 
1 (5.6) 
6 (33.3) 
2 (11.1) 
 
 
1 (33.3) 
0 (0) 
2 (66.7) 
0 (0) 
 
Clinical characteristics   
MI Severity, No. (%) 
STEMI 
NSTEMI 
 
7 (38.9) 
11 (61.1) 
 
2 (66.7) 
1 (33.3) 
Mean troponin (SD) in ng/mL 1081.9 (2314) 1757.3 (1132.5) 
Mean LVEF (SD) in % 48.5 (12.3) 57 (6.3) 
(N)STEMI: ST(Non)-Elevated Myocardial Infarction; LVEF: Left Ventricular Ejection Fraction 
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Table 4. 2 - Mean scores and changes on sexual function, anxiety, depression, and sexual fear in male post-MI patients (n=18) 
 Two Weeks  Three Months  % change  p-value 
 Mean (SD) Mean (SD)   
MSFI: Total Scores (range 2-30)* 8.9 (7.3) 14.6 (8.9) 18.8 0.03 
Desire (range 1.2-6) 2.6 (1.6) 3.1 (1.3) 8.9 0.06 
Arousal (range 0-6) 1.3 (1.8) 2.4 (2) 17.9 0.13 
Erection (range 0-6) 1.2 (1.8) 2.8 (2.4) 27.8 0.01 
Orgasm (range 0-6) 1.3 (2.2) 2.8 (2.5) 25.9 0.04 
Satisfaction (range 0.8-6)*  2.2 (1.3) 2.9 (1.8) 11 0.18 
PROMIS: Anxiety (range 0-20) 7.9 (3.1) 7.5 (3.1) -2.2 0.57 
PROMIS: Depression (range 0-20) 7.1 (2.6) 7.3 (3.4) 1.1 0.59 
MSQ: Sexual Fear (range 0-20) 8.3 (5.9) 7.2 (5.5) -5.3 0.4 
CSI: Seeking Support (range 11-33) 20.5 (5.0) 20.4 (7.1) -0.3 0.92 
CSI: Problem Solving (range 11-33) 25.8 (4.7) 25.4 (5.8) -1.2 0.76 
CSI: Avoidance (range 11-33) 18 (3.7) 17.6 (4.6) -1.3 0.68 
MSFI: Male Sexual Function Index, MSQ: Multidimensional Sexuality Questionnaire, PROMIS: Patient-Reported Outcomes Measurement Information System. 
CSI: Coping Strategy Indicator 
Higher scores on the MSFI total scores and subscales indicate higher sexual function. Higher scores on the PROMIS measurements indicate worse anxiety and 
depression. Higher scores on the MSQ indicate more sexual fear. Higher scores on the CSI subscales indicate greater use of coping strategies. 
Paired sample t-test utilized for analysis 
* Satisfaction and total scores calculated with missing participants removed (n=4) 
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Table 4. 3 - Mean scores and changes on sexual function, anxiety, depression, and sexual fear in males post-MI by sexual status 
(n=18) 
 Sexually Active (n=13) Sexually Inactive (n=5) 
 Two Weeks Three Months % Change Two Weeks Three Months % Change 
 Mean (SD) Mean (SD)  Mean (SD) Mean (SD)  
MSFI: Total Scores (range 2-30)* 10.2 (8.2) 18.4 (7.7) 27.3┼ 5.7 (1.6) 5 (1.0) -2.3 
Desire (range 1.2-6) 2.8 (1.7) 3.6 (1.1) 12.3 1.9 (1.0) 1.9 (1.0) 0 
Arousal (range 0-6) 1.4 (2.0) 3.1 (2.0) 27.9┼ 1.1 (1.1) 0.6 (0.8) -8 
Erection (range 0-6) 1.5 (2.0) 3.9 (2.0) 38.8┼ 0.2 (0.2) 0.1 (0.2) -1 
Orgasm (range 0-6) 1.8 (2.4) 3.9 (2.0) 35.9┼ 0 0 0 
Satisfaction (range 0.8-6)* 2.3 (1.4) 3.4 (1.9) 15.3 2.0 (1.2) 2.0 (1.2) 0 
PROMIS: Anxiety (range 0-20) 7.8 (3.1) 7.1 (2.4) -3.5 8.4 (2.9) 8.6 (4.2) 1 
PROMIS: Depression (range 0-20) 6.9 (2.3) 6.7 (2.6) -1.2 7.6 (3) 9 (4.4) 7 
MSQ: Sexual Fear (range 0-20) 6 (4.6) 5.5 (5.3) -2.3 14.2 (4.6) 11.6 (3.3) -13 
CSI: Seeking Support (range 11-33) 20.5 (5.7) 21.4 (8) 2.6 20.4 (2.87) 17.8 (1.9) -7.9 
CSI: Problem Solving (range 11-33) 27.1 (4.1) 27.2 (5.2) 0.5 22.6 (4.6) 20.8 (4.5) -5.5 
CSI: Avoidance (range 11-33) 18.2 (3.7) 17.2 (3.8) -3 17.6 (3.8) 18.6 (6.1) 3 
Higher scores on the MSFI total scores and subscales indicate higher sexual function. Higher scores on the PROMIS measurements indicate worse anxiety and 
depression. Higher scores on the MSQ indicate more sexual fear. Higher scores on the CSI subscales indicate greater use of coping strategies. 
Paired sample t-test utilized for analysis, ┼ p<0.05 
* Satisfaction and total scores calculated with missing participants removed (n=3 sexually active, 1 sexually inactive) 
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Table 4. 4 - Mean scores and changes on sexual function, anxiety, depression, and sexual fear in females over three months (n=3) 
 Two Weeks Three Months % change  p-value 
 Mean (SD) Mean (SD)   
FSFI: Total Scores (range 2-36)* 13.7 (10.5) 16.3 (12.2) 7.1 0.5 
Desire (range 1.2-6) 2 (1.1) 2.4 (1.7) 6.7 >0.99 
Arousal (range 0-6) 1.6 (2.1) 2 (2.8) 6.7 >0.99 
Lubrication (range 0-6) 2 (2.8) 2 (2.8) 0 - 
Orgasm (range 0-6) 1.9 (2.6) 2 (2.8) 2.2 >0.99 
Satisfaction (range 0.8-6)* 2.6 (0.6) 3.6 (0.8) 16.7 0.12 
Pain (range 0-6) 0.4 (0.6) 0.4 (0.6) 0 - 
PROMIS: Anxiety (range 0-20) 5.7 (2.4) 7 (2.5) 6.7 0.3 
PROMIS: Depression (range 0-20) 6 (1.4) 8 (2.8) 10 0.4 
MSQ: Sexual Fear (range 0-20) 4 (3.3) 5 (3.6) 5 0.42 
CSI: Seeking Support (range 11-33) 20.7 (3.4) 15.7 (5.2) -15.2 0.16 
CSI: Problem Solving (range 11-33) 27.3 (4) 21.3 (7) -18.2 0.23 
CSI: Avoidance (range 11-33) 17.7 (3.7) 16.3 (1.7) -4.3 0.66 
Higher scores on the FSFI total scores and subscales indicate higher sexual function. Higher scores on the PROMIS measurements indicate worse anxiety and 
depression. Higher scores on the MSQ indicate more sexual fear. Higher scores on the CSI subscales indicate greater use of coping strategies. 
Paired sample t-test utilized for analysis 
* Satisfaction and total scores calculated with missing participants removed (n=1) 
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Figure Legend 
Figure 4.1 - Baseline and follow up total and subscale MSFI scores in males post-MI (n=18) 
Abbreviations: MSFI: Male Sexual Function Index 
* p-value < 0.05 
** p-value < 0.01 
+ Satisfaction and total scores calculated with missing participants removed (n=4) 
 
Figure 4.2 - Baseline and follow up MSQ, PROMIS, and CSI scores in males post-MI (n=18) 
Abbreviations: PROMIS: Patient-Reported Outcomes Measurement Information System; 
MSQ: Multidimensional Sexuality Questionnaire; CSI: Coping Strategy Indicator 
* p-value < 0.05 
** p-value < 0.01 
 
Figure 4.3 - Baseline and follow up total and subscale FSFI scores in females post-MI (n=3) 
Abbreviations: FSFI: Female Sexual Function Index 
* p-value < 0.05 
** p-value < 0.01 
+ Satisfaction and total scores calculated with missing participants removed (n=1) 
 
Figure 4.4 - Baseline and follow up MSQ, PROMIS, and CSI scores in females post-MI (n=3) 
Abbreviations: PROMIS: Patient-Reported Outcomes Measurement Information System; 
MSQ: Multidimensional Sexuality Questionnaire; CSI: Coping Strategy Indicator 
* p-value < 0.05 
** p-value < 0.01 
 
Figure 4.5 - Individual changes in MSFI scores from two weeks to three months in males post-
MI (n=18) 
Figure 4.6 - Individual changes in scores on the FSFI from two weeks to three months in females 
post-MI (n=3) 
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Figure 4. 1 - Baseline and follow up total and subscale MSFI scores in males post-MI (n=18) 
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Figure 4. 2 - Baseline and follow up MSQ, PROMIS, and CSI scores in males post-MI (n=18)  
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Figure 4. 3 - Baseline and follow up total and subscale FSFI scores in females post-MI (n=3) 
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Figure 4. 4 - Baseline and follow up MSQ, PROMIS, and CSI scores in females post-MI (n=3) 
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Figure 4. 5 - Individual changes in MSFI scores from two weeks to three months in males post-
MI (n=18) 
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Figure 4. 6 - Individual changes in scores on the FSFI from two weeks to three months in 
females post-MI (n=3) 
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Abstract 
Sexual dysfunction often persists among males post-myocardial infarction (MI). However, there 
are no known modifiable targets for intervention. Identification of predictors is necessary to 
improve interventions for sexual dysfunction post-MI. This study aimed to explore modifiable 
predictive factors of higher sexual function and activity in a cohort of males post-MI. In a 
longitudinal study design, sexual function (MSFI), sexual fear (MSQ), anxiety and depression 
(PROMIS), and coping strategies (CSI) data were collected from 18 males post-MI at two weeks 
and three months post discharge. Linear regression and logistic regression models were 
conducted for sexual function and activity, respectively, while controlling for age. Sexual fear 
and problem-solving/seeking support coping strategies were moderately correlated with MSFI 
scores at three months. Problem-solving and support-seeking strategies also predicted increased 
function at three months (seeking support 1.47, p<0.01; problem-solving 0.95, p=0.02). 
However, additional studies are needed to further examine these preliminary relationships. 
 
 
 
 
 
 
 
Keywords: Prediction, sexual dysfunction, myocardial infarction 
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Introduction 
 Myocardial infarction (MI) can negatively impact male sexual function and satisfaction 
(Kriston, Gunzler, Agyemang, Bengel, Berner, & SPARK Study Group, 2010). While many 
patients resume sexual activity post-event, sexual function problems often persist among 
sexually active men (Lindau et al., 2014; Lindau et al., 2016). This is due to the impact of MI on 
blood flow to sex organs which impairs erectile function and orgasm (Vlachopoulos, Jackson, 
Stefanadis, & Montorsi, 2013). Recent estimates of sexual dysfunction in men post-MI are 
approximately 59.4% (Lindau et al., 2014). 
While there is some literature establishing the physiologic sequelae of MI and sexual 
dysfunction, additional research has begun to examine contributing factors. Diagnosis and 
treatment of MI can subsequently increase depression, anxiety, and fear of causing a repeat event 
post discharge, particularly while sexually active. Cross-sectional descriptive studies have linked 
anxiety to decreased sexual satisfaction and general avoidance of sexual activity (Steinke et al., 
2013). A recent cohort study of 99 reported anxiety rates of 37% among patients post-MI, 
compared to 7% in a general population (Daniel et al., 2018). Other studies have found that 
anxiety can persist upwards of five months into recovery post-MI (Steinke & Swan, 2004).  
Like anxiety, depression has also been associated with reduced interest for sexual activity 
and intimacy engagement (Steinke, Mosack, Hertzog, & Wright, 2013; Steinke & Wright, 2006). 
Depression rates were reported as high as 35% in post-MI patients and were considerably higher 
than the general population (9%) (Daniel et al., 2018). Previously conducted cross-sectional 
studies have found that increased depression was associated with decreased sexual function and 
reduced health-related quality of life (Kriston, Gunzler, Agyemang, Bengel, Berner, & SPARK 
Study Group, 2010). An additional cross-sectional study of 493 patients found that depression 
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was a large mediator of associations between sexual dysfunction and quality of life (Kriston, 
Gunzler, Agyemang, Bengel, Berner, & SPARK Study Group, 2010). A systematic review and 
meta-analysis also found a bidirectional relationship between depression and sexual dysfunction 
(Atlantis & Sullivan, 2012). 
In addition to depression and anxiety, some patients post-MI can experience fear of 
inducing a repeat event during sexual activity. Sexual fear has been associated with avoidance 
from sexual activity which can exacerbate depression and anxiety (Kazemi Saleh, Pishgou, 
Assari, & Tavallaii, 2007). Two cross-sectional studies have reported prevalence rates of sexual 
fear from 58.82% (Eyada & Atwa, 2007) to 88.4% (Oskay, Can, & Camci, 2015). Qualitative 
studies have also reported that patients expressed both sexual fear and subsequently desired 
recommendations regarding the proper timing for returning to sexual activity (Garcia, Denardin 
Budó, Schwartz, Simon, & da Silva, 2015; Søderberg, Johansen, Herning, & Berg, 2013).  
The trajectory of diagnosis, treatment and discharge post-MI leaves many patients facing 
new challenges both with sexual health and other domains of life. As a result, both patients and 
partners wish to develop positive coping strategies in managing of post-infarction depression and 
anxiety (Nilsson, Ivarsson, Alm-Roijer, & Svedberg, 2013). There is some preliminary evidence 
to support the effect of coping strategies as a mediator of distress and well-being post-MI. A 
previous cross-sectional quantitative study of 121 male post-MI patients found a mediating effect 
of emotion-focused coping over time on negative emotions and general well-being (Kroemeke, 
2016). Indeed, higher anxiety and depression have been linked to negative coping and thus to 
decreased quality of life, which may also extend to issues of sexuality (Son, Friedmann, Thomas, 
& Son, 2016).  
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While current evidence has demonstrated possible positive associations between 
depression, anxiety, sexual fear, and coping on sexual function, little prediction research has 
been conducted in this population. Overall, the existing literature remains largely descriptive, 
and so identifying predictors of sexual function is a necessary step towards developing 
interventions that can support patients’ sexual recovery after MI. This gap has become evident in 
a recent meta-analysis which found an overall poor quality of evidence and minimal effect sizes 
for interventions such as sexual counseling or therapy (Byrne et al., 2016). Identifying predictors 
of sexual function and satisfaction will be crucial for development of an effective intervention. 
Therefore, the primary aim of this study was to identify modifiable predictive factors of higher 
sexual function among males at three months post-MI. A secondary aim was to identify the 
predictors of engaging in sexual activity at three months after MI.  
Methods 
We conducted a prospective longitudinal cohort study design that measured sexual 
function and satisfaction at two weeks and three months post-discharge. Recruitment took place 
in a Midwestern teaching hospital, where patients were consented at the bedside, then mailed two 
packets of questionnaires to complete at two weeks and three months following their discharge. 
This study only analyzed the males consented due to sample size limitations (only 3 females 
completed all survey items). Institutional Review Board (IRB) approval was obtained before 
recruitment and data collection. 
Study Population 
A total of 52 adult males who had experienced an MI and were hospitalized were 
consented for this study. A diagnosis of MI in the patient record combined with a troponin value 
exceeding the 99th percentile of a normal reference population was used to assess for patient 
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eligibility (>18 ng/mL) (Thygesen et al., 2012). Other inclusion criteria were the ability to read 
and write in English. Patients were excluded if they were medically unstable (suicide, alcohol 
withdrawal), had a diagnosis of COPD, HIV, or prostate cancer, or had an overall life expectancy 
of less than 1 year. Of the 52 males that signed informed consent, 18 individuals returned all 
survey materials (final study completion rate was 34.6%). 
Measures 
The dependent variable of sexual function was measured using the Male Sexual Function 
Index (MSFI). The MSFI utilizes the same question structure and subscales of the Female Sexual 
Function Index (FSFI) (Rosen et al., 2000), which is considered the gold standard in sexual 
function measurement. However, the MSFI uses an erection subscale instead of lubrication and 
removes the pain with intercourse subscale (Kalmbach, Ciesla, Janata, & Kingsberg, 2012). The 
Cronbach’s alphas for the MSFI total scores and subscales range from 0.66 to 0.85 with a score 
range of 0-30 (Kalmbach et al., 2015). A higher score indicates greater sexual function. The 
hypothesized predictors that were selected based on the current best empirical evidence included 
sexual fear, anxiety, depression, and coping strategies. Sexual fear was measured using the 
sexual fear subscale of the Multidimensional Sexuality Questionnaire (MSQ) (Snell, Fisher, & 
Walters, 1993). The MSQ has a Cronbach’s alpha of 0.82 and a score range of 0-20, with higher 
scores indicating more sexual fear. Anxiety and depression were measured with the Patient-
Reported Outcomes Measurement Information System (PROMIS) – Anxiety and Depression 
Short Form 4a (Cella et al., 2007). These two measurements are scored from 0-20, with a 
Cronbach’s alpha of 0.93 for depression and 0.89 for anxiety (Kroenke, Yu, Wu, Kean, & 
Monahan, 2014). A higher score indicates more depression and anxiety. Lastly, use of coping 
strategies was measured with the Coping Strategy Indicator (CSI) (Amirkhan, 1990). The CSI 
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consists of three subscales: Seeking Support, Problem Solving, and Avoidance. The subscales 
have a Cronbach’s alpha of 0.84 to 0.93, and each is scored from 11-33, with higher scores 
indicating greater use of coping strategies (Amirkhan, 1990).  
Demographic variables that were collected included education status, employment status, 
marital status, and status within cardiac rehabilitation. Cardiac function was assessed with left 
ventricular ejection fraction (LVEF) percentages. Whether the MI was ST or non-ST segment 
elevated (STEMI/NSTEMI) and troponin values were used to assess for severity of the MI. 
Demographic variables were collected with a separate questionnaire, while LVEF, troponin and 
MI severity data (STEMI/NSTEMI) were collected from the medical record. 
Statistical Analyses 
Means and standard deviations of the demographic data were calculated using descriptive 
statistics. The dependent variable of sexual function and satisfaction were operationalized using 
the MSFI and its subscales and was structured as a continuous outcome. Linear regression 
modelling was done to check for multicollinearity. A Shapiro-Wilk test was conducted to check 
for the normality of the data. Spearman rank correlation tables were created for the two 
timepoints of independent and predictor variables. A weak correlation coefficient was 0.1-0.39, a 
moderate correlation coefficient was 0.4-0.69, and a strong correlation coefficient was 0.7-0.99 
(Schober, Boer, & Schwarte, 2018). T-score transformation of depression and anxiety scores was 
calculated to assess for clinical significance (Rothrock, Amtmann, & Cook, 2020).  
Modeling for both the primary and secondary aims was conducted using SAS software 
version 9.4 (SAS Institute, Cary, NC). Power analysis for both aims was performed using a 
treatment by time approach with two groups of covariate scores (low and high) in SAS. A 
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hypothesized data set with means for each group of predictor scores across the two timepoints 
was conjectured prior to data collection (Castelloe, 2014). The results of the power analysis 
using this method for improved sexual function with a sample of 14 equaled 0.936.  
For the primary aim of improved sexual function, linear regression was used to model 
three-month sexual function data. In the model, three-month function scores were the dependent 
variable while the predictors utilized the collapsed change scores, and age. Four participants did 
not provide complete answers to the MSFI satisfaction subscale and so they were excluded from 
this analysis. The missing questions all dealt with the presence of a partner, so they were not 
likely to be missing at random and so imputation was deemed not appropriate. Individual 
analyses were conducted with each predictor as the sample size precluded the inclusion of all 
effects in one model.  
For the secondary aim of sexual activity, logistic regression was applied using the change 
scores in covariates as the independent variable while controlling for age. The entire sample of 
18 was used for this analysis. A power analysis utilizing the same methods described above with 
a sample size of 18 equaled 0.993. Activity status at three months was coded as a binary variable 
(0=not active, 1=active). As in the primary aim, individual analyses were conducted with each 
predictor separately. A statistical significance level of 0.05 was applied for both analyses. 
Results 
The sample consisted of 17 Caucasian men and one Native American man. The sample 
was aged 60.5 (SD 13.6) years with a range of 29 to 86 years. The sample of males was primarily 
married (61.1%), while 33.3% were either single, divorced, or widowed. Half the male 
participants were well educated with at least a college degree, and half were still employed. The 
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sample was below a normal LVEF compared to a reference population (48.5, normal 55%-70%). 
Three-month scores on the MSFI fell along an approximately normal distribution (Shapiro-Wilk 
p-value= 0.1). There was no evidence of multicollinearity between the covariates within the total 
sample (tolerance range 0.2-0.8; variance inflation range 1.20-4.6; eigenvalue range 0.01-4.6). 
Table 5.1 presents the sociodemographic and clinical characteristics of the sample. 
 The longitudinal results are described in a previous paper and are briefly summarized 
here. Approximately 28% of the sample was sexually active at two weeks which improved to 
72% at three months. Sexual function scores improved in approximately 61% of the males 
sampled. Depression scores worsened slightly among all male participants, while anxiety 
improved slightly. Sexual fear scores improved slightly, while use of problem-solving and 
seeking support coping strategies decreased among all males but improved among those who 
were sexually active. None of the longitudinal changes in covariates were statistically significant. 
First examined were the correlations at the two week timepoint. None of the predictor 
variables at two weeks showed moderate or strong correlations with total MSFI scores at the 
same timepoint. Moderate strength positive correlations within the two-week variables were 
found among fear with depression (r= 0.49), anxiety with depression (r= 0.48), and use of 
avoidance coping strategies with both anxiety (r= 0.57) and depression (r= 0.64). Use of 
problem-solving coping was positively correlated with use of social support coping at two weeks 
(r= 0.49). Table 5.2 displays correlations among the total MSFI scores and covariates at two 
weeks and three months. 
Second, correlations at the three-month timepoint were examined. Worsened sexual fear 
scores were associated with decreased MSFI scores (r= -0.67). Unsurprisingly, anxiety and 
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depression at three months were strongly correlated (r= 0.88). Although worse anxiety was 
associated with improved coping at two weeks, this did not continue at the three-month 
timepoint. Interestingly, use of support-seeking and problem-solving coping strategies at three 
months were positively correlated with MSFI scores at three months (r= 0.56, r= 0.67). Use of 
avoidance coping strategies was positively correlated with both anxiety (r= 0.50) and depression 
scores (r= 0.58) at three months. Comparable to what was observed at two weeks, use of 
problem-solving and seeking support coping strategies were also positively intercorrelated at 
three months (p= 0.47). 
Third, we examined correlations from two weeks to three months. As expected, scores on 
the MSFI at two weeks were positively correlated with MSFI scores at three months (r= 0.46). 
However, none of the two-week covariates were significantly associated with MSFI scores, with 
the exception being sexual fear which presented a similar negative correlation (r= -0.44). All the 
covariates at two weeks were either moderately or strongly positively correlated with their three-
month counterparts (fear: r= 0.61; anxiety: r= 0.54; depression: r= 0.80; seeking support: r= 
0.77; problem-solving: r= 0.51; avoidance: r= 0.48). A strong positive correlation was observed 
between depression at two weeks and anxiety at three months (r= 0.77). Two-week fear scores 
were positively correlated with three-month anxiety and depression scores (anxiety: r= 0.48; 
depression: r= 0.45). Lastly, two-week depression scores and fear scores were negatively 
correlated with problem-solving coping strategies at three months (depression: r= -0.50; fear: r= 
-0.56). Depression scores at two weeks were also negatively correlated with avoidance coping 
strategies at three months (r= 0.59). Figure 5.1 displays the full correlation matrix of the two 
week and three-month MSFI and covariate scores. Figure 5.2 displays bivariate plots between 
the predictors and 3-month MSFI scores. 
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The individual regression models for the primary aim of better sexual function produced 
negative effects for anxiety (β coeff.= -0.43), depression (β coeff.= -1.23), and fear (β coeff.= -
0.31). For coping, a statistically significant positive effect was found for seeking support (β 
coeff.= 1.47, p<0.01) and problem-solving (β coeff.= 0.95, p= 0.02), while a non-statistical 
significant negative effect was found for avoidance coping strategies (β coeff.= -0.55). The 
variance explained in the model by each predictor was low, except for support-seeking (R2= 
0.64) and problem-solving (R2= 0.44) coping strategies. Despite these findings, the effect sizes 
were still relatively small, with a 1-point change in the predictors from two weeks to three 
months only predicting a <5% overall change in the MSFI. Regression models for the secondary 
aim of activity status did not produce statistically significant effects, and the overall odds ratios 
were small with the exception of depression and use of support-seeking coping strategies (fear 
odds ratio: 1.1; anxiety odds ratio: 0.91; depression odds ratio: 0.66; seeking support odds ratio: 
1.5; problem-solving odds ratio: 1.09; avoidance odds ratio: 0.89). An unexpected finding was 
that fear predicted negative MSFI scores but an increased likelihood of returning to activity at 
three months. Table 5.2 displays both models of increased function and activity with a 95% 
confidence interval (CI) and p-values, and R2 values for the increased function models.  
Discussion 
This study modeled several potential predictors of sexual function and activity at three 
months post discharge in a post-MI population utilizing multidimensional longitudinal data. 
Previous predictive research has utilized cross-sectional data in general cardiac patients, lumping 
MI with coronary/peripheral bypass, pacemaker and defibrillator implantation, heart failure, and 
angina (Mosack, Hill, & Steinke, 2015). This study adds to the literature by examining a 
different subset of psychosocial predictors and measuring a post-MI sample instead of a general 
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cardiac population, which to our understanding has not been studied previously. Given that 
longitudinal studies have reported a potential protective effect of sexual activity on cardiac risk 
in older patients, understanding the predictors of enjoyable sexual activity in post-MI patients are 
important to elucidate given their unique demarcation from other cardiac conditions (Liu, Waite, 
Shen, & Wang, 2016). However, previously conducted longitudinal studies of function in 
patients post-MI have only focused on sexual activity or percentage of sexual problems (Lindau 
et al., 2016; Lindau et al., 2012). These studies do not capture severity of functional problems, 
which are crucial for optimal assessment and intervention (Steinke et al., 2013). Furthermore, the 
effects of MI on sexual function in males outside of erection are understudied. The MSFI 
measures frequency and severity of orgasmic, erectile and arousal problems as well as 
satisfaction with both functional and overall emotional closeness and sex life, which provide a 
more robust representation of function (Kalmbach, Ciesla, Janata, & Kingsberg, 2012). 
While there are no studies that model predictors of function post-MI, two studies have 
identified possible predictors of sexual activity in men. These included having a discussion with 
a physician, and having a partner (Lindau et al., 2016; Lindau et al., 2012). However, these 
studies did not measure anxiety, depression, fear, or use of coping strategies as potential 
predictors, and did not model for dysfunction. While these two previous studies modeled for 
activity status, this study did not find any significant effects in the activity models. Additionally, 
this study did not produce a significant predictive effect for anxiety or depression. This may be 
due to a floor effect among covariate scores in the sample. Approximately 57% of depression 
and 42-47% of anxiety t-scores were within normal limits, and an additional 19-33% of anxiety 
and depression t-scores were of mild severity. There were also relatively few moderate and no 
severe cases of either anxiety or depression. 
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Scores on the MSFI and all the covariates showed moderate correlations from two weeks 
to three months. Furthermore, scores on anxiety, depression and sexual fear were often 
intercorrelated, which is supported by previous literature detailing the high rates of depression 
and anxiety among post-MI populations (Daniel et al., 2018). Consistent with the correlation 
tables, the final models found that sexual function scores were negatively affected by increased 
age, anxiety, and depression, though these effect sizes were modest. Nonetheless, the negative 
relationships between age, anxiety and depression with sexual function seen in the models are 
expected findings based on the current cross-sectional literature (Daniel et al., 2018; Steinke, 
Mosack, Hertzog, & Wright, 2013). Altogether, the findings and models provide preliminary 
evidence that worsening depression and anxiety over time could decrease sexual function at three 
months. This constitutes a unique contribution to the current literature; while previous cross-
sectional research has measured associations between sexual fear, anxiety, depression or coping 
strategies in tandem with sexual function, this has not been previously conducted in a 
longitudinal study (Steinke & Wright, 2006). However, it is important to consider the low overall 
effect size and R2 of anxiety and depression, which affects the clinical significance. Additionally, 
for every unit increase in change scores of anxiety or depression over time, function decreased 
by only 1.43% and 4.1% in this model. 
An interesting finding is that as fear worsened, sexual function worsened both in the 
correlation tables and in the models, while the activity models produced an increased odds ratio. 
However, the observed odds ratio was relatively modest, and the confidence interval included 
both negative and positive values, so this relationship could be explored further with a larger 
sample. Additionally, this is the first study that examined the effect of coping strategies on 
sexual function. While previous literature has found a mediating effect of coping on several 
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affective outcomes (anxiety, depression), this has not been previously combined with changes to 
sexual function (Kroemeke, 2016). Alongside the promising relationships seen in the correlation 
matrix, both support-seeking and problem-solving strategies produced statistically significant 
predictors of increased function scores at three months. However, like with anxiety and 
depression, the overall net changes to function were among 3-4%. Regardless, these exploratory 
findings provide some interesting preliminary data that could be researched further. 
While this study improves our understanding of factors that influence sexual activity and 
function, there are additional environmental predictors that may warrant further investigation. 
Examples of external predictors may include availability of sexual counseling services, the 
partner’s sexual function and interest, and presence of dyadic support. Furthermore, while 
functional problems have been studied more robustly in women (Oskay, Can, & Camci, 2015), 
there is little research on predictors in female post-MI patients. Additional research is needed to 
understand how predictors of sexual function in women may compare to men. 
The results of this study were affected by some limitations. One shortcoming was that the 
sample was predominately white, well educated, and married, which limits generalizability to 
other populations. However, this sample did include other marital statuses including participants 
who were unpartnered, which are understudied in the sexual health literature. As mentioned, the 
small sample size limits the ability to make clinical recommendations, and so caution should be 
used in implementing these results into practice. As this was largely an unadjusted analysis, 
future research with a larger sample could also include clinical predictors such as cardiac 
function, and should also control for additional covariates. 
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Implications for Practice/Research 
 While the limited sample size prevents specific clinical recommendations, it has been 
previously documented that patients post-MI desire discussion with their providers about sexual 
function issues. Approximately 39.1% of sexually active males and 17.9% of sexually active 
females discuss sexual health with their physician post-MI (Lindau et al., 2012), and this 
partially stems from a lack of provider knowledge (Byrne, Doherty, McGee, & Murphy, 2010; 
Jaarsma et al., 2010). This study addresses a current gap in knowledge by identifying changes 
and factors associated with sexual function at a short term timepoint post discharge. Facilitating 
communication and education has improved intimacy between the individual and their partner 
(D’Eath, Byrne, Doherty, McGee, & Murphy, 2013). Another future direction would be to 
examine if utilization of coping strategies is either a mediator or moderator of function, and if 
coping strategies could be utilized as a modifiable target in intervention research and ultimately 
practice.  
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Key Highlights 
• Utilization of positive coping strategies and decreased sexual fear were associated with 
MSFI scores at three months. 
• The study found statistically significant correlations among anxiety and depression scores 
with avoidance based coping strategies at three months, and relationships between sexual 
fear with anxiety and depression. 
• Use of support-seeking and problem-solving coping strategies were identified as a 
significant predictor of sexual function in the final model.  
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Tables and Figures 
Table 5. 1 - Characteristics of study participants 
 Male (n=18) 
Sociodemographic characteristics 
Mean age (SD) in years 
60.5 (13.6) 
Race, No. (%) 
White/Caucasian 
Other 
 
17 (94.4) 
1 (5.6) 
Marital status, No. (%) 
Single 
In a relationship 
Married 
Divorced 
Widowed 
 
2 (11.1) 
2 (11.1) 
11 (61.1) 
2 (11.1) 
1 (5.6) 
Education status, No. (%) 
Some high school 
High school degree 
Some college 
College degree 
Graduate degree 
 
2 (11.1) 
2 (11.1) 
5 (27.8) 
3 (16.7) 
6 (33.3) 
Rehabilitation status, No. (%) 
Currently enrolled 
Planning to enroll 
Not enrolled 
 
3 (16.7) 
7 (38.9) 
8 (44.4) 
Employment status, No. (%) 
Employed 
Unemployed 
Retired 
Medical leave 
 
9 (50) 
1 (5.6) 
6 (33.3) 
2 (11.1) 
Clinical characteristics  
MI Severity, No. (%) 
STEMI 
NSTEMI 
 
7 (38.9) 
11 (61.1) 
Mean troponin (SD) in ng/mL 1081.9 (2314) 
Mean LVEF (SD) in % 48.5 (12.3) 
LVEF: Left Ventricular Ejection Fraction; (N)STEMI: (Non)ST-Segment elevated Myocardial Infarction 
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Figure Legend 
Figure 5.1 - Bivariate plots of association between predictors and sexual function scores at long-
term (three months) follow-up 
Abbreviations: MSFI: Male Sexual Function Index; PROMIS: Patient-Reported 
Outcomes Measurement Information System; MSQ: Multidimensional Sexuality 
Questionnaire; CSI: Coping Strategy Indicator 
Lines represents least-squares regression and dashed line represents LoWeSS (locally 
weighted scatterplot smoothing) moving average fitted curve 
 
Figure 5.2 - Unadjusted associations between predictors and sexual function scores at short-term 
(two weeks) and long-term (three months) follow-up 
Abbreviations: MSFI: Male Sexual Function Index 
rs: Spearman correlation coefficient 
* p-value < 0.05 
** p-value < 0.01 
+ Total scores calculated with missing participants removed (n=4) 
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Figure 5. 1 - Bivariate plots of association between predictors and sexual function scores at long-
term (three months) follow-up 
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Figure 5. 2 - Unadjusted associations between predictors and sexual function scores at short-term 
(two weeks) and long-term (three months) follow-up 
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Table 5. 2 - Association between predictors and 3-month sexual function scores and sexual activity status while controlling for age 
  Function (n=14) Activity (n=18) 
  Intercept β (95% CI)* % of MSFI p-value R2 Odds (95% CI) p-value 
Increasing sexual fear (MSQ) 24.4 -0.31 (-1.47, 0.83) -1.03% 0.55 0.09 1.1 (0.87, 1.37) 0.73 
Increasing anxiety (PROMIS) 24.3 -0.43 (-2.31, 1.4) -1.43% 0.62 0.08 0.91 (0.65, 1.26) 0.84 
Increasing depression (PROMIS) 25.8 -1.23 (-4.4, 1.9) -4.1% 0.41 0.11 0.66 (0.38, 1.16) 0.35 
Increasing seeking support (CSI) 19 1.47 (0.71, 2.23) 4.9% <0.01 0.64 1.5 (0.9, 1.8) 0.39 
Increasing problem solving (CSI) 27.5 0.95 (0.19, 1.72) 3.16% 0.02 0.44 1.09 (0.87, 1.4) 0.75 
Increasing avoidance (CSI) 25.4 -0.55 (-1.89, 0.8) -1.83% 0.39 0.12 0.89 (0.69, 1.15) 0.66 
MSFI: Male Sexual Function Index, MSQ: Multidimensional Sexuality Questionnaire, PROMIS: Patient-Reported Outcomes Measurement Information System, 
CSI: Coping Strategy Indicator. 
Higher scores on the MSFI total scores and subscales indicate higher sexual function. Higher scores on the PROMIS measurements indicate worse anxiety and 
depression. Higher scores on the MSQ indicate more sexual fear. Higher scores on the CSI indicate a larger use of the associated coping strategy. 
* Unstandardized β coefficients 
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Abstract  
Myocardial infarction (MI) negatively influences many physical aspects of patient’s sexual 
function. However, there is limited literature that examines sexual function beyond the most 
basic physical components, such as erectile function. Exploring sexual function with a broader 
psychosocial perspective is paramount to advance the science in this area. This study aimed to 
describe the relationships between the physical, psychologic, and social domains of sexual 
function in male and female post-MI patients. Adults post-MI were mailed self-report surveys at 
two weeks post discharge. Physical domains of sexual function were measured with the arousal, 
orgasm, erection, lubrication, and pain subscales of the Female/Male Sexual Function Index, 
(FSFI/MSFI). The social domain utilized the sexual satisfaction subscale of the FSFI/MSFI. The 
psychologic domain was represented by desire (subscale of FSFI/MSFI) and sexual fear 
(Multidimensional Sexuality Questionnaire (MSQ)). Spearman correlations were constructed to 
examine associations among the different measurement subscales. Twenty-four males and four 
females post-MI were analyzed. Average scores on the FSFI were 10.8 ± 11.5, and on the MSFI 
were 9.2 ± 7.7. Correlations among the physical components of function were strong to moderate 
in both sexes. Desire and satisfaction were only weakly to moderately correlated with arousal, 
erection, and orgasm in male participants, while satisfaction was not correlated with any of the 
subscales in female participants. There was minimal support for sexual fear’s relationship with 
function in both sexes. However, there is preliminary support for other dimensions of sexual 
functioning. More research is also needed with larger samples.  
 
 
Keywords: Myocardial infarction, sexual health, sexual dysfunction 
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Background 
More than 8.4 million individuals are living post myocardial infarction (MI) in the United 
States (Virani et al., 2020). Current prevalence predictions suggest that 40.5% of the United 
States population will have had an MI in 2030 (Heidenreich et al., 2011). The impact of MI 
presentation and subsequent treatment produces new challenges to patients’ lives, one of which 
is sexual health (Kazukauskas & Lam, 2010; Clayton, Harsh, & Clayton, 2016). Sexual health is 
a vital facet of health-related quality of life as an integration of emotional, social, and somatic 
dimensions, and a crucial component of this is sexual function. Sexual function is defined as 
“sexual activity with transition through the phases from arousal to relaxation with no problems, 
and with a feeling of pleasure, fulfilment and satisfaction” (Corona, Jannini, & Maggi, 2006). As 
such, embedded within sexual function are physical, psychological, and social domains (Tierney, 
2008). 
The physical domain of sexual function consists of four main phases including 
excitement, plateau, orgasm, and resolution (Masters & Johnson, 1966). These phases are 
conceptualized in a linear fashion among men, but revisions have modeled function in females as 
a more circular representation (Basson, 2001). This domain has received the most study given 
the frequent co-occurrence of erectile dysfunction with chronic cardiovascular disease and MI 
(Goldstein, Chambers, Tang, Stecher, & Hassan, 2018). Sexual dysfunction in patients post-MI 
is thought to be caused by an impairment of blood flow to sex organs. Symptoms of sexual 
dysfunction in males include erectile dysfunction, orgasmic dysfunction, and decreased sexual 
desire (Puchalski, Szymanski, Kowalik, & Filipiak, 2013). Sexual dysfunction in females post-
MI is characterized by decreased vaginal lubrication, decreased libido, and orgasmic problems 
(Søderberg, Johansen, Herning, & Berg, 2013; Zeydi, Sharafkhani, Armat, Gould, Soleimani, & 
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Hosseini, 2016). These changes in function can also decrease frequency of sexual activity. 
Among previously sexually active patients, the average percentage that had resumed activity at 
one-month post-MI had decreased to 54% for women and 63-64% for men (Lindau et al., 2014; 
Lindau et al., 2016). 
The above-mentioned physiologic changes can subsequently influence the psychological 
domain of sexual function, such as sexual desire. In post-MI patients, fear of inducing a repeat 
event often plays into hesitancy for many activities, including sexual intercourse (Oskay, Can, & 
Camci, 2015). In addition, several studies have identified sexual fear as a common complication 
of MI development which has been documented in as high as 88% of women and in 58% of their 
husbands (Oskay, Can, & Camci, 2015). In one cross-sectional study of 35 women post-MI, fear 
of resuming sexual activity was expressed by 51% of patients and 44% of partners, and these 
rates of sexual fear were also found to negatively impact sexual activity rates (Eyada & Atwa, 
2007). 
The physical and psychological components also tie into a broader relationship-centered 
domain of sexual function, of which one component is sexual satisfaction. Sexual satisfaction is 
defined as an individual’s physical and emotional appraisal of the contentedness of their sexual 
relationship (Ashdown, Hackathorn, & Clark, 2011). In general cardiovascular populations, 
sexual satisfaction remains high even in the context of diminished physical function (Ghanbari 
Afra, Taghadosi, & Gilasi, 2015; Kaya, Yilmaz, Nurkalem, Ilktac, & Karaman, 2007). A 
previous cross-sectional study of 45 women post-MI found relatively high sexual satisfaction 
scores comparable to a general population (Oskay, Can, & Camci, 2015). Furthermore, sexual 
satisfaction has been linked to changes in other non-sexual psychosocial outcomes including 
anxiety. A cohort study of 64 men and women found that sexual satisfaction was inversely 
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related to significantly higher anxiety in both sexes with an odds ratio of -2, and that sexual 
satisfaction also accounted for 42% of the variance in anxiety scores (Steinke & Wright, 2006).  
Objective 
Given that sexual function is a multi-faceted construct, a comprehensive approach is 
necessary to promote positive sexual function in patients post-MI. However, there is a lack of a 
complete multi-dimensional representation of sexual function in the MI literature, partially due 
to the challenges in measuring sexuality empirically. Although sexual function is conceptualized 
as an intersection of biopsychosocial components in other chronic conditions, such as cancer 
(Tierney, 2008; Walker, Wassersug, & Robinson, 2015), the physical domain is given the most 
attention in the MI literature. Ultimately, understanding the relationships between each domain 
of sexual function is paramount to building effective interventions. Therefore, the purpose of this 
study was to describe the relationships between the physical, psychologic, and relationship 
domains of sexual function in male and female post-MI patients. 
Methods 
The study was a longitudinal design, evaluating dimensions of sexual function at two 
weeks and three months post-MI. The data for this paper represents the first timepoint only given 
the lack of early data on sexual function post discharge for MI in the currently available 
literature. Within seven days post discharge, a baseline survey was sent to 63 consented 
participant’s homes for completion. A phone call was made to follow up after the initial point of 
contact to remind patients of study requirements and answer potential questions that may have 
developed. This study received approval from the local Institutional Review Board (IRB). 
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Study Population 
A total of 99 patients in a Midwestern hospital were approached of 395 screened, and 63 
signed informed consent (consent/decline rate 63.6%). To be eligible, patients had to have a 
diagnosis of an MI in the past seven days within their medical record combined with a troponin 
value greater than the 99th percentile of a normal reference population (>18 ng/mL) (Thygesen 
et al., 2012). Patients also had to be able to read and write in English. Exclusion criteria included 
those who were medically unstable (suicide, alcohol withdrawal), presented with medical 
conditions that would interfere with the sexual function data collected (prostate cancer, 
breast/gynecologic cancer, COPD, or HIV infection) or had a life expectancy of less than one 
year. A total of 63 signed informed consent, with 28 individuals returning the first round of 
surveys (response rate 44%). 
Measures 
The physical domain of sexual function was operationalized using the arousal, 
lubrication, orgasm, and pain subscales of the Female Sexual Function Index (FSFI) (Rosen et 
al., 2000), and the arousal, erection, and orgasm subscales of the Male Sexual Function Index 
(MSFI) (Kalmbach, Ciesla, Janata, & Kingsberg, 2012). Both the MSFI and FSFI contain the 
same wording and question structure, though the subscales are adjusted to contain relevant 
aspects of sexual function for both sexes (erection vs. lubrication). The Cronbach's alphas for the 
FSFI are 0.95 for arousal, 0.96 for lubrication, 0.94 for orgasm, and 0.94 for pain with 
intercourse (Rosen et al., 2000). The Cronbach's alphas for the MSFI are 0.82 for arousal, 0.76 
for erection, and 0.66 for orgasm (Kalmbach et al., 2015). The score ranges for the subscales are 
from 0-6, except for pain with intercourse (0.8-6) (Rosen et al., 2000). Higher scores on the total 
score and subscales of the MSFI and FSFI indicate better sexual function. The FSFI has a 
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designated cut-off score for sexual dysfunction, which is 26.55 (Wiegel, Meston, & Rosen, 
2005).  
The psychological domain utilized the desire subscale of the MSFI and FSFI. The 
Chronbach’s alpha for the desire subscale is 0.92 in the FSFI and 0.85 in the MSFI (Rosen et al., 
2000; Kalmbach et al., 2015). The score range is 1.2-6 in both measurements (Rosen et al., 2000; 
Kalmbach, Ciesla, Janata, & Kingsberg, 2012). The psychological domain of sexual function 
also included sexual fear, which was measured using the sexual fear subscale of the 
Multidimensional Sexuality Questionnaire (MSQ). The MSQ sexual fear subscale has a 
Cronbach's alpha of 0.82 (Snell, Fisher, & Walters, 1993). Higher scores on the MSQ indicate 
more sexual fear. 
The social domain of sexual function was operationalized with the sexual satisfaction 
subscale of the FSFI and MSFI. This subscale asks participants to rate their level of satisfaction 
with their partner and in their sex life overall. The Cronbach’s alpha for this subscale is 0.89 
within the FSFI, and 0.82 within the MSFI (Rosen et al., 2000; Kalmbach et al., 2015). The 
possible score range is 0.8-6 in both measurements (Rosen et al., 2000; Kalmbach, Ciesla, 
Janata, & Kingsberg, 2012).  
Other covariates that were collected included left ventricular ejection fraction (LVEF) to 
assess for cardiac function. Type and severity of the MI were assessed with troponin T and 
whether the MI was ST or non-ST segment elevated (STEMI/NSTEMI). These were collected 
from the medical record. Other demographic variables that were collected included marital 
status, education status, employment status, and cardiac rehabilitation status, which were 
collected with a separately mailed demographic survey. 
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Statistical Analyses 
All analysis was conducted using SAS software version 9.4 (SAS Institute, Cary, NC). 
Descriptive statistics were calculated for demographic data including means, ranges, and 
standard deviations. Independent samples t-tests and chi-square tests were performed to check 
for any statistically significant differences in the sociodemographic characteristics among males 
and females. Normality of the MSFI and MSQ was checked using Shapiro-Wilk. Because the 
MSFI and FSFI scores did not meet assumptions of normality, nonparametric Spearman rank 
correlations were used. Five participants did not answer all questions on the satisfaction subscale 
of the MSFI/FSFI (four males, one female). The missing questions in this subscale dealt with 
activity between a partner, so they were not likely to be missing at random and so multiple 
imputation was deemed not appropriate. To address this, total scores and satisfaction subscale 
scores are analyzed with those participants removed. Correlation coefficients were calculated 
between the subscales of the FSFI/ MSFI with the sexual fear subscale of the MSQ. A coefficient 
of 0.1-0.39 was considered weak correlation, a coefficient of 0.4-0.69 was considered moderate 
correlation, and a coefficient of 0.7-0.99 was considered strong correlation (Schober, Boer, & 
Schwarte, 2018). A statistical significance level of 0.05 was applied. 
Results 
The study sample consisted of 23 Caucasian males and 1 Native American male with a 
mean age of 62.5 ± 13.8 years, and 4 Caucasian females with a mean age of 70.8 ± 8.2 years. 
The sample was primarily married (M: 70.8%, F: 100%) and with at minimum some college 
education (M: 79.2%, F: 75%). Approximately 53% of males and 75% of females had either 
enrolled in a cardiac rehabilitation program or were planning to enroll at the time of the survey. 
Participants were considered below normal heart health based on LVEF scores (M: 48.7%, F: 
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50.9%, normal range: 55%-70%). One-third of males and half of females in the sample were 
diagnosed with an ST-segment elevated MI (STEMI). There were no statistically significant 
differences among the males and females surveyed. Additional clinical and sociodemographic 
characteristics are presented in Table 6.2. 
In this sample, 58.3% of males and 25% of females were sexually active two weeks post 
discharge. Mean total scores on the MSFI and FSFI were 9.2 for males out of a possible 30, and 
10.8 for females out of a possible 36 (M range: 2-26.2, F range: 3.2-24.1). All four female 
participants scored in the dysfunction range for the total score and all subscales of the FSFI. 
Mean scores of the MSQ were 7.5 in males and 6.3 in females out of a possible 20 (M range: 0-
17, F range: 0-13). Table 6.3 provides the full means, standard deviations, and ranges of the total 
scores and subscale scores for the MSFI and FSFI along with the MSQ scores. 
In men, total scores on the MSFI were all either highly or moderately correlated with the 
individual subscales, which ranged from 0.63 to 0.88. Among the physical subscales (arousal, 
erection, and orgasm) the strongest correlations were between erection and arousal (r= 0.73). 
The remaining physical components were moderately correlated (see table 6.4). When examining 
the psychologic variables, desire was moderately correlated with orgasm (r= 0.45) and weakly 
correlated with arousal and erection. Fear was weakly correlated with all the subscales and the 
total scores of the MSFI but did show the highest correlations with orgasm. The social domain of 
sexual satisfaction was moderately correlated with orgasm (r= 0.50). All the correlations of the 
MSQ with the other subscales of the MSFI were negative, meaning that as function scores 
improved, fear decreased.  
In females, the total scores of the FSFI were all highly correlated (r= 0.87) except for the 
satisfaction subscale, which was moderately correlated (r= 0.50). Strong positive correlations 
  
166 
 
were found between desire, lubrication, and orgasm with other subscales. However, the social 
domain (satisfaction) had no correlation with any FSFI subscale. As in the men, all interactions 
between the MSQ and the FSFI subscales were expectedly negative, with the exception being 
fear with satisfaction (r= 0.50). Table 6.5 provides a complete summary of the correlations 
among the FSFI total score with its subscales and the MSQ. 
Discussion 
The results of this study helped to illuminate the relationships between the domains of 
sexual function with sexual satisfaction and sexual fear within two weeks of discharge for MI, 
which to our understanding has not been studied previously. While these results are modest, the 
clinical relevancy uncovers important short-term relationships between function and satisfaction 
in males and females. Currently available rigorous studies of post-MI sexual function and 
satisfaction in both sexes have focused on one month (Lindau et al., 2016), three months (Oskay, 
Can, & Camci, 2015) and one year post-event (Lindau et al., 2012; Lindau et al., 2014). This 
study also adds to the current literature by measuring sexual function and satisfaction scores in 
males using a multidimensional instrument with a comparable structure to the FSFI. This is an 
important contribution, as sexual activity in terms of intercourse is given far more focus in the 
current MI literature, and non-physical components of sexual function overall are less 
understood, particularly in men.  
An explanation for the observed low function scores might be the relatively low levels of 
sexual activity among the females (25%) and males (58.3%) surveyed. Another explanation 
could be the age of the sample, and possibly the menopausal status among the female 
participants. However, the effects of menopause and sexual function should be considered within 
the context of other influencing biopsychosocial variables, and may not be an indicator of 
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dysfunction necessarily (Heidari, Ghodusi, Rezaei, Kabirian Abyaneh, Sureshjani & Sheikhi, 
2019). In a previously conducted multi-site study of over 2,800 patients post-MI, 73% of females 
and 85% of males were sexually active (Lindau et al., 2016). This disparity could be due to the 
older age in this sample compared to this previous study (62.5 years vs. 49 years). Physical 
function scores also appeared to be related to sexual activity status, but a weaker relationship was 
observed between sexual activity status and other components of function (desire, sexual fear, 
and satisfaction). The short time post-discharge to survey completion may also explain the low 
overall sexual function scores observed in this sample. This is consistent with a previous cross-
sectional study of 45 females at three months post-MI using the FSFI, which reported a total 
score of approximately 16.4, compared to 9.2 observed in this study (Oskay, Can, & Camci, 
2015). Importantly, American Heart Association (AHA) guidelines have indicated that sexual 
activity is reasonable within 1-2 weeks post discharge, given an uncomplicated MI with no 
adverse cardiac symptoms during physical activity (Levine et al., 2012; ACC/AHA, 2004). 
However, the question remains whether patients are counseled about sexual issues. There is some 
literature that has reported that women are generally counseled less often than men, which is an 
important consideration given that activity often decreases at one year post event without 
counseling (Lindau et al., 2016). As such, these results may indicate that patients’ sexual 
function and satisfaction require attention even in the first weeks following discharge. Patients 
post-MI frequently disclose issues with diminished sexual function prior to discharge, and so 
education and counseling on both short- and long-term expectations for sexual health changes is 
crucial regardless of sexual activity status (Steinke et al., 2013). 
As would be expected, this cross-sectional study found strong correlations among five 
subscales of the MSFI and FSFI, providing evidence for validation of this instrument in the post-
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MI population. However, the correlation between sexual desire with the other subscales of the 
MSFI was weak to moderate. There were also a mix of moderate and weak correlations between 
satisfaction and the other subscales of the MSFI. This could suggest the absence of a relationship 
among satisfaction with erection, orgasm, or arousal in male post-MI patients. However, it is 
important to consider the role that the partner’s interest and sexual function could play in sexual 
function neither of which are captured on the FSFI or MSFI. 
In this small sample of females post-MI, sexual satisfaction was not correlated with the 
other subscales of the FSFI. While these relationships have not been examined previously, this 
disconnect is consistent with a study of 45 post-MI women which found high satisfaction scores 
on the FSFI, compared to diminished scores on the other subscales (Oskay, Can, & Camci, 
2015). This previously conducted study also found no statistically significant differences in 
sexual satisfaction among women post-MI in comparison with healthy participants. Overall, 
there is very little literature that captures these relationships between the different components of 
function and satisfaction in females post-MI. However, this study was only able to measure a 
small sample of female participants, so it is difficult to make any concrete hypotheses or 
conclusions. The small sample size also increases the likelihood of producing extreme positive 
and negative correlations (0.99 and 0), which would likely stabilize with a larger sample. These 
limitations implicate further research with a larger female sample to clarify these potential 
relationships. 
An expected finding was the negative correlations seen in both males and female 
participants among fear with the other subscales. It is conceivable that someone might either 
develop fear as they engage more in activity, but this relationship should be studied further. In 
addition, while scores on the MSQ landed a cross a broad range, only 16% of male and 25% of 
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female participants had scores ≥10 out of 20, indicating relatively low sexual fear levels in this 
sample. These low scores might explain why sexual fear was only weakly correlated with sexual 
function and satisfaction in men. While the correlations between fear with the FSFI subscales 
were higher in female compared to male participants, it is unclear whether these correlations 
would change with a larger sample size. The low levels of fear seen in this sample contrasted 
with the growing body of literature surrounding sexual fear in patients post-MI. Several 
quantitative studies have produced a range of prevalence rates for sexual fear as high as 88.4% 
(Oskay, Can, & Camci, 2015). However, measurements of sexual fear in these studies were 
investigator-developed and so their validity and reliability remain largely unknown. In the 
qualitative literature, a study of 19 post-MI participants found themes of sexual fear in the 
interviews alongside a desire for recommendations of how and when to engage in sexual activity 
without increasing risk for a repeat MI (López-Medina, Gil-García, Sánchez-Criado, & 
Pancorbo-Hidalgo, 2016). Another qualitative study of 130 women after a first-time MI found 
that 51% expressed fear of resuming sexual activity (Søderberg, Johansen, Herning, & Berg, 
2013). These qualitative studies found that patients post-MI are often afraid of a repeat MI or 
death during intercourse, which is exacerbated by a hesitancy among both patients and clinicians 
to discuss sexual health topics (Zeydi, Sharafkhani, Armat, Gould, Soleimani, & Hosseini, 
2016). However, patients still desire some form of sexual activity or intimate relationships, 
which may explain the lack of correlation among the physical and psychosocial domains of 
sexual function (López-Medina, Gil-García, Sánchez-Criado, & Pancorbo-Hidalgo, 2016).  
There were some limitations of this study. Firstly, the small sample size limits much of 
the ability to control for covariates and make concrete conclusions regarding the findings. In 
particular, the small sample of female participants produced a relatively unstable correlation 
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matrix that would require a much larger sample to fully investigate. Furthermore, the 
homogenous sample in terms of education, race, and marital status limits external 
generalizability to other populations. Secondly, this sample included a very small number of 
female compared to male participants. Recent estimates of MI prevalence are approximately 
60% male and 40% female compared to 86% and 14% in this sample (Benjamin et al., 2019). 
This may be related to a greater interest in discussion of sexual health topics from males (Lindau 
et al., 2007). Age might have also influenced activity rates and as a result inclination to join the 
study. Lastly, some aspects of the psychosocial domain were not measured, such as self-image, 
general intimacy, role engagement, and emotional closeness (Mosack & Steinke, 2009). 
Conclusion 
In this limited preliminary study, the relationships among the physical components of 
function were strongly to moderately correlated in both sexes. However, relationships between 
the physical and psychosocial components of function were only moderately to weakly 
correlated in men. Low desire was strongly correlated with low physical function in females, but 
they reported a reasonable level of satisfaction, indicating that the relationship component may 
play a significant role in female sexuality in older age and possibly after an MI. There was 
minimal support for a relationship between sexual fear and the other components of sexual 
function in both males and females. However, the next step is to conduct further research with a 
larger sample to further solidify the hypothesized relationships observed in this study. A larger 
sample size of females is especially needed. In addition, qualitative research may be especially 
enlightening to provide a more detailed and nuanced representation of sexual desire and sexual 
satisfaction with overall relationship satisfaction beyond the capacity of the MSFI/FSFI.  
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What’s New? 
• Physical components of sexual function (erection, lubrication, orgasm) were moderately 
to strongly correlated in both sexes. 
• While physical components were moderately intercorrelated, physical and psychological 
(desire, satisfaction), were weakly to moderately correlated among males and strongly to 
weakly correlated among females. 
• Fear of sexual activity did not appear to significantly influence sexual function or 
satisfaction scores, though there was an expected negative relationship.  
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Tables and Figures 
Table 6. 1 - Domains and operationalization of sexual function 
Domain Operationalization Questions 
Physical Arousal, orgasm 
Erection (male) 
Lubrication (female), pain (female) 
MSFI: Q3-13  
FSFI: Q3-13, Q17-19 
Psychological Desire, sexual fear MSFI: Q1-2 
FSFI: Q1-2  
MSQ: Q1-5 
Social Satisfaction MSFI: Q14-16 
FSFI: Q14-16 
MSFI: Male Sexual Function Index; FSFI: Female Sexual Function Index; MSQ: Multidimensional Sexuality 
Questionnaire  
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Table 6. 2 - Characteristics of study participants 
 Male (n=24) Female (n=4) 
   
Sociodemographic characteristics 
Mean age (SD) in years 
 
62.5 (13.8) 
 
70.8 (8.2) 
Race, No. (%) 
White/Caucasian 
Other 
 
23 (95.8) 
1 (4.2) 
 
4 (100) 
0 (0) 
Marital status, No. (%) 
Single 
In a relationship 
Married 
Divorced 
Widowed 
 
2 (8.3) 
2 (8.3) 
17 (70.8) 
2 (8.3) 
1 (4.2) 
 
0 (0) 
0 (0) 
4 (100) 
0 (0) 
0 (0) 
Education status, No. (%) 
Some high school 
High school degree 
Some college 
College degree 
Graduate degree 
 
2 (8.3) 
3 (12.5) 
7 (29.2) 
5 (20.8) 
7 (29.2) 
 
0 (0) 
1 (25) 
1 (25) 
1 (25) 
1 (25) 
Rehabilitation status, No. (%) 
Currently enrolled 
Planning to enroll 
Not enrolled 
 
5 (20.8) 
8 (33.3) 
11 (45.8) 
 
0 (0) 
3 (75) 
1 (25) 
Employment status, No. (%) 
Employed 
Unemployed 
Retired 
Medical leave 
 
11 (45.8) 
1 (4.2) 
10 (41.7) 
2 (8.3) 
 
1 (25) 
0 (0) 
3 (75) 
0 (0) 
MI Severity, No. (%) 
STEMI 
NSTEMI 
 
8 (33.3) 
16 (66.7) 
 
2 (50) 
2 (50) 
Clinical characteristics   
Mean troponin (SD) in ng/mL 907.6 (1990.7) 1502.3 (1132.5) 
Mean LVEF, No. (%) 48.7 (18.0) 50.9 (13.3) 
MI: Myocardial infarction; STEMI: ST-segment elevated myocardial infarction; LVEF: Left ventricular ejection 
fraction  
  
180 
 
Table 6. 3 - Means (standard deviation) of FSFI, MSFI and MSQ scores at two weeks (n=28) 
Male (n=24) Mean (SD) 
Possible 
Scores 
Female (n=4) Mean (SD) 
Possible 
Scores 
MSFI: Total* 9.2 (7.7) 2-30 FSFI: Total* 10.8 (11.5) 2-36 
Desire 2.5 (1.5) 1.2-6 Desire 1.8 (1.2) 1.2-6 
Arousal 1.5 (1.9) 0-6 Arousal 1.2 (2.2) 0-6 
Erection 1.2 (1.9) 0-6 Lubrication 1.5 (3.0) 0-6 
Orgasm 1.4 (2.3) 0-6 Orgasm 1.4 (2.8) 0-6 
Satisfaction* 2.36 (1.6) 0.8-6 Satisfaction* 3.1 (1) 0.8-6 
   Pain 0.3 (0.6) 0-6 
MSQ: Sexual Fear 7.5 (5.6) 0-20 MSQ: Sexual Fear 6.3 (5.6) 0-20 
SD: Standard deviation; MSFI: Male Sexual Function Index; FSFI: Female Sexual Function Index; MSQ: 
Multidimensional Sexuality Questionnaire 
* Satisfaction and total scores calculated with missing participants removed (male=4, female=1) 
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Figure Legend 
Figure 6.1 - Association between sexual function (MSFI) and sexual fear (MSQ) in males post 
myocardial infarction (n=24) 
Abbreviations: MSFI: Male Sexual Function Index; MSQ: Multidimensional Sexuality 
Questionnaire 
r
s
: Spearman correlation coefficient 
* p-value < 0.05 
** p-value < 0.01 
+ Satisfaction and total scores calculated with missing participants removed (n=4) 
 
Figure 6.2 - Association between sexual function (FSFI) and sexual fear (MSQ) in females post 
myocardial infarction (n=4) 
Abbreviations: FSFI: Female Sexual Function Index; MSQ: Multidimensional Sexuality 
Questionnaire 
r
s
: Spearman correlation coefficient 
* p-value < 0.05 
** p-value < 0.01 
+ Satisfaction and total scores calculated with missing participants removed (n=1) 
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Figure 6. 1 - Association between sexual function (MSFI) and sexual fear (MSQ) in males post 
myocardial infarction (n=24) 
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Figure 6. 2 - Association between sexual function (FSFI) and sexual fear (MSQ) in females post 
myocardial infarction (n=4) 
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CHAPTER VII 
Conclusion 
 
This dissertation aimed to understand how sexual function and satisfaction change over 
time post-MI using several quantitative methods. A multidimensional measurement of sexual 
function and satisfaction was collected from patients along with several covariates including 
fear, anxiety, depression, and utilization of coping strategies. These surveys were used to 
examine longitudinal changes in sexual function over a three-month time period. Linear and 
logistic regression were then applied to explore possible predictors of sexual function and 
satisfaction. Lastly, a cross-sectional examination of the interconnected domains of sexual 
function, satisfaction, and sexual fear was conducted at two weeks. 
Major Research Findings 
The first aim was to longitudinally describe sexual function and satisfaction from two 
weeks to three months post-MI. Rather than an isolated point in time, this study uncovered 
several interesting overall changes in sexual function which have not been previously captured in 
this patient population. Indeed, this study illuminated the degree to which sexual function and 
satisfaction could improve - or not improve - over three months, with erection and orgasm scores 
improving by almost 30% while desire and satisfaction only improved by approximately 10%. 
Furthermore, the percent of male participants who were sexually active improved from 33.3% to 
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72%. However, perhaps the most interesting sexual health variable studied in this dissertation 
was sexual satisfaction. While satisfaction scores improved overall, more than half of males and 
one third of females remained either dissatisfied with the amount of emotional closeness with 
their partner or were dissatisfied with their sexual relationship or overall sex life. Despite this, 
satisfaction appeared to change regardless of changes in function or activity status. Sexual 
satisfaction is often left unaddressed in the MI literature as dysfunction and activity are given 
more focus. Altogether, these results broadened our understanding of the full breadth of issues 
patients face post-MI and reinforced the importance of assessing for both sexual dysfunction and 
dissatisfaction prior to discharge. These results also generated some interesting hypotheses that 
the overall relationship between satisfaction and function is complex and nuanced and should be 
studied in further detail.  
The second aim was to determine the impact of depression, fear, anxiety, and use of 
coping strategies on predicting sexual function and satisfaction at three months post-MI. 
Previous cross-sectional literature has found multiple associations between these covariates and 
sexual health, and this research aimed to explore their capacity for predicting changes in sexual 
function. There was an expected negative association among anxiety, depression, and fear with 
function. Positive coping strategies were associated with increased function and likelihood of 
being active at three months, while avoidance strategies achieved the opposite effect, which were 
also expected findings. While this research was limited in its ability to conclusively determine a 
predictive effect, the results provide some hypotheses for future research with a larger sample, 
particularly with examining the effects of coping strategies.  
The third aim was to describe the relationships between the domains of sexual function, 
satisfaction, and sexual fear at two weeks post-MI. This analysis explored relationships between 
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the physical and psychosocial components of function among males and females. This study 
provided an important contribution, being the first to profile sexual function, satisfaction, and 
fear within the earliest weeks suitable for sexual activity post-discharge. An interesting finding 
was the lack of a strong relationship between desire and satisfaction with overall function 
compared to arousal, erection, and orgasm. These findings in combination with the longitudinal 
findings in this dissertation and previously conducted 1-year outcome studies furthers our 
understanding of sexual function over time (Lindau et al., 2012; Lindau et al., 2014). While 
previous studies have provided the percentage of those with sexual problems at 1 year, this study 
provides some detail into functional severity before that one-year timepoint (Lindau et al., 2014). 
This was also the first study to empirically study sexual fear using a validated measurement in a 
post-MI population, as previous research has only used investigator developed instruments with 
unspecified development or validation beforehand (Oskay, Can, & Camci, 2015). 
The results of all three aims largely supported one another with one major inconsistency. 
First, the disconnect between satisfaction and function was observed both in the cross-sectional 
and longitudinal findings. Sexual satisfaction did not appear to correlate with function in the 
cross-sectional analysis, and satisfaction increased among females in the longitudinal analysis, 
despite lower function scores. Taken together, these results could indicate that the relationship 
between satisfaction and function may be more complex than previously studied, especially 
considering that sexual satisfaction has remained high despite diminished function in both CAD 
and MI populations, and was comparable to health controls (Kaya, Yilmaz, Nurkalem, Ilktac, & 
Karaman, 2007; Oskay, Can, & Camci, 2015). Second, while net changes on the covariates were 
minimal, the negative correlations observed between fear and function, and the positive 
correlations seen between support-seeking and problem-solving coping strategies with function 
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were consistently reflected in the models. The largely inconsistent findings were among the 
sexual fear data. Sexual fear was negatively associated with function in the models, which was 
expected. However, increasing fear over time was also associated with an increased likelihood of 
becoming sexually active. Furthermore, in the cross-sectional findings, sexual fear was positively 
correlated at two weeks and negatively correlated at three months (the expected correlation 
would be positive). As mentioned previously, it is temporally unclear whether someone might 
either develop fear as they engage more in activity, or if their fear precludes them from engaging 
in the first place. 
Patients post-MI can have more depression and anxiety than a general population, and 
these affective conditions can reduce sexual health in addition to overall quality of life (Daniel et 
al., 2018; Steinke et al., 2013; Kriston, Gunzler, Agyemang, Bengel, Berner, & SPARK Study 
Group, 2010). Depression and anxiety often present together, which would explain the 
relationships seen among the correlation tables, and makes sense clinically, given the evidence 
regarding their relationship with sexual function. Interestingly, sexual satisfaction has remained 
high in previous literature among patients with both MI and CAD, despite lower function scores 
(Kaya, Yilmaz, Nurkalem, Ilktac, & Karaman, 2007; Oskay, Can, & Camci, 2015). This was in 
contrast to the comparable satisfaction scores with other components of function seen in this 
study, and so the contrast between these results with previous literature indicates that these 
relationships are complex and need additional research. Theoretically, the conceptual definition 
of satisfaction used in this dissertation is simply “the desire for one’s sexual needs to be met”, 
which may or may not include intercourse (Ashdown, Hackathorn, & Clark, 2011). As such, it 
may be that satisfaction is independent of function and can be high or low regardless of physical 
function scores. 
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Reflection 
 Upon reflection, several changes were considered should this study be repeated with the 
same aims. One possible change might be the adjustment of the measurements. One of the 
advantages of the FSFI and MSFI is its remarkably detailed measurement of multiple 
components of function and satisfaction. However, such granularity might have increased 
discomfort among participants, so a broader survey might have improved overall response rates, 
but with the tradeoff of a less detailed dataset. Another survey that might have been changed was 
the CSI. Rather than measuring the number of coping strategies one uses, it may have been more 
informative to assess whether someone was employing more positive or negative coping, general 
coping styles, or directly measure whether one was coping effectively with their illness. Many 
conceptualizations and measurements of coping have been created over the past decades, such as 
the Coping Self-Efficacy Scale (CSES) (Chesney, Neilands, Chambers, Taylor, & Folkman, 
2006), which measures confidence in application of coping strategies, and the Brief Resilient 
Coping Scale (BRCS) (Sinclair & Wallston, 2004), which measures highly adaptive coping. 
These measurements may have been more clinically useful to capture.  
The eligibility criteria were also reconsidered. In a perfect recruitment scenario, the 
patients approached would only have an MI and no other comorbidities. Unfortunately, a balance 
had to be struck between controlling for some chronic conditions while also maintaining the 
feasibility of the study. As such, the criteria were structured to exclude for the conditions that 
had the strongest representation in the literature. However, because of this, there may have been 
some unidentified chronic conditions that were influencing patient’s sexual health that were not 
accounted for. The idea of requiring patients to be sexually active was also considered as part of 
the eligibility criteria. This has been part of the inclusion criteria for multiple studies conducted 
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in this population (Oskay, Can, & Camci, 2015; Ghanbari Afra, Taghadosi, & Gilasi, 2015; 
Kazemi Saleh, Pishgou, Farrohki, Assari, Fotros, & Naseri, 2008). However, the intention of this 
dissertation was to measure sexual function in a general population of patients post-MI, 
regardless of sexual status. Given that the MSFI/FSFI do not exclude patients who were not 
active, the measurement could still be completed by both subgroups, though activity status does 
substantially impact the scoring. 
One of the largest weaknesses of this dissertation was that 56% did not provide data after 
consent, and only 33% of participants completed all the surveys. Several modifications were 
considered to reduce attrition should this study be repeated in the future. Response rates might 
have improved if the participant filled out the questionnaire at the bedside immediately upon 
consent rather than waiting until after discharge. This could have improved response rates at the 
first timepoint, where attrition was the highest. However, surveying patients who were still in the 
hospital might not be appropriate, as they are likely not ready to start considering sexual health 
issues. Thus, while response rates might improve, any data collected would likely not be useful 
clinically. Additionally, this method may not reduce attrition at the second timepoint. Increasing 
the number of follow up contact points may also have improved the response rates over time, but 
it may not have been ethical to continuously contact the participant and could be perceived as 
manipulative. 
Another possible change involves the consent process. All consent procedures were 
conducted by the primary investigator alone. As such, there may have been some hesitancy to 
share sexual health information given the age and gender of the primary investigator. While 
consent rates were reasonable (63%), the inclusion of a nurse or physician involved in the 
patient’s care may have increased response rates. A disadvantage to this method is that it would 
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have likely produced a substantial burden on nurses’ and physicians’ already demanding and 
busy schedules. As an alternative, letters with a signature from the lead cardiac physician may 
have been a suitable workaround. However, some patients who deferred contact in the hospital 
were mailed letters in this dissertation, but response rates were very low (14%), and no 
additional patients were recruited using this method. It is therefore unlikely that response rates 
would have improved using mailed letters, especially given the sensitive subject matter of the 
study combined with the lack of any face-to-face interaction with the primary investigator. 
Another shortcoming was the overall small sample size and low numbers of female 
participants. If a more comprehensive screening tool such as DataDirect had been employed at 
the outset of the dissertation, a wider pool of patients post-MI could have been identified. 
DataDirect is a self-service analytic platform that provides up-to-date admission data on the 
entire inpatient census at the University of Michigan Health System. Supplemental screening 
through DataDirect was implemented into the study IRB, but was approved with only one month 
of recruitment remaining. Given more time and the additional bandwidth provided by 
DataDirect, purposive sampling could have been employed to recruit more females and 
minorities to the study.  
A final change that could be implemented is collecting pre-MI sexual health data to 
provide an even better understanding of the effects of MI longitudinally. The weakness of 
collecting such data retrospectively is that asking patients about pre-MI sexual function 
introduces a high risk of recall bias and may not be reliable or accurate information. There is also 
the increased burden of requiring patients to fill out another set of questionnaires, which would 
have likely exacerbated the already high attrition rates. 
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The conceptual model was also revisited. It is unclear whether education or employment 
status would truly influence sexual function, so these variables might be dropped from a revision 
to the model. Partner status could be expanded into capturing partner sexual function to better 
capture those effects. Rehabilitation status could be replaced as an environmental factor with 
education/resources provided to encompass the quality of education (or lack thereof) regarding 
management of sexual function issues. While the selected predictors largely matched with the 
conceptual framework, coping strategies may still require additional investigation. Coping was 
conceptualized as a mediator in the original model, but a mediation analysis was not conducted 
in this dissertation. A full mediation analysis utilizing a Baron and Kenny approach might be an 
informative follow-up study (Baron & Kenny, 1986). 
Implications for Further Research 
Taken together, the results of this dissertation contribute to our understanding of sexual 
function and satisfaction post-MI by both describing and modeling changes over time. Through 
this study, the groundwork has been created for four main avenues of future research. The first 
are additional studies examining sexual function and satisfaction changes in women. While some 
cross-sectional work in women with the FSFI has been conducted, longitudinal and predictive 
research is still needed, as this dissertation was unfortunately unable to recruit enough females 
for a suitable analysis. A follow up longitudinal study with an adequate sample of females post-
MI could provide an informative companion to this work. Outside of the increasing the number 
of female participants, a larger study over a longer period of time in general is also indicated. 
The second relates to our lack of knowledge surrounding outcomes further than one year. 
Long term sexuality research has been previously conducted with registries such as the National 
Social Life, Health, and Aging Project (NSHAP), which is entering its fourth renewal after a 
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decade of data collection. While promising, this initiative collected self-report data on MI status 
with no methods of determining the length of time post-event (Laumann & Waite, 2008). 
Furthermore, the NSHAP sexuality data primarily revolves around physical and emotional 
satisfaction, and amount of activity, and does not assess quality of physical function. Regardless, 
measuring the same outcomes in this dissertation at one year and beyond, while challenging to 
implement, could identify the long-term trajectory of functional changes, and determine if scores 
eventually plateau or decrease. However, the overall length of such a study and the number of 
data collection points needed would require careful consideration to avoid the risk of attrition 
bias. A recent systematic review and meta-analysis reported that the most effective attrition 
reduction strategies include barrier reduction (a shorter questionnaire, less intrusive sexual health 
questions), and improving community and follow up strategies (incentives for every stage of data 
collection, more follow up contact points) (Teague et al., 2018). Ultimately, it is important to 
consider the advantages and disadvantages with regards to quality vs. quantity of the any 
resultant data when implementing these changes.  
The third is for research that incorporates a more robust representation of sexual health 
overall, which would provide additional clarity and could supplement the findings observed in 
the cross-sectional research conducted in this dissertation. Topics in sexual health that were not 
assessed in this dissertation included self-image, general intimacy, and stratification among 
penetrative and non-penetrative forms of intercourse. In particular, the conceptualization of 
intimacy in this work could be more comprehensive, which is one limitation of the 
measurements utilized. Qualitative research may be especially helpful in this regard to capture a 
more personal open-ended discussion on the many nuances and intricacies of sexuality.  
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Fourth, additional research is needed of post-MI patients who are unpartnered. Patients 
who do not have a partner are still sexual beings, but they are often neglected in sexual health 
research. While this study did collect data from unpartnered individuals, the sample size limited 
any subgroup analysis. The MSFI/FSFI also require some element of partnered sexual activity to 
complete some of the survey items, which limits its applicability to all post-MI patients and led 
to some missing data. As such, a larger sample is needed in future studies to elucidate if there are 
any possible differences between partnered and unpartnered patients. 
Future intervention research might also be informed by the findings from this 
dissertation, particularly with regards to satisfaction. For example, despite the low rates of sexual 
activity, satisfaction improved by 16.7% among all females. There was frequent disconnect 
between satisfaction and function in both the cross-sectional and descriptive findings. Sexual 
health literature post-MI is often focused solely on activity, but even patients who are sexually 
active may be dissatisfied with their sex lives. As mentioned, previous literature has 
demonstrated that satisfaction remains high in comparison to function in both general 
populations of CAD and MI patients (Kaya, Yilmaz, Nurkalem, Ilktac, & Karaman, 2007; 
Oskay, Can, & Camci, 2015). Given this evidence, satisfaction and function may constitute 
separate targets for intervention. It may be that participants are not prioritizing function and 
activity, and as such interventions that stem from any future descriptive work may be best suited 
in addressing sexual dissatisfaction. Regardless of if, or how often, an individual engages in 
activity, all have the potential to create a healthy view of themselves as a sexual being and enjoy 
a satisfactory intimate relationship with their partner, if applicable. However, this hypothesis will 
need additional descriptive research to fully evaluate. 
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Implications for Practice and Policy 
The results of this study can be used to inform providers about the potential short-term 
changes to sexual function and its trajectory over the first three months post-discharge. The 
limited scope of these data hinder recommendations for high-level policy. However, previous 
studies have found that only 39.1% of sexually active men and 17.9% of sexually active women 
discuss sexual health with their physician (Lindau et al., 2012), which provide an important 
commentary on how little providers are presenting sexual health education to patients at 
discharge. A portion of this disparity stems from a lack of provider knowledge (Byrne, Doherty, 
McGee, & Murphy, 2010), which means patients are typically not given the proper tools to 
address sexual issues (Brännström, Kristofferzon, Ivarsson, Nilsson, Svedberg & Thylén, 2014; 
Nilsson, Svedberg, Fridlund, Alm-Roijer, & Thylén, 2012). This research could help inform 
providers more comprehensively, although further sexual health training in general is needed to 
assuage the discomfort that many providers feel with regards to sexual education (Byrne, 
Doherty, McGee, & Murphy, 2010). Ultimately, the objective is promoting standard assessment 
of functional issues in all post-MI patients prior to discharge, and these results, along with 
additional descriptive research, can help providers with determining whether a patient post-MI 
needs additional assistance beyond standard education. 
Nurses play an important role in the management of sexual dysfunction. Sexual 
dysfunction is classified as a human response to disease processes, and therefore is within 
nursing’s scope of practice for intervention (Ackley & Ladwig, 2014). Indeed, assessing sexual 
health has been defined as a component of holistic nursing practice by the American Nurses’ 
Association (ANA) since 1974 (Dattilo & Brewer, 2005). Given the extraordinary trust that 
patients have put in nurses throughout the past two decades, nurses are uniquely positioned to 
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discuss sexual health issues with patients (Reinhart, 2020). As mentioned, however, nurses often 
lack the knowledge, confidence, and practice to discuss sexual health, and this research can 
provide nurses with additional information to assess sexual function problems in a 
nonjudgmental and respectful manner (Jaarsma et al., 2010). Continuing education for nurses 
may include workshops or role-playing to build nurse’s knowledge and confidence with 
discussing sexual health issues (Gazestani, Shahrbabaki, Rabori, & Forouzi, 2019). This could 
involve active reflection of a nurse’s potential barriers to discussing sexual concerns, which may 
include discomfort, lack of knowledge, or embarrassment (Steinke, Mosack, Barnason, & 
Wright, 2011). The findings from this research solidified previous evidence that patients who are 
single or older are still sexually active, which are important to remain cognizant of to reduce 
bias. The changes that sexual function can undergo in a short period of time also behooves 
nurses to assess sexual function early and comprehensively. Lastly, sexual satisfaction is crucial 
to assess, given the lack of connection with function, and placement within a holistic 
representation of sexual health. 
Approximately half of patients who are post-MI are admitted to cardiac rehabilitation 
following discharge (Fang, Ayala, Luncheon, Ritchey, & Loustalot, 2017). However, while core 
components of cardiac rehabilitation include management of psychosocial factors as a 
preventative measure to reduce the probability of a repeat event, sexual fears and anxieties are 
often not included (Sandesara et al., 2015). Furthermore, a review of exercise-based cardiac 
rehabilitation protocols did not identify guidelines or educational standards for sexual health 
(Price, Gordon, Bird, & Benson, 2016). Unfortunately, sexual health education remains an 
understudied component of standard rehabilitation care for patients post-MI. There is an urgent 
need for more consideration and study of sexual counseling within rehabilitation services 
  
196 
 
(Araújo, Stein, & Sardinha, 2018). This is because sexual activity post-MI requires a tailored set 
of recommendations depending on the patient’s physical capabilities. These include encouraging 
intercourse positions with less energy expenditure, avoidance of anal sex, and identification and 
report of warning signs associated with sexual activity (i.e., chest pain, shortness of breath) 
(Steinke et al., 2013).  
Strengths and Limitations 
Sexual health remains understudied in many chronic illness populations, of one cardiac 
illness is included (Basson, Rees, Wang, Montejo, & Incrocci, 2010). This research aimed to 
address several key gaps in the current literature: the lack of short-term sexual function data, the 
paucity of research on longitudinal changes in function, and the absence of robust predictive 
research. The strengths of this dissertation work include the application of a well validated 
multidimensional instrument of sexual function and satisfaction (FSFI and MSFI). This study 
was also designed using well developed sampling, recruitment, consent, and follow up 
techniques. Furthermore, the study used comprehensive screening and diagnostic methods for 
identification of patients post-MI, utilizing a combination of diagnostic reports and clinical 
biomarkers. The application of a comprehensive exclusion criteria also helped to alleviate some 
issues of confounding factors, which are important given the rates of comorbidities generally 
seen in U.S. adult and geriatric populations. The study collected data from patients who were 
unpartnered, who are critically understudied. Lastly, <2% of data were missing from the surveys 
that were collected, which aided the statistical analysis. 
The results of this dissertation work should be considered within the context of some 
limitations. One shortfall was the disproportionate percentage of females to males recruited (17% 
to 83%). Several factors may explain this disparity. First, MI tends to affect more males than 
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females, with national rates at approximately 60% to 40% respectively (Virani et al., 2020). In 
addition, rates of females with MI were in fact lower at the recruitment site than the national 
average based on admission data tabulated from DataDirect. A cohort of all patients admitted 
with an MI diagnosis during the recruitment period of the study (September 2018 to November 
2019) were gathered. This analysis produced an admission diagnosis breakdown of 67% male 
and 33% female (n=1337). Second, the exclusion criteria might have disproportionately 
excluded females, particularly in terms of cancer diagnoses. This is because breast, uterine, and 
ovarian cancer account for a larger percentage of cancer diagnoses over prostate cancer (59.2% 
vs. 44.8%) (American Cancer Society, 2019). A final possibility might be a greater willingness 
among men to share information on sexual health compared to women (Lindau et al., 2012). 
However, there were only minimal differences in consent and decline rates among males and 
females to the study (70.2% male vs. 64.3% female), and for response rates (46.2% male vs. 
44.4% female, first timepoint). 
The small sample size produced unique limitations. These analyses were unable to be 
adjusted for covariates other than age due to the sample size. In addition to low numbers of 
females, the sample was predominately white, married, and well educated, which limits the 
dissertation’s external validity. Attrition rates were high from consent to three months (66.7%), 
which raises questions about the internal validity of the study findings (i.e. the people who 
completed all the data were different than those who dropped out.) That said, there were no 
identifiable differences among those who consented vs. declined nor those who turned in data vs. 
those who did not. However, it is impossible to know the sexual function scores of those who 
declined to participate or submit data. The MSFI/FSFI ask two questions in the satisfaction 
subscale that pertain to partnered sexual activity, which produced some missing responses 
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among the unpartnered individuals. Finally, familial support was collected in this dissertation but 
was dropped from analysis to give priority to the predictors with a more robust representation in 
the literature. However, this could still be explored with a larger sample size in future research. 
Next Steps 
The first immediate step of this work will be to disseminate the findings. The results of 
this dissertation will be implemented into three academic manuscripts. The process of 
recruitment, consent, and data collection will be integrated into an additional methods paper. By 
doing this, the intention is to include assessment of sexual health as a standard of post-MI care 
by bringing patient’s voices and needs to the decision-making table when future interventions are 
being created. Furthermore, this dissertation experience will be utilized as the foundation for 
training on development and implementation of dyadic-focused interventions for management of 
chronic illness in a future postdoctoral fellowship.  
Conclusion 
In summary, this dissertation work provided some important preliminary data into 
changes of function and satisfaction over time and their possible predictive factors for patients 
post-MI. While the results from this dissertation were modest, and the applicability to female 
participants was unfortunately minimal, the results still provide important information that helps 
build towards a more complete understanding of sexual function and satisfaction in the post-MI 
population.  
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Appendix A 
Female Sexual Function Index (FSFI)  
(Rosen et al., 2000) 
INSTRUCTIONS: The following questions evaluate your sexual interest or functioning. 
Remember that all responses to these questions will be kept confidential. Please circle the 
number next to the answer to each question. 
 
1. Over the past week, how often did you feel sexual desire or interest? 
  
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half 
the time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never 
or never 
  
            
2. Over the past week, how would you rate your level (degree) of sexual desire or interest? 
  
5 
Very high 
4 
High 
3 
Moderate 
2 
Low 
1 
Very low or 
none at all 
  
            
3. Over the past week, how often did you feel sexually aroused (“turned on”) during sexual 
activity or intercourse? 
  
0 
No sexual  
activity 
  
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half 
the time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never 
or never 
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4. Over the past week, how would you rate your level of sexual arousal (“turn on”) during 
sexual activity or intercourse? 
  
0 
No sexual  
activity 
5 
Very high 
4 
High 
3 
Moderate 
2 
Low 
1 
Very low or 
none at all 
 
 
  
 
        
5. Over the past week, how confident were you about becoming sexually aroused during sexual 
activity or intercourse? 
  
0 
No sexual  
activity 
5 
Very high  
confidence 
4 
High 
confidence 
3 
Moderate  
confidence 
2 
Low 
confidence 
1 
Very low or 
no confidence 
            
6. Over the past week, how often have you been satisfied with your arousal (excitement) during 
sexual activity or intercourse? 
  
0 
No sexual  
activity 
  
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half 
the time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never 
or never 
      
7. Over the past week, how often did you become lubricated (“wet”) during sexual activity or 
intercourse? 
0 
No sexual  
activity 
  
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half 
the time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never 
or never 
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8. Over the past week, how difficult was it to become lubricated (“wet”) during sexual activity 
or  
intercourse? 
  
0 
No sexual  
activity 
  
1 
Extremely  
difficult or  
impossible 
2 
Very difficult 
3 
Difficult 
4 
Slightly 
difficult 
5 
Not difficult 
            
9. Over the past week, how often did you maintain your lubrication (“wetness”) until 
completion of sexual activity or intercourse?  
  
0 
No sexual  
activity 
  
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half 
the time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never 
or never 
            
10. Over the past week, how difficult was it to maintain your lubrication (“wetness”) until 
completion of sexual activity or intercourse? 
  
0 
No sexual  
activity 
  
1 
Extremely  
difficult or  
impossible 
2 
Very difficult 
3 
Difficult 
4 
Slightly 
difficult 
5 
Not difficult 
  
        
11. Over the past week, when you had sexual stimulation or intercourse, how often did you 
reach orgasm (climax)? 
  
0 
No sexual  
activity 
  
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half 
the time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never 
or never 
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12. Over the past week, when you had sexual stimulation or intercourse, how difficult was it 
for you to reach orgasm (climax)? 
  
0 
No sexual  
activity 
  
1 
Extremely  
difficult or  
impossible 
2 
Very difficult 
3 
Difficult 
4 
Slightly 
difficult 
5 
Not difficult 
            
13. Over the past week, how satisfied were you with your ability to reach orgasm (climax) 
during sexual  
activity or intercourse? 
  
0 
No sexual  
activity 
  
5 
Very satisfied 
4 
Moderately 
satisfied 
3 
About 
equally 
satisfied and 
dissatisfied 
2 
Moderately  
dissatisfied 
1 
Very  
dissatisfied 
  
 
        
14. Over the past week, how satisfied have you been with the amount of emotional closeness 
during sexual activity between you and your partner? 
  
0 
No sexual  
activity 
  
5 
Very satisfied 
4 
Moderately 
satisfied 
3 
About 
equally 
satisfied and 
dissatisfied 
2 
Moderately  
dissatisfied 
1 
Very  
dissatisfied 
  
15. Over the past week, how satisfied have you been with your sexual relationship with your 
partner? 
  
5 
Very satisfied 
4 
Moderately 
satisfied 
3 
About 
equally 
satisfied and 
dissatisfied 
2 
Moderately  
dissatisfied 
1 
Very  
dissatisfied 
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16. Over the past week, how satisfied have you been with your overall sex life? 
  
5 
Very satisfied 
4 
Moderately 
satisfied 
3 
About 
equally 
satisfied and 
dissatisfied 
2 
Moderately  
dissatisfied 
1 
Very  
dissatisfied 
  
            
17. Over the past week, how often did you experience discomfort or pain during vaginal 
penetration? 
  
0 
Did not 
attempt 
intercourse 
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half 
the time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never 
or never 
            
18. Over the past week, how often did you experience discomfort or pain following 
vaginal penetration? 
 
0 
Did not 
attempt 
intercourse 
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half 
the time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never 
or never 
      
19. Over the past week, how would you rate your level (degree) of discomfort or pain during or 
following vaginal penetration? 
 
0 
Did not 
attempt 
intercourse 
5 
Very high 
4 
High 
3 
Moderate 
2 
Low 
1 
Very low or 
none at all 
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FSFI Domain and Full-Scale Scores and Factors 
  
Domain Question #s Score Range Factor Minimum 
Score 
Maximum 
Score 
Desire 1, 2 1 - 5 0.6 1.2 6 
Arousal 3, 4, 5, 6 0 - 5 0.3 0 6 
Lubrication 7, 8, 9, 10 0 - 5 0.3 0 6 
Orgasm 11, 12, 13 0 - 5 0.4 0 6 
Satisfaction 14, 15, 16 0 (or 1) - 5 0.4 0.8 6 
Pain 17, 18, 19 0-5 0.4 0 6 
Total Score    2 36 
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Appendix B 
Male Sexual Function Index (MSFI) 
 (Kalmbach, Ciesla, Janata, & Kingsberg, 2012) 
 
INSTRUCTIONS: The following questions evaluate your sexual interest or functioning. 
Remember that all responses to these questions will be kept confidential. Please circle the 
number next to the answer to each question. 
 
1. Over the past week, how often did you feel sexual desire or interest? 
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half the 
time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never 
or never 
  
            
2. Over the past week, how would you rate your level (degree) of sexual desire or interest? 
  
5 
Very high 
4 
High 
3 
Moderate 
2 
Low 
1 
Very low or 
none at all 
  
            
3. Over the past week, how often did you feel sexually aroused (“turned on”) during sexual 
activity or intercourse? 
  
0 
No sexual  
activity 
  
5 
Almost always 
or always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half the 
time) 
2 
A few times 
(less than 
half the time) 
1 
Almost never 
or never 
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4. Over the past week, how would you rate your level of sexual arousal (“turn on”) during 
sexual activity or intercourse? 
  
0 
No sexual  
activity 
5 
Very high 
4 
High 
3 
Moderate 
2 
Low 
1 
Very low or 
none at all 
  
 
 
 
        
5. Over the past week, how confident were you about becoming sexually aroused during sexual 
activity or intercourse? 
  
0 
No sexual  
Activity 
5 
Very high  
confidence 
4 
High 
confidence 
3 
Moderate  
confidence 
2 
Low 
confidence 
1 
Very low or no 
confidence 
            
6. Over the past week, how often have you been satisfied with your arousal (excitement) during 
sexual activity or intercourse? 
  
0 
No sexual  
activity 
  
5 
Almost always 
or always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half the 
time) 
2 
A few times 
(less than 
half the time) 
1 
Almost never 
or never 
  
7. Over the past week, how often did your penis become erect when trying to engage in sexual 
activity or intercourse? 
0 
No 
sexual  
activity 
  
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half 
the time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never or 
never 
      
8. Over the past week, how difficult was it to produce an erection during sexual activity or 
intercourse? 
  
0 
No 
sexual  
activity 
  
1 
Extremely  
difficult or  
impossible 
2 
Very 
difficult 
3 
Difficult 
4 
Slightly 
difficult 
5 
Not difficult 
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9. Over the past week, how often did you maintain your erection for the desired length of time? 
  
0 
No 
sexual  
activity 
  
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half 
the time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never or 
never 
 
 
  
 
        
10. Over the past week, how difficult was it to maintain your erection for the desired length of 
time? 
  
0 
No 
sexual  
activity 
  
1 
Extremely  
difficult or  
impossible 
2 
Very 
difficult 
3 
Difficult 
4 
Slightly 
difficult 
5 
Not difficult 
            
11. Over the past week, when you had sexual stimulation or intercourse, how often did you 
reach orgasm (climax)? 
  
0 
No 
sexual  
activity 
  
5 
Almost 
always or 
always 
4 
Most times 
(more than 
half the time) 
3 
Sometimes 
(about half 
the time) 
2 
A few times 
(less than half 
the time) 
1 
Almost never or 
never 
            
12. Over the past week, when you had sexual stimulation or intercourse, how difficult was it 
for you to reach orgasm (climax)? 
  
0 
No 
sexual  
activity 
  
1 
Extremely  
difficult or  
impossible 
2 
Very 
difficult 
3 
Difficult 
4 
Slightly 
difficult 
5 
Not difficult 
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13. Over the past week, how satisfied were you with your ability to reach orgasm (climax) 
during sexual  
activity or intercourse? 
  
0 
No 
sexual  
activity 
  
1 
Very 
satisfied 
2 
Moderately 
satisfied 
3 
About equally 
satisfied and 
dissatisfied 
4 
Moderately  
dissatisfied 
5 
Very  
dissatisfied 
 
 
 
  
 
    
14. Over the past week, how satisfied have you been with the amount of emotional closeness 
during sexual activity between you and your partner? 
  
0 
No sexual  
activity 
  
1 
Very satisfied 
2 
Moderately 
satisfied 
3 
About equally 
satisfied and 
dissatisfied 
4 
Moderately  
dissatisfied 
5 
Very  
dissatisfied 
            
15. Over the past week, how satisfied have you been with your sexual relationship with your 
partner? 
5 
Very 
satisfied 
4 
Moderately 
satisfied 
3 
About equally satisfied 
and dissatisfied 
2 
Moderately  
dissatisfied 
1 
Very  
dissatisfied 
  
    
 
      
16. Over the past week, how satisfied have you been with your overall sex life? 
5 
Very 
satisfied 
4 
Moderately 
satisfied 
3 
About equally 
satisfied and 
dissatisfied 
2 
Moderately  
dissatisfied 
1 
Very  
dissatisfied 
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MSFI Domain and Full-Scale Scores and Factors 
 
Domain Question #s Score Range Factor Minimum 
Score 
Maximum 
Score 
Desire 1, 2 1 - 5 0.6 1.2 6 
Arousal 3, 4, 5, 6 0 - 5 0.3 0 6 
Erection 7, 8, 9, 10 0 - 5 0.3 0 6 
Orgasm 11, 12, 13 0 - 5 0.4 0 6 
Satisfaction 14, 15, 16 0 (or 1) - 5 0.4 0.8 6 
Total Score    2 30 
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Appendix C 
Sexual Fear Subscale of the Multidimensional Sexuality Questionnaire (MSQ)  
(Snell, Fisher, & Walters, 1993) 
INSTRUCTIONS: Please read each item, and then indicate how distressing each difficulty has 
been for you with respect to your MI. How much have you been distressed or bothered by these 
activities? 
 
1. I am somewhat afraid of becoming sexually involved with another person 
  
4 
Very  
characteristic 
of me 
3 
Moderately  
characteristic of 
me 
2 
Somewhat  
characteristic of 
me 
1 
Slightly  
characteristic of 
me 
0 
Not at all  
characteristic of 
me 
  
            
2. I sometimes have a fear of sexual relationships 
  
4 
Very  
characteristic 
of me 
3 
Moderately  
characteristic of 
me 
2 
Somewhat  
characteristic of 
me 
1 
Slightly  
characteristic of 
me 
0 
Not at all  
characteristic of 
me 
  
            
3. I sometimes am fearful of sexual activity 
  
4 
Very  
characteristic 
of me 
3 
Moderately  
characteristic of 
me 
2 
Somewhat  
characteristic of 
me 
1 
Slightly  
characteristic of 
me 
0 
Not at all  
characteristic of 
me 
  
            
4. I don’t have very much fear about engaging in sex 
  
0 
Very  
characteristic 
of me 
1 
Moderately  
characteristic of 
me 
2 
Somewhat  
characteristic of 
me 
3 
Slightly  
characteristic of 
me 
4 
Not at all  
characteristic of 
me 
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5. I’m not very afraid of becoming sexually active 
0 
Very  
characteristic 
of me 
1 
Moderately  
characteristic of 
me 
2 
Somewhat  
characteristic of 
me 
3 
Slightly  
characteristic of 
me 
4 
Not at all  
characteristic of 
me 
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Appendix D 
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety 4a 
(Cella et al., 2007) 
INSTRUCTIONS: Please read each item, and then indicate your response by circling one 
option below. 
 
1. In the past 7 days, I felt fearful 
  
5 
Always 
4 
Often 
3 
Sometimes 
2 
Rarely 
1 
Never 
  
            
2. In the past 7 days, I found it hard to focus on anything other than my anxiety 
  
5 
Always 
4 
Often 
3 
Sometimes 
2 
Rarely 
1 
Never 
  
            
3. In the past 7 days, my worries overwhelmed me 
  
5 
Always 
4 
Often 
3 
Sometimes 
2 
Rarely 
1 
Never 
  
            
4. In the past 7 days, I felt uneasy 
  
5 
Always 
4 
Often 
3 
Sometimes 
2 
Rarely 
1 
Never 
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Appendix E 
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression 4a 
(Cella et al., 2007) 
INSTRUCTIONS: Please read each item, and then indicate your response by circling one 
option below. 
 
1. In the past 7 days, I felt worthless 
  
5 
Always 
4 
Often 
3 
Sometimes 
2 
Rarely 
1 
Never 
  
            
2. In the past 7 days, I felt helpless 
  
5 
Always 
4 
Often 
3 
Sometimes 
2 
Rarely 
1 
Never 
  
            
3. In the past 7 days, I felt depressed 
  
5 
Always 
4 
Often 
3 
Sometimes 
2 
Rarely 
1 
Never 
  
            
4. In the past 7 days, I felt hopeless 
  
5 
Always 
4 
Often 
3 
Sometimes 
2 
Rarely 
1 
Never 
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Appendix F 
Coping Strategy Indicator (CSI)  
(Amirkhan, 1990) 
INSTRUCTIONS: Keeping the heart attack in mind, indicate the extent to which you: 
 
1. Let your feelings out to a friend? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
2. Rearranged things around you so that your problem had the best chance of being resolved?  
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
3. Brainstormed all possible solutions before deciding what to do? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
4. Tried to distract yourself from the problem? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
5. Accepted sympathy and understanding from someone? 
  
3 
A lot 
2 
A little 
1 
Not at all 
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6. Did all you could to keep others from seeing how bad things really were? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
 
 
          
7. Talked to people about the situation because talking about it helped you to feel better? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
8. Set some goals for yourself to deal with the situation? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
9. Weighed your options very carefully? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
10. Daydreamed about better times? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
11. Tried different ways to solve the problem until you found one that worked? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
12. Confided your fears and worries to a friend or relative? 
  
3 
A lot 
2 
A little 
1 
Not at all 
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13. Spent more time than usual alone? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
14. Told people about the situation because just talking about it helped you to come up with solutions? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
15. Thought about what needed to be done to straighten things out? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
16. Turned your full attention to solving the problem? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
17. Formed a plan of action in your mind? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
  
18. Watched more television than usual? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
19. Went to someone (friend or professional) in order to help you feel better? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
20. Stood firm and fought for what you wanted in the situation? 
  
3 
A lot 
2 
A little 
1 
Not at all 
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21. Avoided being with people in general? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
22. Buried yourself in a hobby or sports activity to avoid the problem? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
23. Went to a friend to help you feel better about the problem? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
24. Went to a friend for advice on how to change the situation? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
25. Accepted sympathy and understanding from friends who had the same problem? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
26. Slept more than usual? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
      
27. Fantasized about how things could have been different? 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
  
28. [Redacted] 
  
3 
A lot 
2 
A little 
1 
Not at all 
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29. [Redacted] 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
30. [Redacted] 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
  
 
 
          
31. [Redacted] 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
32. [Redacted] 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
            
33. [Redacted] 
  
3 
A lot 
2 
A little 
1 
Not at all 
      
 
NOTE: Selected questions within each subscale of this survey were withheld at the request of the 
instrument developer. 
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CSI Subscale Distribution 
Question Item Subscale 
2. Rearranged things around you so that your problem had the best chance of 
being resolved? 
Problem 
Solving 
3. Brainstormed all possible solutions before deciding what to do? 
8. Set some goals for yourself to deal with the situation? 
9. Weighed your options very carefully? 
11. Tried different ways to solve the problem until you found one that 
worked? 
15. Thought about what needed to be done to straighten things out? 
16. Turned your full attention to solving the problem? 
17. Formed a plan of action in your mind? 
20. Stood firm and fought for what you wanted in the situation? 
29. [Redacted] 
33. [Redacted] 
1. Let your feelings out to a friend? 
Seeking 
Support 
5. Accepted sympathy and understanding from someone? 
7. Talked to people about the situation because talking about it helped you to 
feel better? 
12. Confided your fears and worries to a friend or relative? 
14. Told people about the situation because just talking about it helped you to 
come up with solutions? 
19. Went to someone (friend or professional) in order to help you feel better? 
23. Went to a friend to help you feel better about the problem? 
24. Went to a friend for advice on how to change the situation? 
25. Accepted sympathy and understanding from friends who had the same 
problem? 
31. [Redacted] 
32. [Redacted] 
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4. Tried to distract yourself from the problem? 
Avoidance 
6. Did all you could to keep others from seeing how bad things really were? 
10. Daydreamed about better times? 
13. Spent more time than usual alone? 
18. Watched more television than usual? 
21. Avoided being with people in general? 
22. Buried yourself in a hobby or sports activity to avoid the problem? 
26. Slept more than usual? 
27. Fantasized about how things could have been different? 
28. [Redacted] 
30. [Redacted] 
 
NOTE: Selected questions within each subscale of this survey were withheld at the request of the 
instrument developer
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Appendix G 
Family Support Subscale of the Multidimensional Scale of Perceived Social Support 
(MSPSS) 
(Zimet, Dalhem, Zimet, & Farley, 1998) 
 
INSTRUCTIONS: We are interested in how you feel about the following statements. Read each 
statement carefully. Indicate how you feel about each statement.  
1. My family really tries to help me  
  
 1 2 3 4 5 6 7 
Very 
strongly 
disagree 
 Strongly  
disagree 
 Mildly 
disagree 
 Neutral Mildly  
agree  
Strongly  
agree 
Very 
strongly  
agree 
              
2. I get the emotional help and support I need from my family  
  
 1 2 3 4 5 6 7 
Very 
strongly 
disagree 
 Strongly  
disagree 
 Mildly 
disagree 
 Neutral Mildly  
agree  
Strongly  
agree 
Very 
strongly  
Agree 
              
 3. I can talk about my problems with my family  
  
 1 2 3 4 5 6 7 
Very 
strongly 
disagree 
 Strongly  
disagree 
 Mildly 
disagree 
 Neutral Mildly  
agree  
Strongly  
agree 
Very 
strongly  
agree 
  
4. My family is willing to help me make decisions 
  
 1 2 3 4 5 6 7 
Very 
strongly 
disagree 
 Strongly  
disagree 
 Mildly 
disagree 
 Neutral Mildly  
agree  
Strongly  
agree 
Very 
strongly  
agree 
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Appendix H 
Nursing Research and Translation Committee Approval Form 
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Appendix I 
Follow Up Letters 
Follow Up Letter 1 - Two weeks 
 
[DATE] 
 
Dear [participant name], 
 
Thank you again for choosing to participate in this study. This envelope includes two different 
questionnaires as well as a copy of the consent form for you to keep for your records. I have 
highlighted my contact information on the consent form should you wish to contact me for any 
reason. 
 
I’d like for you to fill out these questionnaires at any time between the [7-14 days post 
discharge date]. If you could fill out both enclosed surveys, place them in the included pre-
stamped envelope, and mail them back to Ann Arbor, that would be greatly appreciated. The 
return envelope purposely has no return address to ensure your confidentiality. 
 
If you have any questions or concerns, you may either call at 810-772-8296, or email at 
smiasa@umich.edu.  
 
Sincerely, 
 
Asa Smith, BSN, RN 
PhD Candidate, Hillman Scholar 
School of Nursing  
University of Michigan, Ann Arbor, MI
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Follow Up Letter 2 - Three months 
 
[DATE] 
 
Dear [participant name], 
 
Thank you again for choosing to participate in this study. This envelope includes the final packet 
of surveys. If you haven’t had a chance to send your first packet, please do so at your 
earliest convenience. Following completion of this packet you will receive a gift card issued 
through the University of Michigan. 
 
I’d like for you to fill out these questionnaires at any time after [three months post discharge 
date], which would be approximately three months after your discharge from the hospital. If you 
could fill out the enclosed survey, place it in the included pre-stamped envelope, and mail it back 
to Ann Arbor, that would be greatly appreciated. The return envelope purposely has no return 
address to ensure your confidentiality. 
 
If you have any questions or concerns, you may either call at 810-772-8296, or email at 
smiasa@umich.edu.  
 
Sincerely, 
 
Asa Smith, BSN, RN 
PhD Candidate, Hillman Scholar 
School of Nursing  
University of Michigan, Ann Arbor, MI
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Appendix J 
Invitation Letter 
[DATE] 
 
[participant name], 
 
You are receiving this letter because you have recently been diagnosed with a heart attack. 
Sometimes the experience of having a heart attack can impact sexual function. The purpose of 
this letter is to let you know about a study that is being done at the University of Michigan to 
better understand changes in sexual function over time in people who have had a recent heart 
attack. Researchers will use this information to develop ways to help people improve sexual 
function after a heart attack. 
 
If you participate, you will be asked to complete a set of questionnaires about sexual function, 
satisfaction, coping, anxiety and depression at 3 weeks and three months after you left the 
hospital related to your heart attack. The questionnaires can be filled out at home and sent back 
in a stamped, self-addressed envelope. Neither your name nor any identifying information will 
be on the questionnaire themselves. You will receive a gift card of $30 for completing both sets 
of questionnaires at 3 weeks and three months.  
 
Taking part in this study is completely voluntary. You do not have to participate if you do 
not want to. The care you receive at Michigan Medicine will not change whether you join 
the study or not. 
 
If you are interested in hearing more about the study, one of our study team members would be 
happy to call you to explain the study in more detail. Hearing more about the study does not 
require you to participate. If you would like us to contact you, please complete the information 
below and send it back to us in the self- addressed, stamped envelope included with this letter. 
If you would rather contact us, you can reach the research investigator, Asa Smith, by calling 
810-772-8296 or by emailing smiasa@umich.edu
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Thank you for your time in considering this request, 
Asa Smith, BSN, RN  
Suite 3236, 400 North Ingalls Building 
Ann Arbor, MI 48109-5482 
Debra Barton PhD, RN, FAAN 
400 North Ingalls Building 
Ann Arbor, MI 48109-5482 
 
Name:   
 
Phone number:   Best days/times to call:   
 
  I am interested in hearing more about the study, please call me. 
 
  It is okay to leave a brief message at this number.
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Appendix K 
Demographic Survey 
1. Age _____ 
2. Gender 
  
  
  
Male Female       
3. Race 
  
  
  
Caucasian/White Black/African 
Descent 
Asian Other  ______________ 
    
   
  
4. Please indicate your educational status 
  
  
  
Some high school High school  
degree 
Some college College 
Degree 
Graduate  
degree 
            
5. Please indicate your relationship status 
  
  
Single In a relationship 
(living together) 
In a relationship  
(not living together) 
Married Divorced Widowed 
            
6. Please indicate your employment status 
  
  
  
Employed 
(full time) 
Employed 
(part time) 
Unemployed Retired Medical 
leave 
 
 
 
    
7. Are you or were you currently enrolled in cardiac rehabilitation (CR) services after you had 
your heart attack? (this current heart attack only) 
  
  
  
Currently enrolled 
in CR 
Previously  
enrolled in CR 
Planning to  
enroll in CR 
Not enrolled 
in CR 
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Supplemental Biomarkers Form 
 
1. Type of MI 
           Type 1           Type 2        Unknown 
2. STEMI vs. NSTEMI 
          STEMI           NSTEMI        Unknown 
3. Troponin levels 
             Troponin T ______________ Troponin I _________________ 
  
  
4. Left Ventricular Ejection Fraction (LVEF) _________________ 
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Appendix L 
Decliner Survey 
1) Age _______ 
2) Gender 
a. Male 
b. Female  
c. Other 
3) Race 
a. Caucasian 
b. African American 
c. Native American 
d. Asian 
e. Pacific Islander 
f. Multiracial 
g. Other 
4) Ethnicity 
a. Hispanic 
b. Non-Hispanic 
 
